Clinical Trials Register

Trials with a EudraCT protocol (73)
Paediatric studies in scope of Art45 of the Paediatric Regulation (3,341)

Query did not match any clinical trials.

These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006).
Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records.

Study title: CLINICAL TRIAL ON PROPHYLAXIS OF FUNGAL INFECTIONS WITH FLCZ OR AMPH IN PATIENTS UNDERGOING BMT

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27868

Study title: CLINICAL TRIALS OF DIFLUCAN ON CRYPTOCOCCOSIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27499

Study title: CLINICAL TRIALS OF DIFLUCAN ON CRYPTOCOCCOSIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27863

Study title: CLINICAL USEFULNESS FOR SYSTEMIC MYCOSIS ASSOCIATED WITH HEMATOLOGICAL MALIGNANCY

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27506

Study title: OPEN, NON-COMPARATIVE STUDY OF FLUCONAZOLE IN PATS WITH NON-MENINGEAL COCCIDIOIDOMYCOSES PROGRESSIVE. (ORIGINATED AT CENTRAL RESEARCH, GROTON UNDER STUDY NO.056-160

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27698

Study title: OPEN, NON-COMPARATIVE STUDY OF FLUCONAZOLE IN PATS WITH NON-MENINGEAL COCCIDIOIDOMYCOSES PROGRESSIVE. (ORIGINATED AT CENTRAL RESEARCH, GROTON UNDER STUDY NO.056-160

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 28060

Study title: OPEN, NON-COMPARATIVE, MULTICENTER STUDY ON THE EFFICACY AND SAFETY OF FLUCONAZOLE EMULGEL 1% IN THE TREATMENT OF DERMATOMYCOSES WITH LOCALIZED LESIONS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27472

Study title: OPEN, NON-COMPARATIVE, MULTICENTER STUDY ON THE EFFICACY AND SAFETY OF FLUCONAZOLE EMULGEL 1% IN THE TREATMENT OF DERMATOMYCOSES WITH LOCALIZED LESIONS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27836

Study title: OPEN,NON-COMPARATIVE STUDY OF INTRAVENOUS AND ORAL FLUCONAZOLE IN THE TREATMENT OF ACUTE CRYPTOCOCCAL MENINGITIS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27351

Study title: OPEN,NON-COMPARATIVE STUDY OF INTRAVENOUS AND ORAL FLUCONAZOLE IN THE TREATMENT OF ACUTE CRYPTOCOCCAL MENINGITIS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27717

Study title: ORAL CANDIDOSIS IN PATIENTS WITH DIABETES MELLITUS THE EFFECT OF FLUCONAZOLE VS. NYSTATIN THERAPY.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27672

Study title: ORAL CANDIDOSIS IN PATIENTS WITH DIABETES MELLITUS THE EFFECT OF FLUCONAZOLE VS. NYSTATIN THERAPY.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 28034

Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS ASSOCIATED WITH BRAIN MALIGNANCY OR CEREBROVASCULAR DISEASES

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27525

Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS ASSOCIATED WITH BRAIN MALIGNANCY OR CEREBROVASCULAR DISEASES

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27889

Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS ASSOCIATED WITH DIGESTIVE ORGAN MALIGNANCY

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27511

Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS ASSOCIATED WITH DIGESTIVE ORGAN MALIGNANCY

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27515

Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS ASSOCIATED WITH DIGESTIVE ORGAN MALIGNANCY

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27875

Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS ASSOCIATED WITH DIGESTIVE ORGAN MALIGNANCY

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27879

Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS ASSOCIATED WITH GYNECOLOGICAL MALIGNANCY

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27514

Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS ASSOCIATED WITH GYNECOLOGICAL MALIGNANCY

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27523

Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS ASSOCIATED WITH GYNECOLOGICAL MALIGNANCY

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27531

Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS ASSOCIATED WITH GYNECOLOGICAL MALIGNANCY

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27878

Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS ASSOCIATED WITH GYNECOLOGICAL MALIGNANCY

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27887

Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS ASSOCIATED WITH GYNECOLOGICAL MALIGNANCY

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27895

Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS IN HOSPITALIZED PATIENT ON IVH.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27521

Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS IN HOSPITALIZED PATIENT ON IVH.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27885

Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS IN HOSPITALIZED PATIENTS IN ICU.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27513

Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS IN HOSPITALIZED PATIENTS IN ICU.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27517

Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS IN HOSPITALIZED PATIENTS IN ICU.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27881

Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS IN HOSPITALIZED PATIENTS ON IVH

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27519

Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS IN HOSPITALIZED PATIENTS ON IVH

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27528

Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS IN HOSPITALIZED PATIENTS ON IVH

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27883

Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS IN HOSPITALIZED PATIENTS ON IVH

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27884

Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS IN HOSPITALIZED PATIENTS ON IVH

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27892

Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS IN HOSPITALIZED PATIENTS ON IVH IN THE FIELD OF UROLOGY

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27526

Study title: CLINICAL USEFULNESS OF DIFLUCAN FOR SYSTEMIC MYCOSIS IN HOSPITALIZED PATIENTS ON IVH IN THE FIELD OF UROLOGY

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27890

Study title: DIFLUCAN THERAPY OR PROPHYLAXIS FOR FUNGAL INFECTIONS ASSOCIATED WITH RENAL TRANSPLANTATION.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27866

Study title: DOSE-FINDING CLINICAL STUDY OF FLUCONAZOLE (UK-49, 858) IN CUTANEOUS MYCOSIS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27535

Study title: DOSE-FINDING CLINICAL STUDY OF FLUCONAZOLE (UK-49, 858) IN CUTANEOUS MYCOSIS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27899

Study title: DOUBLE - BLIND CLINIC PHASE 3 STUDY OF FLUCONAZOLE (UK - 49 858) IN CUTANEOUS MYCISISTINEA CORPORIS/CRURIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27572

Study title: DOUBLE - BLIND CLINIC PHASE 3 STUDY OF FLUCONAZOLE (UK - 49 858) IN CUTANEOUS MYCISISTINEA CORPORIS/CRURIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27936

Study title: PHARMACOKINETIC STUDY OF INJECTABLE AND ORAL FLUCONAZOLE IN PEDIATRIC PATIENTS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27365

Study title: PHARMACOKINETIC STUDY OF INJECTABLE AND ORAL FLUCONAZOLE IN PEDIATRIC PATIENTS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27730

Study title: PHARMACOKINETICS OF A SINGLE ORAL DOSE OF FCA ADMINISTERED TO NORMAL VOLUNTEERS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27496

Study title: PHARMACOKINETICS OF A SINGLE ORAL DOSE OF FCA ADMINISTERED TO NORMAL VOLUNTEERS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27860

Study title: PHASE 3 CLINCIAL STUDY OF FLUCONAZOLE IN OROPHARYNGEAL CANDIDIASIS IN ACQUIRED IMMUNO-DEFICIENCY SYNDROME (AIDS) PATIENTS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27568

Study title: PHASE 3 CLINCIAL STUDY OF FLUCONAZOLE IN OROPHARYNGEAL CANDIDIASIS IN ACQUIRED IMMUNO-DEFICIENCY SYNDROME (AIDS) PATIENTS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27932

Study title: PHASE 3 CLINICAL STUDY OF FLUCONAZOLE FOR MAINTENANCE THERAPY FOR SUPRESSION OF ITS RELASPE IN CRYPTOCOCCAL MENINGITIS WITH AIDS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27567

Study title: Comparison of Cefprozil and Erythromycin in the Treatment of Children with Acute Group A Streptococcal Tonsillopharyngitis.

Active substance: CEFPROZIL

Study summary document link (including results): Protocol ai414-140 Cefprozil.pdf

View full study record

Document reference: 23564

Study title: Efficacy and safety of cefsulodin in the treatment of acute, severe Pseudomonas aeruginosa infections of different localisations.

Active substance: CEFSULODIN

Study summary document link (including results): Cefsulodin_European_synopsis_en.pdf

View full study record

Document reference: 47591

Study title: Efficacy and safety of cefsulodin in the treatment of infections of different localisations.

Active substance: CEFSULODIN

Study summary document link (including results): Cefsulodin_Modai_synopsis_en.pdf

View full study record

Document reference: 47593

Study title: A comparative, two-centre randomised study of the safety, tolerance and efficacy of CAZ/ARG and CAZ/NA in children aged one month to 16 years, with serious or moderately serious bacterial infections and with no evidence of underlying chronic renal or hepatic impairment

Active substance: CEFTAZIDIME

Study summary document link (including results): Study CART04 Ceftazidime.xls

View full study record

Document reference: 23584

Study title: Comparison of immunogenicity of combined DTP inactivated injectable polio vaccine (DTP-IPV) and association of DTP and attenuated oral polio vaccine (DTP+OPV) in Pakistani children

Active substance: Diphtheria, Tetanus and Pertussis Vaccine (Adsorbed)

Study summary document link (including results):

View full study record

Document reference: 41000

Study title: Evaluation of a new combined DTP-Polio vaccine

Active substance: Diphtheria, Tetanus and Pertussis Vaccine (Adsorbed)

Study summary document link (including results):

View full study record

Document reference: 40999

Study title: LATE PHASE 2 CLINICAL DOSE-FINDING STUDY OF ORAL FLUCONAZOLE IN VAGINAL CANDIDIASIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27934

Study title: MANAGEMENT OF FUNGAL INFECTIONS DURING THE REMISSION PERIOD OF LEUKEMIC PATIENTS; COMPARISON OF DIFLUCAN WITH AMPHOTERICIN B

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27488

Study title: MANAGEMENT OF FUNGAL INFECTIONS DURING THE REMISSION PERIOD OF LEUKEMIC PATIENTS; COMPARISON OF DIFLUCAN WITH AMPHOTERICIN B

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27852

Study title: MULTI-CENTER COMPARISON OF FLUCONAZOLE (UK-49,858) AND AMPHOTERICIN B AS TREATMENT FOR ACUTE CRYPTOCOCCAL MENINGITIS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27346

Study title: MULTI-CENTER COMPARISON OF FLUCONAZOLE (UK-49,858) AND AMPHOTERICIN B AS TREATMENT FOR ACUTE CRYPTOCOCCAL MENINGITIS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27712

Study title: MULTI-CENTER DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF FLUCONAZOLE IN THE EARLY EMPIRICAL TREATMENT OF SUSPECTED FUNGAL INFECTIONS IN FEBRILE NEUTROPENIC PATIENTS UNDERGOING THERAPY FOR CANCER

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27694

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 28056

Study title: EFFICACY AND SAFETY OF FLUCONAZOLE IN OROPHARYNGIAL AND/OR OESOPHAGEAL CANDIDIASIS IN NEUTROPENIC PATIENTS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 28012

Study title: EFFICACY AND SAFETY OF FLUCONAZOLE IN PATIENTS WITH OROPHARINGEAL CANDIDIASIS WITHOUT AIDS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27769

Study title: EFFICACY AND SAFETY OF FLUCONAZOLE IN THE TREATMENT OF FUNGAL INFECTIONS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27661

Study title: The use of chlorhexidine in the management of gingivitis in childrenDe La Rosa 1988

Active substance: CHLORHEXIDINE

Study summary document link (including results): 1988-de la rosa-the use of chlorhexidine in the management of gingivitis in children.pdf

View full study record

Document reference: 48174

Study title: VIALATEL C. Rapport d'expertise clinique. Février 1977

Active substance: CHLORHEXIDINE

Study summary document link (including results):

View full study record

Document reference: 23888

Study title: H.Scholz et al., Prospective comparison of ceftriaxone and cefotaxime for the short-term treatment of bacterial meningitis in children, Chemotherapy, 1998;44:142-147H.Scholz et al., Prospective comparison of ceftriaxone and cefotaxime for the short-term treatment of bacterial meningitis in children, Chemotherapy, 1998;44:142-147

Active substance: CEFOTAXIME

Study summary document link (including results):

View full study record

Document reference: 23486

Study title: Hsieh-Shong Leu, R.Lasserre, Ceftriaxone Once daily compared with four daily doses of cefotaxime in the treatement of severe gram-negative septicemia or pyemia:a randomized study, Chang Gung Med.J., 1995, 18/1 (36-42)Hsieh-Shong Leu, R.Lasserre, Ceftriaxone Once daily compared with four daily doses of cefotaxime in the treatement of severe gram-negative septicemia or pyemia:a randomized study, Chang Gung Med.J., 1995, 18/1 (36-42)

Active substance: CEFOTAXIME

Study summary document link (including results):

View full study record

Document reference: 23487

Study title: Impact of cefotaxime on the fecal flora in children - Lambert - Zechovsky N., Bingen E., Aujard Y., Mathieu H. - 1985 (Infection; 13: S 140-4)Impact of cefotaxime on the fecal flora in children - Lambert - Zechovsky N., Bingen E., Aujard Y., Mathieu H. - 1985 (Infection; 13: S 140-4)

Active substance: CEFOTAXIME

Study summary document link (including results):

View full study record

Document reference: 23488

Study title: Infections in childrenInfections in children (Study 37 in BGA file) - Pr. Dr. Marget - No date (München, Germany)

Active substance: CEFOTAXIME

Study summary document link (including results): Cefotaxime STUDY 9.3.22 (Study 37- infections in children).xls

View full study record

Document reference: 23489

Study title: Infections in childrenInfections in children (Study 39 in BGA file) - Dr Grinstein - No date (Buenos Aires, Argentina)

Active substance: CEFOTAXIME

Study summary document link (including results): Cefotaxime STUDY 9.3.24 (Study 39- infections in children).xls

View full study record

Document reference: 23490

Study title: Infections in dialysis unit (sepsis)(Study 20)

Active substance: CEFOTAXIME

Study summary document link (including results): Cefotaxime STUDY 9.3.6 (Study 20- infections in dialysis unit).xls

View full study record

Document reference: 47982

Study title: AN OPEN MULTICENTER COMPARATIVE STUDY OF THE EFFICACY AND SAFETY AND TOLERATION OF ONCE WEEKLY ORAL FCA 150MG OR TOPICAL CLOTRIMAZOLE IN THE TREATMENT OF PATIENTS WITH TINEA CORPORIS, CRURIS AND PEDIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27998

Study title: AN OPEN MULTICENTER COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF ONCE WEEKLY ORAL FCA OR TOPICAL CLOTRIMAZOLE OF PATIENTS WITH TINEA CORPORIS, CRURIS OR PEDIS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27678

Study title: AN OPEN MULTICENTER COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF ONCE WEEKLY ORAL FCA OR TOPICAL CLOTRIMAZOLE OF PATIENTS WITH TINEA CORPORIS, CRURIS OR PEDIS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 28040

Study title: AN OPEN MULTICENTER COMPARATIVE STUDY OF THE EFFICACY SAFETY AND TOLERATION OF FLUCONAZOLE ORAL SUSPENSION OR NYSTATIN ORAL SUSPENSION IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS IN PATIENTS WITH MALIGNANCY.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27616

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27978

Study title: Ruddy, J., Proops, D. W., Pearman, K., and Ruddy, H. Department of ENT Surgery, Birmingham Children's Hospital, U.K Management of epistaxis in children Int.J.Pediatr.Otorhinolaryngol. 1991;21:139-142.

Active substance: CHLORHEXIDINE_AND_NEOMYCIN

Study summary document link (including results):

View full study record

Document reference: 23935

Study title: A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF FLUCONAZOLE IN THE PREVENTION OF FUNGAL INFECTIONS IN PATIENTS UNDERGOING ORTHOTOPIC LIVER TRANSPLANTATION

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27696

Study title: A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF FLUCONAZOLE IN THE PREVENTION OF FUNGAL INFECTIONS IN PATIENTS UNDERGOING ORTHOTOPIC LIVER TRANSPLANTATION

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 28058

Study title: A DOUBLE-BLIND, MULTICENTER AND PARALLEL COMPARISON OF THE EFFICACY, SAFETY AND TOLERATION OF FCA SINGLE DOSE THERAPY ADMINISTERED ORALLY TO TERCONAZOLE SEVEN DAYS OF ADMINISTERED INTRAVAGINALLY IN THE TREATMENT OF VULVOVAGINAL CANDIDIASIS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27391

Study title: AN OPEN COMPARATIVE STUDY OF ORAL FCA VS STANDARD ORAL ANTIFUNGAL FOR PROPHYLAXIS AND TREATMENT OF PRESUMPTIVE FUNGAL INFECTION IN PATIENTS UNDER-GOING BONE MARROW TRANSPLANTATION AND CHEMOTHERAPY FOR ACUTE LEUKEMIA/LYMPHOMA

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27966

Study title: NON-COMPARATIVE OPEN STUDY OF THE EFFICACY OF SULBACTAM/AMPICILLIN/SULTAMICILLIN IN THE TREATMENT OF MODERATE TO SEVERE BACTERIAL INFECTIONS IN GYNECOLOGY.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42948

Study title: NONCOMPARATIVE, OPEN STUDY OF THE EFFICACY OF SULBACTAM/AMPICILLIN AND SULTAMICILLIN IN THE TREATMENT OF SEPTIC ABORTION AND AMNIONITIS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42947

Study title: OPEN COMPARATIVE STUDY OF STM VS CEFACLOR IN THE TREATMENT OF ACUTE OTITIS MEDIA

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42969

Study title: OPEN MULTICENTER COMPARATIVE RANDOMIZED STUDY OF S/A,STM VS. CLINDAMYCIN/GENTAMICIN IN THE TREATMENT OF SEVERE GYNECOLOGICAL INFECTIONS

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42949

Study title: TO ASSESS THE EFFICACY AND SAFETY OF SULTAMICILLIN VS. AUGMENTIN IN PEDIATRIC PATIENTS WITH LOWER RESPIRATORY TRACT INFECTION.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42999

Study title: TO ASSESS THE EFFICACY AND TOLERATION OF SULTAMICILLIN IN THE TREATMENT OF PATIENTS WITH BACTERIAL INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43010

Study title: TO ASSESS THE EFFICACY AND TOLERATION OF SULTAMICILLIN IN THE TREATMENT OF PATIENTS WITH BACTERIAL INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43016

Study title: TO COMPARE STM TO CURRENT STANDARD THERAPEUTIC AGENT, PENICILLIN, FOR THE TREATMENT OF STREPTO PHARYM. GITS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43017

Study title: TO DETERMINE THE EFFICACY AND SAFETY OF STM VS JOSAMYCIN IN THE TREATMENT OF ACUTE TONSILLITIS, PHARYNGITIS .

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42992

Study title: TO DETERMINE THE SAFETY AND EFFICACY OF ORAL SULTAMICILLIN (50MG/KG) VS. CEFACLOR (40MG/KG) IN PEDIATRIC PATIENTS WITH ACUTE OTITIS MEDIA.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43023

Study title: AN OPEN MULTICENTER NON-COMPARATIVE STUDY OF THE EFFICACY, SAFETY AND TOLERATION OF FLUCONAZOLE IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27609

Study title: AN OPEN MULTICENTER NON-COMPARATIVE STUDY OF THE EFFICACY, SAFETY AND TOLERATION OF FLUCONAZOLE IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27971

Study title: AN OPEN MULTICENTER STUDY COMPARING INTRAVENOUS FLUCONAZOLE WITH INTRAVENOUS AMPHOTERICIN B IN THE MANAGEMENT OF NEUTROPENIC PATIENTS WITH HEMATOLOGICAL MALIGNANCIES WHO HAVE FEBRILE EPISODES UNRESPONSIVE TO BROAD SPECTRUM ANTIBIOTICS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27362

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27724

Study title: AN OPEN MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF ONCE WEEKLY ORAL FCA 150MG IN THE TREATMENT OF PATIENTS WITH TINEA CORPORIS OR CRURIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27680

Study title: AN OPEN MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF ONCE WEEKLY ORAL FCA 150MG IN THE TREATMENT OF PATIENTS WITH TINEA CORPORIS OR CRURIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 28042

Study title: AN OPEN MULTICENTER TRIAL OF FLUCONAZOLE ORAL SUSPENSION IN THE TREATMENT OF ESOPHAGEAL CANDIDIASIS IN IMMUNOCOMPROMISED PATIENTS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27699

Study title: AN OPEN MULTICENTER TRIAL OF FLUCONAZOLE ORAL SUSPENSION IN THE TREATMENT OF ESOPHAGEAL CANDIDIASIS IN IMMUNOCOMPROMISED PATIENTS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 28061

Study title: AN OPEN NON COMPARATIVE STUDY ON THE EFFICACY AND SAFETY OF FLUCONAZOLE 150 MG (1 CAPSULE) SINGLE DOSE IN THE VAGINAL CANDIDIASIS TREATMENT.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27584

Study title: CEFUROXIME AXETIL VS COTRIMOXAZOLO NEL TRATTTAMENTO DELLE INFEZIONI DELLE BASSE VIE RESPIRATORIE IN PAZIENTI PEDIATRICI.

Active substance: CEFUROXIME

Study summary document link (including results): Study CAET23 Cefuroxime Axetil.xls

View full study record

Document reference: 47728

Study title: Cefuroxime serum and middle ear effusion concentrations in children with otitis media

Active substance: CEFUROXIME

Study summary document link (including results): Study CAE-418 Cefuroxime Axetil (Suspension).xls

View full study record

Document reference: 47722

Study title: SPERIMENTAZIONE MULTICENTRICA DELL' ACETOSSIETIL CEFUROXIMA SOSPENSIONE NEL TRATTAMENTO DELLE INFEZIONI IN PAZIENTI PEDIATRICI.

Active substance: CEFUROXIME

Study summary document link (including results): Study VCL-89-013 CAET20 Cefuroxime axetil.xls

View full study record

Document reference: 47733

Study title: The efficacy of cefuroxime in the treatment of bacterial meningitis in infants and children

Active substance: CEFUROXIME

Study summary document link (including results): Study RID-CT-05 Cefuroxime Sodium.xls

View full study record

Document reference: 48334

Study title: To assess the combination of a cephalosporin and an amino glycoside antibiotic in children with cancer who develop a fever from presumed bacterial sepsis while neutropenic and presumed bacterial sepsis.

Active substance: CEFUROXIME

Study summary document link (including results): Study RID-CT-22 Cefuroxime sodium.xls

View full study record

Document reference: 48335

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27756

Study title: A DOUBLE-BLIND, MULTICENTER STUDY TO COMPARE THE SAFETY AND EFFICACY OF TWO SHORT COURSE DOSAGE REGIMENS OF FCA IN THE TREATMENT OF PATIENTS WITH ONYCHOMYCOSIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27613

Study title: A DOUBLE-BLIND, MULTICENTER STUDY TO COMPARE THE SAFETY AND EFFICACY OF TWO SHORT COURSE DOSAGE REGIMENS OF FCA IN THE TREATMENT OF PATIENTS WITH ONYCHOMYCOSIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27975

Study title: A MULTICENTER DOUBLE BLIND COMPARATIVE STUDY OF THE EFFICACY SAFETY AND TOLERATION OF FCA 150MG/WEEK VS. 50MG/DAY IN THE TREATMENT OF PATIENTS WITH TINEA CORPORIS, CRURIS AND PEDIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27607

Study title: A MULTICENTER DOUBLE BLIND COMPARATIVE STUDY OF THE EFFICACY SAFETY AND TOLERATION OF FCA 150MG/WEEK VS. 50MG/DAY IN THE TREATMENT OF PATIENTS WITH TINEA CORPORIS, CRURIS AND PEDIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27969

Study title: A MULTICENTER NONCOMPARATIVE STUDY OF THE EFFICACY AND TOLERABILITY OF ORAL SUSPENSION IN THE TREATMENT OF T. CORPORIS AND T. CAPITIS IN PEDIATRIC PT.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27467

Study title: A MULTICENTER NONCOMPARATIVE STUDY OF THE EFFICACY AND TOLERABILITY OF ORAL SUSPENSION IN THE TREATMENT OF T. CORPORIS AND T. CAPITIS IN PEDIATRIC PT.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27831

Study title: A MULTICENTER, DOUBLE-BLIND, COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF FCA 150MG/WEEK VS. KETOCONAZOLE 200MG/DAY. IN THE TREATMENT OF PATIENTS WITH TINEA CORPORIS, CRURIS OR PEDIS OR CUTANEOUS CANDIDIASIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27610

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27972

Study title: A MULTICENTER, OPEN, NON-COMPARATIVE STUDY ON THE EFFICACY AND TOLERABILITY OF FCA 150 MG ONCE WEEKLY, IN THE TREATMENT OF PATIENTS WITH TINEA CORPORIS, CRURIS AND PEDIS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27622

Study title: OPEN MULTICENTER STUDY OF SULBACTAM/AMPICILLIN (UNACYN) INJECTABLE FOLLOWED BY ORAL SULTAMICILLIN IN URINARY TRACT INFECTIONS

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42950

Study title: OPEN NON-COMPARATIVE STUDY ON THE EFFICACY AND SAFETY OF STM IN THE TREATMENT OF ACUTE RESPIRATORY INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43034

Study title: OPEN NON-COMPARATIVE STUDY ON THE EFFICACY AND SAFETY OF STM IN THE TREATMENT OF ACUTE RESPIRATORY INFECTIONS

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43035

Study title: OPEN, NON-COMPARATIVE STUDY OF EFFICACY AND SAFETY OF STM IN THE TREATMENT OF ACUTE RESPIRATORY INFECTIONS IN CHILDREN

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43033

Study title: OPEN, NON-COMPARATIVE STUDY TO ASSESS THE EFFICACY AND TOLERATION OF UNASYN IV/17 (AMPICILLIN, SULBACTAM) AND UNASYN TABLETS (SULTAMICILLIN) IN THE TREATMENT OF GYNECOLOGICAL INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42952

Study title: TO DETERMINE THE SAFETY AND EFFICACY OF ORAL SULTAMICILLIN 25 MG/KG IN COMPARISON TO AMOXYCILLIN 20 MG/KG IN PEDIATRIC PATIENTS WITH MILD TO MODERATE URTI.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43021

Study title: TO DETERMINE THE SAFETY AND EFFICACY OF ORAL SULTAMICILLIN 25 MG/KG IN PEDIATRIC PATIENTS WITH MILD TO MODERATE UPPER RESPIRATORY TRACT INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42970

Study title: TO DETERMINE THE SAFETY AND EFFICACY OF ORAL SULTAMICILLIN IN PEDIATRIC PATIENTS TREATED IN GENERAL PRACTICE FOR ACUTE UPPER RESPIRATORY TRACT AND/OR SKIN AND SOFT TISSUE INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43025

Study title: To study the efficacy, safety and tolerance of cefuroxime in the treatment of infections in neonates and children and to assess this activity both bacteriologically and clinically.

Active substance: CEFUROXIME

Study summary document link (including results): Study Stamboulian Cefuroxime Sodium.xls

View full study record

Document reference: 48336

Study title: EFFICACY OF CLINDAMYCIN VAGINAL OVULE (3-DAY TREATMENT) VS. CLINDAMYCIN VAGINAL CREAM (7-DAY TREATMENT) IN BACTERIAL VAGINOSIS

Active substance: CELECOXIB

Study summary document link (including results): M11140001 EMA Pediatrics Web Synopsis.pdf

View full study record

Document reference: 23631

Study title: EVALUATION OF TWO DOSE REGIMENS OF CLEOCIN HCL CAPSULES IN COMPARISON WITH DICLOXACILLIN IN THE TREATMENT OF MILD TO MODERATE SKIN AND SOFT TISSUE INFECTIONS

Active substance: CELECOXIB

Study summary document link (including results): M11200241 EMA Pediatrics Web Synopsis.pdf

View full study record

Document reference: 23630

Study title: AN OPEN COMPARATIVE STUDY OF THE EFFICACY, SAFETY AND TOLERATION OF ORAL FLUCONAZOLE VERSUS A STANDARD ORAL POLYENE REGIMEN IN PROPHYLAXIS OF FUNGAL COLONIZATION AND INFECTION IN PATIENTS UNDERGOING BONE MARROW TRANSPLANTATION OR HIGH-DOSE MELPHS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27360

Study title: AN OPEN COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF FCA VS. KETOCONAZOLE IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS IN PEDIATRIC PATIENTS WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27600

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27963

Study title: AN OPEN COMPARATIVE TRIAL OF FLUCONAZOLE VS. AMPHOTERICIN B IN THE TREATMENT OF LIFE-THREATENING DEEP MYCOSES

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27662

Study title: AN OPEN COMPARATIVE TRIAL OF FLUCONAZOLE VS. AMPHOTERICIN B IN THE TREATMENT OF LIFE-THREATENING DEEP MYCOSES

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 28024

Study title: AN OPEN EVALUATION MULTICENTER STUDY ON THE EFFICACY, SAFETY AND TOLERATION OF DIFLUCAN (FCA) IN THE TREATMENT OF PATIENTS WITH CRYPTOCOCCOSIS, SYSTEMIC AND MUCOSAL CANDIDIASIS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27633

Study title: AN OPEN EVALUATION MULTICENTER STUDY ON THE EFFICACY, SAFETY AND TOLERATION OF DIFLUCAN (FCA) IN THE TREATMENT OF PATIENTS WITH CRYPTOCOCCOSIS, SYSTEMIC AND MUCOSAL CANDIDIASIS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27995

Study title: AN OPEN LABEL, MULTICENTER TRIAL OF DIFLUCAN (FLUCONAZOLE) FOR 6 WEEKS GIVEN ONCE DAILY TO PEDIATRIC PATIENTS WITH TINEA CAPITIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27729

Study title: AN OPEN MULTI-CENTER STUDY OF THE EFFICACY AND SAFETY OF ONCE WEEKLY ORAL FCA 150MG IN THE TREATMENT OF PATIENTS WITH TINEA CORPORIS OR CRURIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27679

Study title: AN OPEN MULTI-CENTER STUDY OF THE EFFICACY AND SAFETY OF ONCE WEEKLY ORAL FCA 150MG IN THE TREATMENT OF PATIENTS WITH TINEA CORPORIS OR CRURIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 28041

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27417

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27636

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27782

Study title: Fucithalmic in acute conjunctivitis. Open, randomized comparison of fusidic acid, chloramphenicol and framycetin eye drops. Dirdal M. Acta Ophthalmol (Copenh). 1987 Apr;65(2):129-33. Fucithalmic in acute conjunctivitis. Open, randomized comparison of fusidic acid, chloramphenicol and framycetin eye drops. Dirdal M. Acta Ophthalmol (Copenh). 1987 Apr;65(2):129-33.

Active substance: CHLORAMPHENICOL_ CHLORAMPHENICOL +CORTISONE ACETATE +ETHACRIDINE LACTATE +ZINC OXIDE / CHLORAMPHENICOL AND MEDROXYPROGESTERONE AND TETRYZOLINE

Study summary document link (including results): Fuscidic acid in acute conjunctivitis.pdf

View full study record

Document reference: 23862

Study title: Effect of the CYP3A4 inhibitor erythromycin on the pharmacokinetics of lignocaine and its pharmacologically active metabolites in subjects with normal and impaired liver function. Orlando R, Piccoli P, De Martin S, Padrini R, Palatini P. Br J Clin Pharmacol. 2003 Jan;55(1):86-93Effect of the CYP3A4 inhibitor erythromycin on the pharmacokinetics of lignocaine and its pharmacologically active metabolites in subjects with normal and impaired liver function. Orlando R, Piccoli P, De Martin S, Padrini R, Palatini P. Br J Clin Pharmacol. 2003 Jan;55(1):86-93

Active substance: CHLORHEXIDINE AND LIDOCAINE

Study summary document link (including results):

View full study record

Document reference: 23917

Study title: TO DETERMINE THE SAFETY AND EFFICACY OF ORAL SULTAMICILLIN IN PEDIATRIC PATIENTS WITH UPPER AND LOWER RESPIRATORY TRACT INFECTIONS S.S.T. AND U.T. INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42993

Study title: AN OPEN NON-COMPARATIVE STUDY OF EFFICACY AND SAFETY OF SINGLE DOSE OF ORAL FLUCONAZOLE 150MG CAP IN THE TREATMENT OF VAGINAL CANDIDIASIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27989

Study title: AN OPEN NON-COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF ORAL FLUCONAZOLE 150MG IN THE TREATMENT OF TINEA CORPORIS, CRURIS OR PEDIS OR CUTANEOUS CANDIDIASIS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27630

Study title: AN OPEN NON-COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF ORAL FLUCONAZOLE 150MG IN THE TREATMENT OF TINEA CORPORIS, CRURIS OR PEDIS OR CUTANEOUS CANDIDIASIS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27992

Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF FLUCONAZOLE IN THE TREATMENT OF IMMUNOCOMPROMISED PATIENTS WITH OROPHARYNGEAL CANDIDIASIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27372

Study title: A THREE ARM RANDOMIZED STUDY COMPARING INTRAVENOUS LIPOSOMAL AMPHOTERICIN, ORAL FLUCONAZOLE AND FLUCONAZOLE PLACEBO AS PROPHYLACTIC ANTIFUNGAL AGENTS AFTER BONE MARROW TRANSPLANTATION.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 28032

Study title: AETIOLOGY OF ONYCHOMYCOSIS IN EGYPT, A MULTICENTER EPIDEMIOLOGIC STUDY.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27447

Study title: Wahle D, Beste DJ, Conley SF. Laryngeal involvement in toxic epidermal necrolysis. Otoryngology-Head and Neck Surgery 1992; 107(6):796-799.Wahle D, Beste DJ, Conley SF. Laryngeal involvement in toxic epidermal necrolysis. Otoryngology-Head and Neck Surgery 1992; 107(6):796-799.

Active substance: CHLOROQUINE AND PROGUANIL

Study summary document link (including results):

View full study record

Document reference: 23975

Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF FLUCONAZOLE IN THE TREATMENT OF IMMUNOCOMPROMISED PATIENTS WITH OROPHARYNGEAL CANDIDIASIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27737

Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF IV AND/OR PO O.S. FLUCONAZOLE IN THE TREATMENT OF PEDIATRIC PATIENTS WITH SYSTEMIC CANDIDIASIS. THIS IS A COMPASSIONATE TREATMENT.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27739

Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF IV FCA IN THE TREATMENT OF CANDIDIASIS IN THE LEUKEMIC PATIENTS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27577

Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL FLUCONAZOLE IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS IN IMMUNOCOMPROMISED PATIENTS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27628

Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL FLUCONAZOLE IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS IN IMMUNOCOMPROMISED PATIENTS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27629

Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL FLUCONAZOLE IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS IN IMMUNOCOMPROMISED PATIENTS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27990

Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL FLUCONAZOLE IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS IN IMMUNOCOMPROMISED PATIENTS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27991

Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL FLUCONAZOLE IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27442

Study title: AETIOLOGY OF ONYCHOMYCOSIS IN EGYPT, A MULTICENTER EPIDEMIOLOGIC STUDY.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27811

Study title: AN OPEN 3 PERIOD CROSS-OVER STUDY IN NORMAL ADULT MALE VOLUNTEERS TO COMPARE THE PHARMACOKINETICS OF A SINGLE DOSE OF FLUCONAZOLE ADMINISTERED ORALLY AS CAPSULE AND PEDIATRIC ELIXIR AND INTRAVENOUSLY AS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27357

Study title: AN OPEN COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL FLUCONAZOLE VS. ORAL POLYENES IN THE PREVENTION OF CANDIDIASIS IN CHILDREN WITH HEMATOLOGIC OR ONCOLOGIC MALIGNANCIES UNDERGOING REMISSION INDUCTION CHEMOTHERAPY.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27597

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27960

Study title: AN OPEN COMPARATIVE MULTICENTER STUDY OF FLUCONAZOLE VERSUS AMPHOTERICIN B IN THE TREATMENT OF LIFE THREATENING SYSTEMIC CANDIDA INFECTIONS IN PEDIATRIC PATIENTS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27356

Study title: AN OPEN COMPARATIVE MULTICENTER STUDY OF FLUCONAZOLE VERSUS AMPHOTERICIN B IN THE TREATMENT OF LIFE THREATENING SYSTEMIC CANDIDA INFECTIONS IN PEDIATRIC PATIENTS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27722

Study title: AN OPEN COMPARATIVE RANDOMIZED PARALLEL STUDY OF THE SAFETY AND EFFICACY OF ORAL FCA CAP VS. NYSTATIN SUSPENSION IN THE PREVENTION OF CANDIDIASIS OF PATIENTS UNDERGOING BONE MARROW TRANSPLANTATION.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27385

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27750

Study title: AN OPEN COMPARATIVE RANDOMIZED STUDY ON THE EFFICACY AND SAFETY OF FCA VS AMPHOTERICIN B IN FUNGAL INFECTIONS,CONCOMITANTLY TO ANTIBIOTIC THERAPY WITH CEFOPERAZONE+AMIKACIN VS IMIPENEM IN CHILDREN WITH LEUKEMIA/LYMPHOMA, FEVER & GRAMULOCITOPEMIA

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27384

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27749

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27604

Study title: OPEN, NONCOMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF SULTAMICILLIN PO IN CHILDREN WITH MILD TO MODERATE UPPER RESPIRATORY INFECTIONS

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42968

Study title: ORAL SULTAMICILLIN IN THE TREATMENT OF UPPER RESPIRATORY TRACT PEDIATRIC INFECTIONS

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42980

Study title: SAFETY AND EFFICACY OF ORAL SULTAMICILLIN IN PEDIATRIC PATIENTS WITH URTI.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43036

Study title: Aldress K et al. Candida meningitis in children: Report of two cases. J Chemother. September 5, 2000, 339-44

Active substance: FLUCOCYTOSIN

Study summary document link (including results):

View full study record

Document reference: 27321

Study title: Ancotil (Flucytosin) als Kombinationspartner in der antimykotischen Therapie tiefsitzender Mykosen - Anwndngsbeobachtung nach §§49, 67 AMG, Statistischer Bericht Teilkolektiv Hämatol-onkol. Pat., 2001

Active substance: FLUCOCYTOSIN

Study summary document link (including results):

View full study record

Document reference: 27333

Study title: Baley J, Meyers C, Kliegman R, Jacobs M, Blumer J. Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonates. J Pediatrics 1990; 116 (no. 5): 791-97

Active substance: FLUCOCYTOSIN

Study summary document link (including results):

View full study record

Document reference: 27332

Study title: Bennett JE et al. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptoccal meningitis. N Engl J Med. 1979 Jul 19;301(3):126-31

Active substance: FLUCOCYTOSIN

Study summary document link (including results):

View full study record

Document reference: 27309

Study title: Berg RA, Stein JM. Medical management of fungal suppurative thrombosis of great central veins in a child. Pediatr Infect Dis J. August 15, 1989, 469-70

Active substance: FLUCOCYTOSIN

Study summary document link (including results):

View full study record

Document reference: 27330

Study title: Brady MT. Management of children with human immunodeficiency virus infection. Comp Ther. May 4, 1995, 139-147

Active substance: FLUCOCYTOSIN

Study summary document link (including results):

View full study record

Document reference: 27328

Study title: Cherrick I, Kveselis DA, Baesl TJ. Medical management of Candida-infected thrombosis in a pediatric oncology patient. Pediatr Infect Dis J. May 30, 1995, 398-400

Active substance: FLUCOCYTOSIN

Study summary document link (including results):

View full study record

Document reference: 27327

Study title: Chotmongkol V, Sukeepaisarncharoen W, Thavornpitak Y. Comparison of amphotericin B, flucytosine and itraconazole with amphotericin B and flucytosine in the treatment of cryptococcal meningitis in AIDS. J Med Assoc Thai. 1997 Jul;80(7):416-25

Active substance: FLUCOCYTOSIN

Study summary document link (including results):

View full study record

Document reference: 27301

Study title: Dismukes WE et al. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. N Engl J Med. 1987 Aug 6;317(6):334-41

Active substance: FLUCOCYTOSIN

Study summary document link (including results):

View full study record

Document reference: 27305

Study title: Filioti J.; Spiroglou K.; Roilides E. Invasive candidiasis in pediatric intensive care patients: Epidemiology, risk factors, management, and outcome. Intensive Care Med. July 1, 2007, 1272-83

Active substance: FLUCOCYTOSIN

Study summary document link (including results):

View full study record

Document reference: 27312

Study title: VIII national congress of SIUP (Italian Society of Pediatric Urology) Messina -Taormina 8-10 June 1992 (in English)

Active substance: CEFTIBUTEN

Study summary document link (including results):

View full study record

Document reference: 23590

Study title: A Comparative Study of Single-Dose Intramuscular (IM) Ceftriaxone and a 10-day Oral (PO) Course of Amoxicillin for the Treatment of Acute Otitis Media in Infants and Children

Active substance: CEFTRIAXONE

Study summary document link (including results):

View full study record

Document reference: 23623

Study title: A Comparative Study of Single-Dose Intramuscular (IM) Ceftriaxone and a 10-day Oral (PO) Course of Cefaclor for the Treatment of Uncomplicated Acute Otitis Media in Infants and Children

Active substance: CEFTRIAXONE

Study summary document link (including results):

View full study record

Document reference: 23624

Study title: A Comparative Study of Single-Dose Intramuscular (IM) Ceftriaxone and a 10-Day Oral (PO) Course of Trimethorprim-sulfamethoxazole for the Treatment of Acute Otitis Media in Infants and Children

Active substance: CEFTRIAXONE

Study summary document link (including results):

View full study record

Document reference: 23622

Study title: A Randomised Open Study to Compare ROCEPHIN with a Combination of Azlocillin plus Netilmicin in Neutropenic Children wth Episodes of Infection (ISN 10401).

Active substance: CEFTRIAXONE

Study summary document link (including results):

View full study record

Document reference: 23620

Study title: An Open Study of ROCEPHIN in the Treatment of Neutropenic Children with Episodes of Infection.

Active substance: CEFTRIAXONE

Study summary document link (including results):

View full study record

Document reference: 23621

Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF ORAL FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27823

Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF ORAL FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27997

Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF ORAL FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 28002

Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF ORAL FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 28007

Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY OF THE TOLERANCE AND EFFICACY OF A WEEKLY SINGLE 150MG DOSE OF ORAL FLUCONAZOLE IN THE TREATMENT OF PATIENTS WITH TINEA PEDIS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27582

Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY OF THE TOLERANCE AND EFFICACY OF A WEEKLY SINGLE 150MG DOSE OF ORAL FLUCONAZOLE IN THE TREATMENT OF PATIENTS WITH TINEA PEDIS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27945

Study title: AN OPEN NON-COMPARATIVE PILOT STUDY OF THE SAFETY AND EFFICACY OF ONE OR TWO ORAL DOSES (150 MG) OF FCA IN ORAL CANDIDIASIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27390

Study title: AN OPEN NON-COMPARATIVE PILOT STUDY OF THE SAFETY AND EFFICACY OF ONE OR TWO ORAL DOSES (150 MG) OF FCA IN ORAL CANDIDIASIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27755

Study title: AN OPEN NON-COMPARATIVE STUDY FOR THE EVALUATION OF FLUCONAZOLE IN EMPIRIC FUNGAL TREATMENT IN FEBRILE GRANULOCYTOPENIC CANCER PATIENT.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27448

Study title: AN OPEN NON-COMPARATIVE STUDY FOR THE EVALUATION OF FLUCONAZOLE IN EMPIRIC FUNGAL TREATMENT IN FEBRILE GRANULOCYTOPENIC CANCER PATIENT.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27812

Study title: AN OPEN NON-COMPARATIVE STUDY IN THE EFFICACY AND SAFETY OF ORAL FLUCONAZOLE IN THE TREATMENT OF TINEA CORPORIS, CRURIS OR PEDIS OR CUTANEOUS CANDIDIASIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27626

Study title: AN OPEN NON-COMPARATIVE STUDY IN THE EFFICACY AND SAFETY OF ORAL FLUCONAZOLE IN THE TREATMENT OF TINEA CORPORIS, CRURIS OR PEDIS OR CUTANEOUS CANDIDIASIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27988

Study title: AN OPEN NON-COMPARATIVE STUDY OF EFFICACY AND SAFETY OF ORAL FLUCONAZOLE 150MG IN THE TREATMENT OF TINEA CORPORIS CRURIS OR CUTANEOUS CANDIDIASIS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27625

Study title: AN OPEN NON-COMPARATIVE STUDY OF EFFICACY AND SAFETY OF ORAL FLUCONAZOLE 150MG IN THE TREATMENT OF TINEA CORPORIS CRURIS OR CUTANEOUS CANDIDIASIS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27987

Study title: CEFTRIAXONE (CRO) VERSUS STANDARD TREATMENT IN CHILDREN WITH BACTERIAL MENINGITIS (BM). A PROSPECTIVE, COMPARATIVE, RANDOMIZED STUDY. Results from H. Peltola, M. D., M. Anttila, M. D., D.-V. Renkonen, M. D., J. Ellmen, M. S.C. and the Finnish Study Group. 24.03.1988

Active substance: CEFTRIAXONE

Study summary document link (including results):

View full study record

Document reference: 23608

Study title: Ceftriaxone versus Penicillin+Chloramphenicol in the treatment of Bacterial Meningitis in Children. Results from Dr. E. Rosen, Baragwanath Hospital, South Africa. 22.04.1986

Active substance: CEFTRIAXONE

Study summary document link (including results):

View full study record

Document reference: 23604

Study title: Ceftriaxone versus standard treatment (ampicillin in combination with chloramphenicol) in pediatric patients suffering from purulent meningitis. An open prospective randomized comparative study. Results of Prof. J. L. Ngu, Dr. T. J. Youmbissi, Centre Universitaire des Sciences de la Sante, Yaounde, Cameroun. 07.04.1986

Active substance: CEFTRIAXONE

Study summary document link (including results):

View full study record

Document reference: 23603

Study title: Ceftriaxone vs Ampicillin (AMP) + Chloramphenicol (CAP) in the Treatment of Purulent Meningitis of Children (Ro 13-9904). 30.11.1993

Active substance: CEFTRIAXONE

Study summary document link (including results):

View full study record

Document reference: 23609

Study title: Comparative study of Rocephin versus cefotaxime in the treatment of purulent meningitis in children. Results from Dr. J. B. de Bary, Hopital Protestant Dabou, Cote d'Ivoire. 03.04.1987

Active substance: CEFTRIAXONE

Study summary document link (including results):

View full study record

Document reference: 23607

Study title: Final Study Report: A Comparative Study of Single-Dose Intramuscular (IM) Ceftriaxone Versus Single-Dose IM Bicillin CR plus Oral Trimethoprim-Sulfamethoxazole for the Treatment of Uncomplicated Acute Otitis Media in Infants and Children (Howie Protocol)

Active substance: CEFTRIAXONE

Study summary document link (including results):

View full study record

Document reference: 23613

Study title: Final Study Report: A Single-Blind Randomized Comparative Study of Single Dose (IM) Ceftriaxone and a Ten-Day Course (PO) of Amoxicillin/Clavulanate Potassium for the Treatment of Acute Otitis Media in Infants and Children [Ident No: NR14545] 14.10.1996

Active substance: CEFTRIAXONE

Study summary document link (including results):

View full study record

Document reference: 23614

Study title: Final Study Report: An Open-Label, Non-Comparative Study Describing the Efficacy and Safety of Rocephin (Ro 13-9904) Administered Once Intramuscularly (50 mg/kg/day: maximum of 1 g/day) in the Treatment of Acute Otitis Media Caused by Streptococcus pneumoniae, Haemophilus influenzae, and/or Moraxella catarrhalis in Infants and Children [Ident No: NR15168] 22.10.1996

Active substance: CEFTRIAXONE

Study summary document link (including results):

View full study record

Document reference: 23612

Study title: Single-dose kanamycin therapy of gonococcal ophthalmia neonatorum. Fransen L, Nsanze H, D'Costa L, Brunham RC, Ronald AR, Piot P. Lancet. 1984 Dec 1;2(8414):1234-7. Single-dose kanamycin therapy of gonococcal ophthalmia neonatorum. Fransen L, Nsanze H, D'Costa L, Brunham RC, Ronald AR, Piot P. Lancet. 1984 Dec 1;2(8414):1234-7.

Active substance: CHLORAMPHENICOL_ CHLORAMPHENICOL +CORTISONE ACETATE +ETHACRIDINE LACTATE +ZINC OXIDE / CHLORAMPHENICOL AND MEDROXYPROGESTERONE AND TETRYZOLINE

Study summary document link (including results): Single-dose kanamycin therapy of gonococcal ophthalmia neona.pdf

View full study record

Document reference: 23859

Study title: AN OPEN NON-COMPARATIVE STUDY OF EFFICACY AND SAFETY OF SINGLE DOSE OF ORAL FLUCONAZOLE 150MG CAP IN THE TREATMENT OF VAGINAL CANDIDIASIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27627

Study title: A RANDOMIZED COMPARATIVE MULTICENTER TRIAL OF FLUCONAZOLE AND KETOCONAZOLE IN THE TREATMENT OF ESOPHAGEAL CANDIDIASIS IN IMMUNOCOMPROMISED PATIENTS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27709

Study title: A RANDOMIZED COMPARATIVE MULTICENTER TRIAL OF FLUCONAZOLE AND AMPHOTERICIN B IN THE TREATMENT OF ESOPHAGEAL CANDIDIASIS IN PATIENTS WITH MALIGNANCIES

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27350

Study title: A RANDOMIZED COMPARATIVE MULTICENTER TRIAL OF FLUCONAZOLE AND AMPHOTERICIN B IN THE TREATMENT OF ESOPHAGEAL CANDIDIASIS IN PATIENTS WITH MALIGNANCIES

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27716

Study title: AN OPEN NON COMPARATIVE STUDY ON THE EFFICACY AND SAFETY OF FLUCONAZOLE 150 MG (1 CAPSULE) SINGLE DOSE IN THE VAGINAL CANDIDIASIS TREATMENT.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27947

Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF ORAL FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27387

Study title: EFFICACY AND SECURITY OF SULTAMICILLIN IN PEDIATRIC PATIENTS WITH SKIN AND SOFT TISSUE INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42965

Study title: EFFICACY OF SULTAMICILLIN IN PATIENTS WITH MODERATE GENERAL INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42962

Study title: Fukushima T et al. Successful treatment of invasive thoracopulmonary mucormycosis in a patient with acute lymphoblastic leukaemia. Cancer. September 8, 1995, 895-9

Active substance: FLUCOCYTOSIN

Study summary document link (including results):

View full study record

Document reference: 27326

Study title: Gaber KA et al. Fungal septicaemia in patients with cystic fibrosis associated with totally implantable venous access device system. Journal of Cystic Fibrosis. September 1, 2007, 317-9

Active substance: FLUCOCYTOSIN

Study summary document link (including results):

View full study record

Document reference: 27310

Study title: Groll AH, Muller F-MC. Advances in prevention and treatment of infectious complications in children and adoloscents with cancer. Klinische Padiatrie. May 28, 1998, 106-14

Active substance: FLUCOCYTOSIN

Study summary document link (including results):

View full study record

Document reference: 27323

Study title: Hofmann H et al. Invasive chromoblastomycosis and sinusitis due to Phialophora verrucosa in a child from northern Africa. Mycoses. November 1, 2005, 456-61

Active substance: FLUCOCYTOSIN

Study summary document link (including results):

View full study record

Document reference: 27313

Study title: Kulkarni S. Infective endocarditis in children. Indian Journal of Practical Pediatrics. Indian J Pract Pediatr. October 1, 2004, 309-15

Active substance: FLUCOCYTOSIN

Study summary document link (including results):

View full study record

Document reference: 27316

Study title: Kurrle E et al. Antimicrobial prophylaxis in acute leukaemia: prospective randomized study comparing two methods of selective decontamination. Klin Wochenschr. 1983 Jul 15;61(14):691-8

Active substance: FLUCOCYTOSIN

Study summary document link (including results):

View full study record

Document reference: 27307

Study title: A RANDOMIZED MULTICENTER STUDY OF THE EFFICACY, SAFETY AND TOLERATION OF FLUCONAZOLE OR CLOTRIMAZOLE TROCHES IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL THRUSH IN ASSOCIATION WITH MALIGNANCY

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27344

Study title: A RANDOMIZED MULTICENTER STUDY OF THE EFFICACY, SAFETY AND TOLERATION OF FLUCONAZOLE OR CLOTRIMAZOLE TROCHES IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS IN ASSOCIATION WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27352

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27710

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27718

Study title: A RANDOMIZED, DOUBLE-BLIND COMPARATIVE MULTICENTER STUDY OF FLUCONAZOLE PLUS AMPHOTERICIN B VERSUS FLUCONAZOLE PLUS PLACEBO IN THE TREATMENT OF CANDIDEMIA AND ITS CONSEQUENCES IN NON-NEUTROPENIC PATIENTS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27702

Study title: A RANDOMIZED, DOUBLE-BLIND MULTICENTER STUDY OF THE ASSESSMENT OF CLINICAL EFFICACY AND SYSTEMIC SAFETY OF FCA 50MG AND 100MG CAP VS. ITRACONAZOLE 100MG CAP IN TREATMENT OF DERMATOMYCOSIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27468

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27832

Study title: A RANDOMIZED, THIRD PARTY BLIND, MULTICENTER TRIAL COMPARING THE EFFICACY AND SAFETY OF DIFLUCAN (FLUCONAZOLE) FOR 3 WEEKS VERSUS DIFLUCAN FOR 6 WEEKS VERSUS GRIFULVIN V (GRISEOFULVIN) FOR 6 WEEKS GIVEN ONCE DAILY TO PEDIATRIC PATIENTS WITH TINEA CAPITIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27727

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27728

Study title: A THREE ARM RANDOMIZED STUDY COMPARING INTRAVENOUS LIPOSOMAL AMPHOTERICIN, ORAL FLUCONAZOLE AND FLUCONAZOLE PLACEBO AS PROPHYLACTIC ANTIFUNGAL AGENTS AFTER BONE MARROW TRANSPLANTATION.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27670

Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF ORAL FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27411

Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF ORAL FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27413

Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF ORAL FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27414

Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF ORAL FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27415

Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF ORAL FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27459

Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF ORAL FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27635

Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF ORAL FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27640

Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF ORAL FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27645

Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF ORAL FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27752

Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF ORAL FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27776

Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF ORAL FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27778

Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF ORAL FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27779

Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY OF THE SAFETY AND EFFICACY OF ORAL FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27780

Study title: SAFETY AND EFFICACY OF S/A, STM IN MODERATE TO SEVERE OSTEOMYELITIS EITHER ACUTE OR PERSISTENT.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42956

Study title: SAFETY AND EFFICACY OF SULBACTAM/AMPICILLIN FOLLOWED BY SULTAMICILLIN IN CHILDREN WITH MODERATE TO SEVERE INFECTIONS

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42953

Study title: STM IN THE TREATMENT OF PEDIATRIC INFECTIONS OF THE UPPER RESPIRATORY TRACT.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42978

Study title: STM IN URINARY TRACT INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42979

Study title: SULTAMICILLIN (UNASYN) IN MILD AND MODERATE RESPIRATORY TRACT INFECTIONS

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42977

Study title: Lehrnbecher T et al. Antifungal usage in children undergoing intensive treatment for acute myeloid leukemia: analysis of the multicenter clinical trial AML-BFM 93. Eur J Clin Microbiol Infect Dis. 2007 Oct;26(10):735-8

Active substance: FLUCOCYTOSIN

Study summary document link (including results):

View full study record

Document reference: 27297

Study title: Lehrnbecher T, Groll AH, Chanock SJ. Treatment of fungal infections in neutropenic children. Curr Opin Pediatr. March 2, 1999, 47-55

Active substance: FLUCOCYTOSIN

Study summary document link (including results):

View full study record

Document reference: 27322

Study title: Link H et al. Interventional antimicrobial therapy in febrile neutropenic patients. Study Group of the Paul Ehrlich Society for Chemotherapy. Ann Hematol. 1994 Nov;69(5):231-43

Active substance: FLUCOCYTOSIN

Study summary document link (including results):

View full study record

Document reference: 27302

Study title: Mavinkurve-Groothuis AMC et al. Cryptococcal meningitis in a child with acute lymphoblastic leukaemia. Pediatr Infect Dis J. June 1, 2003, 576

Active substance: FLUCOCYTOSIN

Study summary document link (including results):

View full study record

Document reference: 27319

Study title: Mirdha BR, Sarkar T. Concurrent cryptococcal meningitis and falciparum malaria in a child with nephrotic syndrome. Indian Pediatr. April 1, 1998, 360-3

Active substance: FLUCOCYTOSIN

Study summary document link (including results):

View full study record

Document reference: 27324

Study title: Mobacken H et al. Transfer factor in the treatment of chronic mucocutaneous candidiasis: a controlled study. Acta Derm Venereol. 1980;60(1):51-5

Active substance: FLUCOCYTOSIN

Study summary document link (including results):

View full study record

Document reference: 27308

Study title: Pasqualotto AC et al. Flucytosine therapeutic monitoring: 15 years experience from the UK J Antimicrob Chemother. April 1, 2007, 791-3

Active substance: FLUCOCYTOSIN

Study summary document link (including results):

View full study record

Document reference: 27311

Study title: Pediatric AIDS and HIV Infection. Treatment trials open to pregnant women, children, and adolescents: Part III: Opportunistic infections and other HIV-related symptomatology. May 31, 1994, 126-54

Active substance: FLUCOCYTOSIN

Study summary document link (including results):

View full study record

Document reference: 27329

Study title: Ridola V et al. Candida Infections in Children Treated with Conventional Chemotherapy for Solid Tumors (Transplant Recipients Excluded): The Institut Gustave Roussy Pediatrics Department Experience. Pediatr Blood Cancer. April 1, 2004, 332-7

Active substance: FLUCOCYTOSIN

Study summary document link (including results):

View full study record

Document reference: 27317

Study title: Schaefer F et al. Management of peritonitis in children receiving chronic peritoneal dialysis. Paediatr Drugs. June 11, 2003, 315-25

Active substance: FLUCOCYTOSIN

Study summary document link (including results):

View full study record

Document reference: 27320

Study title: Schwartz S et al. Poor efficacy of amphotericin B-based therapy in CNS aspergillosis.Mycoses. 2007 May;50(3):196-200

Active substance: FLUCOCYTOSIN

Study summary document link (including results):

View full study record

Document reference: 27298

Study title: Schwarze R, Seebacher C, Blaschke-Hellmessen R. Candida infections in infants and children. Z Arztl Fortbild Qual Sich. April 1, 1998, 163-8

Active substance: FLUCOCYTOSIN

Study summary document link (including results):

View full study record

Document reference: 27325

Study title: Serra G, Mezzano P, Bonacci W. Therapeutic treatment of systemic candidiasis in newborns. J Chemother. 1991 Jan;3 Suppl 1:240-4

Active substance: FLUCOCYTOSIN

Study summary document link (including results):

View full study record

Document reference: 27304

Study title: Silling G et al. Early empiric antifungal therapy of infections in neutropenic patients comparing fluconazole with amphotericin B/flucytosine. Mycoses. 1999;42 Suppl 2:101-4

Active substance: FLUCOCYTOSIN

Study summary document link (including results):

View full study record

Document reference: 27300

Study title: Final Study Report: Clinical and Statistical: Ro 13-9904/ /Once daily ceftriaxone plus amikacin compared to three times daily ceftazidime plus amikacin in the treatment of febrile neutropenic children with cancer. 22.11.1994

Active substance: CEFTRIAXONE

Study summary document link (including results):

View full study record

Document reference: 23611

Study title: Germano G*,Bergamini N: ROCEPHIN versus ampicillin + chloramphenicol in the treatment of bacterial meningitis in children. Prof. D. Stamboulian, Argentina, Centre No. 18.1569. 24.06.1986

Active substance: CEFTRIAXONE

Study summary document link (including results):

View full study record

Document reference: 23605

Study title: Kissling M: Rocephin tretment of severe pediatric infections including meningitis. An open, non comparative multicentre trial in 232 patients including neonates, infants and young children. 24.08.1983

Active substance: CEFTRIAXONE

Study summary document link (including results):

View full study record

Document reference: 23626

Study title: Kurzzeitbehandlung der eitrigen Meningitis - Vergleich zwischen Ceftriaxon und Cefotaxim

Active substance: CEFTRIAXONE

Study summary document link (including results):

View full study record

Document reference: 23625

Study title: Once-A-Day Administration of Ceftriaxone in Pediatric Meningitis16.11.1994

Active substance: CEFTRIAXONE

Study summary document link (including results):

View full study record

Document reference: 23610

Study title: Efficacy and safety of topical ciprofloxacin/dexamethasone versus neomycin/polymyxin B/hydrocortisone for otitis externa. Roland PS, Pien FD, Schultz CC, Henry DC, Conroy PJ, Wall GM, Garadi R, Dupre SJ, Potts SL, Hogg LG, Stroman DW; Ciprodex Otic AOE Study Group. Curr Med Res Opin. 2004 Aug;20(8):1175-83.Efficacy and safety of topical ciprofloxacin/dexamethasone versus neomycin/polymyxin B/hydrocortisone for otitis externa. Roland PS, Pien FD, Schultz CC, Henry DC, Conroy PJ, Wall GM, Garadi R, Dupre SJ, Potts SL, Hogg LG, Stroman DW; Ciprodex Otic AOE Study Group. Curr Med Res Opin. 2004 Aug;20(8):1175-83.

Active substance: CIPROFLOXACIN

Study summary document link (including results):

View full study record

Document reference: 24248

Study title: A PILOT STUDY OF FLUCONAZOLE PLUS FLUCYTOSINE FOR THE TREATMENT OF AIDS PATIENTS WITH ACUTE CRYPTOCOCCAL MENINGITIS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27697

Study title: A PILOT STUDY OF FLUCONAZOLE PLUS FLUCYTOSINE FOR THE TREATMENT OF AIDS PATIENTS WITH ACUTE CRYPTOCOCCAL MENINGITIS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 28059

Study title: A PROSPECTIVE COMPARATIVE MULTICENTER TRIAL COMPARING FLUCONAZOLE WITH AMPHOTERICIN B FOR ANTIFUNGAL PROPHYLAXIS IN LIVER TRANSPLANT RECIPIENTS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27671

Study title: A PROSPECTIVE COMPARATIVE MULTICENTER TRIAL COMPARING FLUCONAZOLE WITH AMPHOTERICIN B FOR ANTIFUNGAL PROPHYLAXIS IN LIVER TRANSPLANT RECIPIENTS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 28033

Study title: A PROSPECTIVE RANDOMIZED TRIAL OF FCA VS. AMPHOTERICIN B FOR EMPERIC ANTI-FUNGAL THERAPY OF THE NEUTROPENIC FEBRILE PATIENTS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27624

Study title: A PROSPECTIVE SURVEY OF OPPORTUNISTIC INFECTIONS IN PATIENTS RECEIVING CHEMOTHERAPY FOR ACUTE LEUKEMIAS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27479

Study title: A PROSPECTIVE SURVEY OF OPPORTUNISTIC INFECTIONS IN PATIENTS RECEIVING CHEMOTHERAPY FOR ACUTE LEUKEMIAS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27480

Study title: SULTAMICILLIN IN MILD AND MODERATE INFECTIONS IN ADULTS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43047

Study title: A PROSPECTIVE SURVEY OF OPPORTUNISTIC INFECTIONS IN PATIENTS RECEIVING CHEMOTHERAPY FOR ACUTE LEUKEMIAS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27482

Study title: A PROSPECTIVE SURVEY OF OPPORTUNISTIC INFECTIONS IN PATIENTS RECEIVING CHEMOTHERAPY FOR ACUTE LEUKEMIAS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27843

Study title: A PROSPECTIVE SURVEY OF OPPORTUNISTIC INFECTIONS IN PATIENTS RECEIVING CHEMOTHERAPY FOR ACUTE LEUKEMIAS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27844

Study title: A PROSPECTIVE SURVEY OF OPPORTUNISTIC INFECTIONS IN PATIENTS RECEIVING CHEMOTHERAPY FOR ACUTE LEUKEMIAS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27845

Study title: SULTAMICILLIN IN MILD TO MODERATE INFECTIONS IN PEDIATRICS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43046

Study title: SULTAMICILLIN PHARMOKINETIC AND THERAPEUTIC TRIAL IN ACUTE SINUSITIS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42916

Study title: SULTAMICILLIN VERSUS AMOXICILLIN IN THE TREATMENT OF ACUTE OTITIS MEDIA IN CHILDREN.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42921

Study title: SULTAMICILLIN VS AMOXICILLIN IN THE TREATMENT OF ACUTE OTITIS MEDIA IN CHILDREN.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42922

Study title: Penetration of Ceftriaxone into the Middle Ear Fluid of Children with Access Established Through Insertion of Tympanostomy Tubes [Ident No: MK102/OE] 25.10.1996

Active substance: CEFTRIAXONE

Study summary document link (including results):

View full study record

Document reference: 23615

Study title: Prospective, randomized, open, comparative study of a five day treatment with ROCEPHIN versus a 3 week course with chloramphenicol in children with acute enteric fever.

Active substance: CEFTRIAXONE

Study summary document link (including results):

View full study record

Document reference: 23602

Study title: Prospective, randomized, open, comparative study of a six day treatment with ROCEPHIN versus a 14 day course with chloramphenicol in children with acute enteric fever. Dr. E. Welch, M. D., Santiago/ Chile, Centre RCH 1717. 13.09.1985

Active substance: CEFTRIAXONE

Study summary document link (including results):

View full study record

Document reference: 23601

Study title: Rocephin (ceftriaxone) in the parenteral therapy of bacterial meningitis in infants and children. 31.01.1984

Active substance: CEFTRIAXONE

Study summary document link (including results):

View full study record

Document reference: 23596

Study title: Rocephin (ceftriaxone) in the parenteral therapy of bacterial meningitis in infants and children. 31.01.1984

Active substance: CEFTRIAXONE

Study summary document link (including results):

View full study record

Document reference: 23598

Study title: Rocephin (ceftriaxone) in the parenteral therapy of serious miscellaneous infections in children. 31.01.1984

Active substance: CEFTRIAXONE

Study summary document link (including results):

View full study record

Document reference: 23599

Study title: Rocephin tretment of severe pediatric infections including meningitis. An open, non comparative multicentre trial in 232 patients including neonates, infants and young children. 24.08.1983

Active substance: CEFTRIAXONE

Study summary document link (including results):

View full study record

Document reference: 23593

Study title: Rocephin versus chloramphenicol in children suffering from typhoid fever. Dr. Eduardo Welch, M.D., Santiago, Chile, centre No. 21.1717, cases Nos. 201-222. 25.05.1984

Active substance: CEFTRIAXONE

Study summary document link (including results):

View full study record

Document reference: 23600

Study title: Rocephin versus chloramphenicol in children suffering from typhoid fever. Dr. Eduardo Welch, Santiago, Chile, centre No. 21.1717. Cases Nos. 1-21, 101-102, 111. 10.01.1984

Active substance: CEFTRIAXONE

Study summary document link (including results):

View full study record

Document reference: 23595

Study title: ROCEPHIN versus chloramphenicol in the treatment of typhoid and paratyphoid fever in paediatric patients. Results from Dr. E. Welch, Hospital P. Jaraquemada, Santiago (Chile). 30.10.1986

Active substance: CEFTRIAXONE

Study summary document link (including results):

View full study record

Document reference: 23606

Study title: Single dose pharmacokinetics and penetration into the CSF of ceftriaxone in pediatric patients. 31.01.1983

Active substance: CEFTRIAXONE

Study summary document link (including results):

View full study record

Document reference: 23592

Study title: Single-blind, Randomized Study Assessing the Efficacy and Safety of a Single Intramuscular Dose of 500 mg of Ceftriaxone, Compared With a Ten Day Oral Course of 750 mg of Penicillin V, in the Treatment of Streptococcal Pharyngitis in Children [Ident No: NR14544B./A] 28.01.1997

Active substance: CEFTRIAXONE

Study summary document link (including results):

View full study record

Document reference: 23616

Study title: Single-blind, Randomized Study Assessing the Efficacy and Safety of a Single Intramuscular Dose of 500 mg of Ceftriaxone, Compared With a Single Intramuscular Dose of Benzathine Penicillin G, in the Treatment of Streptococcal Pharyngitis in Children [Ident No: NR14690B./A] 28.01.1997

Active substance: CEFTRIAXONE

Study summary document link (including results):

View full study record

Document reference: 23617

Study title: absorption of chlorhexidine from the intact skin of newborn infantsCowen 1979

Active substance: CHLORHEXIDINE

Study summary document link (including results): 1979-cowen-absorption of chlorhexidine from the intact skin of newborn infants.pdf

View full study record

Document reference: 48171

Study title: BENQUE E. Report of Expert clinical trial. April 1977.

Active substance: CHLORHEXIDINE

Study summary document link (including results):

View full study record

Document reference: 23884

Study title: BENQUE E.P.;CADENAT H.;FABERT G.;CLOUET M. Rapport d'expertise clinique. Octobre 1976.

Active substance: CHLORHEXIDINE

Study summary document link (including results):

View full study record

Document reference: 23886

Study title: CADENAT P.; FABIE D.; BARTHELEMY D. Utilisation d'un bain de bouche à actions antiseptique et antalgique. Inf. dent., 1970, 46, 4333-4337.

Active substance: CHLORHEXIDINE

Study summary document link (including results):

View full study record

Document reference: 23881

Study title: COMMISSIONAT Y.Clinical Appraisal. October 1976

Active substance: CHLORHEXIDINE

Study summary document link (including results):

View full study record

Document reference: 23889

Study title: DHOBLE V., PHADKE M.A. Role du Chl. De buclizine pour favoriser le gain de poids chez les enfants INDIAN PRACTITIONER MAR-1981. 34(3):147-149.

Active substance: CHLORHEXIDINE

Study summary document link (including results):

View full study record

Document reference: 23887

Study title: Effect of chlorexidine on dental plaque and gingivitis in mentally retarded childrenBay LM, Russel BG, 1975

Active substance: CHLORHEXIDINE

Study summary document link (including results): 1975-bay-effect of chlorhexidine on dentalplaque and gingivitis in mentally retarded children.pdf

View full study record

Document reference: 48170

Study title: Effects on supervised chlorhexidine mouth rinses in childrenLang 1982

Active substance: CHLORHEXIDINE

Study summary document link (including results): 1982-lang-effects on supervised chlorhexidine mouthrinses in children .pdf

View full study record

Document reference: 48172

Study title: FABIE M.;BARTHELEMY R. Clinical Study of a locally active solution. Rev. Odonto-stomatol. Midi Fr., 1969, 4, 267-273.

Active substance: CHLORHEXIDINE

Study summary document link (including results):

View full study record

Document reference: 23882

Study title: FIERE P.;BRYON P.A.;GUYON J.M. Study and tests for protection of the buccal mucosa during chemotherapy of hemopathies by a mouthwash containing chlorhexidine. Lyon Méditerrannée Medical, 1971, 18, 3-7.

Active substance: CHLORHEXIDINE

Study summary document link (including results):

View full study record

Document reference: 23883

Study title: FRANCHEBOIS P., SOUYRIS A. Clinical expert report. March 1970

Active substance: CHLORHEXIDINE

Study summary document link (including results):

View full study record

Document reference: 23894

Study title: LAUDENBACH L. Report of expert clinical trial. November 1976.

Active substance: CHLORHEXIDINE

Study summary document link (including results):

View full study record

Document reference: 23892

Study title: LESTRADET H.;DANON J. Clinical Apraisal Report. October 1978.

Active substance: CHLORHEXIDINE

Study summary document link (including results):

View full study record

Document reference: 23890

Study title: A PROSPECTIVE SURVEY OF OPPORTUNISTIC INFECTIONS IN PATIENTS RECEIVING CHEMOTHERAPY FOR ACUTE LEUKEMIAS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27846

Study title: A RANDOMIZED COMPARATIVE MULTICENTER TRIAL OF FLUCONAZOLE AND KETOCONAZOLE IN THE TREATMENT OF ESOPHAGEAL CANDIDIASIS IN IMMUNOCOMPROMISED PATIENTS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27343

Study title: Haustete: Report on a clinical trial (1963)

Active substance: CETRIMIDE AND LIDOCAINE

Study summary document link (including results):

View full study record

Document reference: 23849

Study title:

Active substance: CETYLPYRIDINIUM AND LIDOCAINE

Study summary document link (including results):

View full study record

Document reference: 23855

Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL FLUCONAZOLE IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27443

Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL FLUCONAZOLE IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27444

Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL FLUCONAZOLE IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27806

Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL FLUCONAZOLE IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27807

Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL FLUCONAZOLE IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL CANDIDIASIS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27808

Study title: EFFICACY OF SULTAMICILLIN IN UTI.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43011

Study title: MULTICENTER TRIAL WITH UNASYN (R) POWDER FOR ORAL SUSPENSION IN CHILDREN WITH OTITIS MEDIA.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42961

Study title: NON-COMPARATIVE MULTICENTER STUDY OF THE EFFICACY OF ORAL SULTAMICILLIN FOR THE TREATMENT OF MILD-MODERATE PEDIATRIC INFECTIONS

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42963

Study title: Smith H, Congdon P. Neonatal systemic candidiasis. Arch Dis Child. 1985; 60: 365-369.36. Johnson D, Thompson T, Green T, Ferrieri P. Systemic candidiasis in very low birthweight infants. Pediatrics 1984: 73; 138-143

Active substance: FLUCOCYTOSIN

Study summary document link (including results):

View full study record

Document reference: 27331

Study title: Stamm AM et al. Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis. Am J Med. 1987 Aug;83(2):236-42

Active substance: FLUCOCYTOSIN

Study summary document link (including results):

View full study record

Document reference: 27306

Study title: Steinbach WJ et al. A meta-analysis of medical versus surgical therapy for Candida endocarditis. J Infect. October 1, 2005, 230-47

Active substance: FLUCOCYTOSIN

Study summary document link (including results):

View full study record

Document reference: 27314

Study title: Veltri MA. Drug Dosing during Intermittent Hemodialysis and Continuous Renal Replacement Therapy: Special Considerations in Pediatric Patients. Paediatr Drugs. March 24, 2004, 45-65

Active substance: FLUCOCYTOSIN

Study summary document link (including results):

View full study record

Document reference: 27318

Study title: Yao Z, Liao W, Wen H. Antifungal therapy for treatment of cryptococcal meningitis.Chin Med J (Engl). 2000 Feb;113(2):178-80

Active substance: FLUCOCYTOSIN

Study summary document link (including results):

View full study record

Document reference: 27299

Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL AND IV FCA IN THE TREATMENT OF PATIENTS WITH SYSTEMIC CANDIDIASIS OR CRYPTOCOCCAL MENINGITIS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27579

Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL AND IV FCA IN THE TREATMENT OF PATIENTS WITH SYSTEMIC CANDIDIASIS OR CRYPTOCOCCAL MENINGITIS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27942

Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL AND IV FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL AND SYSTEMIC CANDIDIASIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27573

Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL AND IV FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL AND SYSTEMIC CANDIDIASIS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27574

Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL AND IV FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL AND SYSTEMIC CANDIDIASIS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27575

Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL AND IV FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL AND SYSTEMIC CANDIDIASIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27937

Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL AND IV FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL AND SYSTEMIC CANDIDIASIS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27938

Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL AND IV FCA IN THE TREATMENT OF PATIENTS WITH OROPHARYNGEAL AND SYSTEMIC CANDIDIASIS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27939

Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL AND IV FLUCONAZOLE IN THE TREATMENT OF PATIENTS WITH DEEP CANDIDIASIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27388

Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL AND IV FLUCONAZOLE IN THE TREATMENT OF PATIENTS WITH DEEP CANDIDIASIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27753

Study title: A MULTICENTER, OPEN, NON-COMPARATIVE STUDY ON THE EFFICACY AND TOLERABILITY OF FCA 150 MG ONCE WEEKLY, IN THE TREATMENT OF PATIENTS WITH TINEA CORPORIS, CRURIS AND PEDIS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27984

Study title: A MULTICENTRE STUDY OF THE EFFICACY AND LOCAL AND SYSTEMIC SAFETY WITH COMBINATION TCN 28% NAIL SOL. PLUS ORAL FCN 50MG CAP VS ORAL FLUCONAZOLE 50 MG IN TREATMENT OF ONYCHOMYCOSIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27465

Study title: A MULTICENTRE STUDY OF THE EFFICACY AND LOCAL AND SYSTEMIC SAFETY WITH COMBINATION TCN 28% NAIL SOL. PLUS ORAL FCN 50MG CAP VS ORAL FLUCONAZOLE 50 MG IN TREATMENT OF ONYCHOMYCOSIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27829

Study title: A NON-COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF FCA IN THE TREATMENT OF PATIENTS WITH ONYCHOMYCOSIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27644

Study title: A NON-COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF FCA IN THE TREATMENT OF PATIENTS WITH ONYCHOMYCOSIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 28006

Study title: A NONCOMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL AND INTRAVENOUS FCA IN THE TREATMENT OF PATIENTS WITH SYSTEMIC CANDIDIASIS OR CRYPTOCOCCAL INFECTIONS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27641

Study title: A NONCOMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL AND INTRAVENOUS FCA IN THE TREATMENT OF PATIENTS WITH SYSTEMIC CANDIDIASIS OR CRYPTOCOCCAL INFECTIONS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 28003

Study title: A PHASE IV RANDOMIZED STUDY OF THE USE OF FLUCONAZOLE AS CHRONIC SUPPRESSIVE THERAPY VERSUS EPISODIC THERAPY IN HIV POSITIVE SUBJECTS WITH RECURRENT OROPHARYNGEAL CANDIDIASIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27703

Study title: Yao Z.-R et al. Management of cryptococcosis in non-HIV-related patients. Medical Mycology. May 1, 2005, 245-51

Active substance: FLUCOCYTOSIN

Study summary document link (including results):

View full study record

Document reference: 27315

Study title: A COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF FCA CAPS VS. AMPHOTERICIN B SUSPENSION IN THE PREVENTION OF FUNGAL INFECTIONS IN LEUKAEMIC PATIENTS UNDERGOING REMISSION INDUCTION CHEMOTHERAPY.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27586

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27949

Study title: A COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF FLUCONAZOLE VS. TOPICAL AMPHOTERICIN IN THE TREATMENT OF OROPHARYNGEAL CANDIDIASIS IN PATIENTS UNDERGOING RADIOTHERAPY FOR HEAD AND NECK TUMORS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27669

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 28031

Study title: A COMPARISON OF PROPHYLACTIC EFFICACY OF FLUCONAZOLE AND AMPHOTERICIN B ON FUNGAL INFECTION IN NEUTROPENIC CHILDREN WITH MALIGNANT DISEASE IN COMBINATION WITH SULBACTAM/CEFOPERAZONE.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27487

Study title: A COMPARISON OF PROPHYLACTIC EFFICACY OF FLUCONAZOLE AND AMPHOTERICIN B ON FUNGAL INFECTION IN NEUTROPENIC CHILDREN WITH MALIGNANT DISEASE IN COMBINATION WITH SULBACTAM/CEFOPERAZONE.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27851

Study title: A DOUBLE BLIND COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF GRISEOFULVIN OR FLUCONAZOLE IN THE TREATMENT OF PATIENTS WITH ONYCHOMYCOSIS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27606

Study title: A DOUBLE BLIND COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF GRISEOFULVIN OR FLUCONAZOLE IN THE TREATMENT OF PATIENTS WITH ONYCHOMYCOSIS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27968

Study title: A DOUBLE BLIND PLACEBO AND DIFFERENT DOSAGES CONTROLLED STUDY OF FCA IN THE PREVENTION OF FUNGAL INFECTIONS IN THE HEAD AND NECK CANCER PATIENTS RECEIVING RADIATION THERAPY.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27602

Study title: A DOUBLE BLIND PLACEBO AND DIFFERENT DOSAGES CONTROLLED STUDY OF FCA IN THE PREVENTION OF FUNGAL INFECTIONS IN THE HEAD AND NECK CANCER PATIENTS RECEIVING RADIATION THERAPY.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27965

Study title: Single-dose pharmacokinetics of ceftriaxone in infants and young children. (For publication in Antimicrobial Agents and Chemotherapy) 09.07.1981

Active substance: CEFTRIAXONE

Study summary document link (including results):

View full study record

Document reference: 23618

Study title: Stoeckel K,Schaad B: Single-dose pharmacokinetics of ceftriaxone in infants and young children. (For publication in Antimicrobial Agents and Chemotherapy) 09.07.1981

Active substance: CEFTRIAXONE

Study summary document link (including results):

View full study record

Document reference: 23627

Study title: Treatment of acute gastroenteritis, shigellosis and cholera in adults, children and infants with Rocephin. Open, non-comparative trial. Final study report. 22.09.1981

Active substance: CEFTRIAXONE

Study summary document link (including results):

View full study record

Document reference: 23619

Study title: Treatment of bacterial meningitis with Rocephin in pediatric patients. Results from Dr. V. Prado, Santiago, Chile, centre No. 21.1723, cases 1-24. 16.04.1984

Active substance: CEFTRIAXONE

Study summary document link (including results):

View full study record

Document reference: 23597

Study title: MICHEL G., MOUCHARD J. Study of the safety and efficacy of the proposed formula. International Report. May 1988.

Active substance: CHLORHEXIDINE

Study summary document link (including results):

View full study record

Document reference: 23893

Study title: MUGNIER A. Etude de la tolérance d'Eludril chez l'enfant. Février 1977.

Active substance: CHLORHEXIDINE

Study summary document link (including results):

View full study record

Document reference: 23885

Study title: Oral complications of acute leukemia. prophylactic impact of chlorhexidine mouth rinse regimenMac Gaw 1985

Active substance: CHLORHEXIDINE

Study summary document link (including results): 1985-MacGaw-oral complications of acute leukemia. prophylactic impact of chlorhexidine mouth rinse regimen.pdf

View full study record

Document reference: 48173

Study title: PAQUELIN F. Clinical Appraisal Report. October 1978.

Active substance: CHLORHEXIDINE

Study summary document link (including results):

View full study record

Document reference: 23891

Study title: Expertise clinique Claforan 0,50 g préparation injectable : étudier l'efficacité et la tolérance d'une nouvelle céphalosporine, le RU 756* en milieu pédiatrique - Pr H. Mathieu - 1979Expertise clinique Claforan 0,50 g préparation injectable : étudier l'efficacité et la tolérance d'une nouvelle céphalosporine, le RU 756* en milieu pédiatrique - Pr H. Mathieu - 1979

Active substance: CEFOTAXIME

Study summary document link (including results):

View full study record

Document reference: 23477

Study title: Expertise clinique Claforan 1 g : préparation injectable - Pr. M. Goulon - 1979Expertise clinique Claforan 1 g : préparation injectable - Pr. M. Goulon - 1979

Active substance: CEFOTAXIME

Study summary document link (including results):

View full study record

Document reference: 23478

Study title: Expertise clinique Claforan 1g I.M. préparation injectable solvant: Lidocaine - Pr J. Kermarec - 1979 Expertise clinique Claforan 1g I.M. préparation injectable solvant: Lidocaine - Pr J. Kermarec - 1979

Active substance: CEFOTAXIME

Study summary document link (including results):

View full study record

Document reference: 23480

Study title: Expertise clinique Claforan 1g préparation injectable - Pr Armengaud, Pr Rey, Pr Aubertin, Pr Bertrand - No dateExpertise clinique Claforan 1g préparation injectable - Pr Armengaud, Pr Rey, Pr Aubertin, Pr Bertrand - No date

Active substance: CEFOTAXIME

Study summary document link (including results):

View full study record

Document reference: 23481

Study title: Expertise clinique Claforan 1g: préparation injectable - Pr J. Mottin - 1979Expertise clinique Claforan 1g: préparation injectable - Pr J. Mottin - 1979

Active substance: CEFOTAXIME

Study summary document link (including results):

View full study record

Document reference: 23482

Study title: Failure of cefotaxime treatment in two children with meningitis caused by highly penicillin-resistant Streptococcus pneumoniae, M.Guibert at al., Acta Pediatr, 84:831-3, 1995Failure of cefotaxime treatment in two children with meningitis caused by highly penicillin-resistant Streptococcus pneumoniae, M.Guibert at al., Acta Pediatr, 84:831-3, 1995

Active substance: CEFOTAXIME

Study summary document link (including results):

View full study record

Document reference: 23483

Study title: Friedland IR, Klugman KP. Cerebrospinal fluid bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in children with meningitis treated with high-dosage cefotaxime. Antimicrob Agents Chemother. 1997 Sep;41(9):1888-91.Friedland IR, Klugman KP. Cerebrospinal fluid bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in children with meningitis treated with high-dosage cefotaxime. Antimicrob Agents Chemother. 1997 Sep;41(9):1888-91.

Active substance: CEFOTAXIME

Study summary document link (including results):

View full study record

Document reference: 23484

Study title: Goldwater PN. Effect of cefotaxime or ceftriaxone treatment on nasopharyngeal Haemophilus influenzae type b colonization in children. Antimicrob Agents Chemother. 1995 Sep;39(9):2150-2.Goldwater PN. Effect of cefotaxime or ceftriaxone treatment on nasopharyngeal Haemophilus influenzae type b colonization in children. Antimicrob Agents Chemother. 1995 Sep;39(9):2150-2.

Active substance: CEFOTAXIME

Study summary document link (including results):

View full study record

Document reference: 23485

Study title: Treatment of severe lower respiratory tract infections with Ro 13-9904 in paediatric patients. An open comparative trial versus tobramycin. Prof. M B Canani, Napoli, Italy, centre No. 11.6107, cases Nos. 1-40. 29.09.1983

Active substance: CEFTRIAXONE

Study summary document link (including results):

View full study record

Document reference: 23594

Study title:

Active substance: CEFUROXIME

Study summary document link (including results): Study CAEH13 Cefuroxime Axetil-Zinnat suspension.xls

View full study record

Document reference: 47723

Study title:

Active substance: CEFUROXIME

Study summary document link (including results): Study CAET95 Cefuroxime Axetil (Suspension).xls

View full study record

Document reference: 47732

Study title: A multicentre, randomized, evaluation of taste acceptability and compliance with a ten day course of cefuroxime axetil suspension compared with cefaclor and amoxicillin/clavulanate suspensions in the treatment of otitis media in paediatric patients

Active substance: CEFUROXIME

Study summary document link (including results): Study CAE-221 Cefuroxime Axetil (Suspension).xls

View full study record

Document reference: 23629

Study title: A single blind randomised multicentre study of the comparative efficacy of cefuroxime axetil suspension and penicillin V syrup in the treatment of children with recurrent tonsillitis due to Group A streptococcal infection.

Active substance: CEFUROXIME

Study summary document link (including results): Study CAEM03 Cefuroxime Axetil (Suspension).xls

View full study record

Document reference: 47724

Study title: A study of intravenous cefuroxime followed by cefuroxime axetil suspension in the treatment of paediatric bacterial pneumonia

Active substance: CEFUROXIME

Study summary document link (including results): Study CAEM05 Cefuroxime Axetil (Suspension).xls

View full study record

Document reference: 47725

Study title: An open multicentre study to investigate the efficacy, safety and pharmacokinetics of cefuroxime axetil suspension in children with urinary tract infection.

Active substance: CEFUROXIME

Study summary document link (including results): Study CAEM09 Cefuroxime Axetil (Suspension).xls

View full study record

Document reference: 47726

Study title: CEFUROXIME AXETIL VS AMOXICILLINA - ACIDO CLAVULANICO NEL TRATTAMENTO DELLE INFEZIONI DELLE BASSE VIE RESPIRATORIE IN PAZIENTI PEDIATRICI.

Active substance: CEFUROXIME

Study summary document link (including results): Study CAET26 Cefuroxime Axetil.xls

View full study record

Document reference: 47730

Study title: CEFUROXIME AXETIL VS AMOXICILLINA NEL TRATTAMENTO DELLE INFEZIONI DELLE BASSE VIE RESPIRATORIE IN PAZIENTI PEDIATRICI.

Active substance: CEFUROXIME

Study summary document link (including results): Study CAET25 Cefuroxime Axetil.xls

View full study record

Document reference: 47729

Study title: CEFUROXIME AXETIL VS COTRIMOXAZOLO NEL TRATTAMENTO DELLE INFEZIONI ORL IN PAZIENTI PEDIATRICI.

Active substance: CEFUROXIME

Study summary document link (including results): Study CAET22 Cefuroxime Axetil.xls

View full study record

Document reference: 47727

Study title: A comparison of ciprofloxacin/dexamethasone with neomycin/polymyxin/hydrocortisone for otitis externa pain. Roland PS, Younis R, Wall GM. Adv Ther. 2007 May-Jun;24(3):671-5. A comparison of ciprofloxacin/dexamethasone with neomycin/polymyxin/hydrocortisone for otitis externa pain. Roland PS, Younis R, Wall GM. Adv Ther. 2007 May-Jun;24(3):671-5.

Active substance: CIPROFLOXACIN

Study summary document link (including results):

View full study record

Document reference: 24235

Study title: A DOUBLE-BLIND, DOUBLE-DUMMY, MULTICENTER STUDY TO COMPARE THE EFFICACY, SAFETY AND TOLERABILITY OF CIPROFLOXACIN AS A SUSPENSION VS.CEFTRIAXONE I.M.AS A TREATMENT OF INVASIV DIARRHEA IN EARLY CHILDHOOD. (AMENDMENT NO.1/03.SEPT.96) (AMENDMENT NO.2/29.OCT.97)

Active substance: CIPROFLOXACIN

Study summary document link (including results): Bayer Pharma_Ciprofloxacin_0573_study_synopsis.pdf

View full study record

Document reference: 24207

Study title: A Prospective, Comparative, Randomised Clinical Trial to Evaluate the Use of a Single Dose Ciprofloxacin vs. Rifampicin in the Eradication of Neisseria Meningitidis from Close Contacts of Meningococcal Meningitis Cases

Active substance: CIPROFLOXACIN

Study summary document link (including results): Bayer Pharma_Ciprofloxacin_1258_study_synopsis.pdf

View full study record

Document reference: 24217

Study title: A prospective, controlled, randomized, double-blind, multicentre study comparing the efficacy and safety of ciprofloxacin oral suspension administered for 3 days (short course) versus ciprofloxacin oral suspension administered for 5 days (standard course) in children and juveniles for the treatment of Shigella dysenteriae type one dysentery.

Active substance: CIPROFLOXACIN

Study summary document link (including results): 570.pdf

View full study record

Document reference: 24225

Study title: A PROSPECTIVE, OPEN, SINGLE-CENTER STUDY TO DETERMINE THE SAFETY OF I.V.AND ORAL CIPROFLOXACIN IN THE TREATMENT OF SELECTED PAEDIATRIC INFECTION.(AMENDMENT NO.2/30.JUN.97)

Active substance: CIPROFLOXACIN

Study summary document link (including results): Bayer Pharma_Ciprofloxacin_0575_study_synopsis.pdf

View full study record

Document reference: 24200

Study title: A prospective, randomized study to compare ciprofloxacin (either as oral suspension or as IV or sequential IV oral suspension therapy) versus control regimens (either trimethoprim/ sulfamethoxazole oral suspension, cefixime oral suspension, IV ceftazidime, sequential IV ceftazidime trimethoprim/ sulfamethoxazole oral suspension therapy or sequential IV ceftazidime PO cefixime) in the treatment of pediatric patients with complicated urinary tract infections or pyelonephritis.

Active substance: CIPROFLOXACIN

Study summary document link (including results): Bayer Pharma_Ciprofloxacin_100169_study_synopsis.pdf

View full study record

Document reference: 24204

Study title: An open, non-comparative, pilot study using magnetic resonance imaging (MRI) scans to investigate any arthropathic effects of a 14 day course of ciprofloxacin bd oral tablets on the joints of children with Pseudomonas aeruginosa exacerbations of cystic fibrosis.

Active substance: CIPROFLOXACIN

Study summary document link (including results): Bayer Pharma_Ciprofloxacin_1427_study_synopsis.pdf

View full study record

Document reference: 24208

Study title: AN OPEN, NON-COMPARATIVE, PILOT STUDY USING MAGNETIC RESONANCE IMAGING (MRI) SCANS TO INVESTIGATE ANY ARTHROPATIC EFFECTS OF A 14 DAY COURSE OF CIPROFLOXACIN BD ORAL TABLETS ON THE JOINTS OF CHILDREN WITH PSEUDOMONAS AERUGINOSA EXACERBATION OF CYSTIC FIBROSIS.

Active substance: CIPROFLOXACIN

Study summary document link (including results): Bayer Pharma_Ciprofloxacin_1427_study_synopsis.pdf

View full study record

Document reference: 24216

Study title: WIRKSAMKEIT UND VERTRAEGLICHKEIT VON CIPROFLOXACIN BEI DER BEHANDLUNG VON JUGENDLICHEN PATIENTEN MIT CYSTISCHER FIBROSE, VERURSACHT DURCH GRAMPOSITIVE UND GRAMNEGATIVE BAKTERIEN.

Active substance: CIPROFLOXACIN

Study summary document link (including results): Bayer Pharma_Ciprofloxacin_1131_study_synopsis.pdf

View full study record

Document reference: 24215

Study title: A comparison of ciprofloxacin/dexamethasone with neomycin/polymyxin/hydrocortisone for otitis externa pain. Roland PS, Younis R, Wall GM. Adv Ther. 2007 May-Jun;24(3):671-5. Ear Drops and Otosporin Ear Drops in otitis externa. Bain DJ. J Int Med Res. 1976;4(1):79-81.A comparison of ciprofloxacin/dexamethasone with neomycin/polymyxin/hydrocortisone for otitis externa pain. Roland PS, Younis R, Wall GM. Adv Ther. 2007 May-Jun;24(3):671-5. Ear Drops and Otosporin Ear Drops in otitis externa. Bain DJ. J Int Med Res. 1976;4(1):79-81.

Active substance: CIPROFLOXACIN HYDROCORTIZONE

Study summary document link (including results):

View full study record

Document reference: 24257

Study title: A randomized clinical trial of two topical preparations (framycitin/gramicidin and oxytetracycline/hydrocortisone with polymyxin B) in the treatment of external otitis. Wadsten CJ, Bertilsson CA, Sieradzki H, EdstrÃm S. Arch Otorhinolaryngol. 1985;242(2):135-9. A randomized clinical trial of two topical preparations (framycitin/gramicidin and oxytetracycline/hydrocortisone with polymyxin B) in the treatment of external otitis. Wadsten CJ, Bertilsson CA, Sieradzki H, EdstrÃm S. Arch Otorhinolaryngol. 1985;242(2):135-9.

Active substance: CIPROFLOXACIN HYDROCORTIZONE

Study summary document link (including results):

View full study record

Document reference: 24290

Study title: Comparison of treatment satisfaction and treatment adherence of a novel application form “Dose Sipping Technology” (DST) of oral clarithromycin vs. clarithromycin syrup in children suffering from acute otitis media, tonsillitis, pharyngitis, or acute bacterial bronchitis (DoSe iT)

Active substance: CLARITHROMYCIN

Study summary document link (including results):

View full study record

Document reference: 24303

Study title: Efficacy and Safety of Clarithromycin Suspension in the Treatment of Pediatric Acute Otitis Media

Active substance: CLARITHROMYCIN

Study summary document link (including results): clarithromycin-cl4P01.pdf

View full study record

Document reference: 48062

Study title: Multizentrische Anwendungsbeobachtung mit einer neuen Darreichungsform für Kinder

Active substance: CLARITHROMYCIN

Study summary document link (including results):

View full study record

Document reference: 24302

Study title: PostMarketing Study of NeoClaroSip. Observational Study on a New Pharmaceutical form of Administration in Pediatrics

Active substance: CLARITHROMYCIN

Study summary document link (including results):

View full study record

Document reference: 24301

Study title: “Seeding Neo-Clarosip“ (Survey on the use of Neoclarosip)

Active substance: CLARITHROMYCIN

Study summary document link (including results):

View full study record

Document reference: 24300

Study title: Results of the Sixth International Society of Pediatric Oncology Wilms' Tumor Trial and Study: a risk-adapted therapeutic approach in Wilms' tumor.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25448

Study title: Results of the United Kingdom Children's Cancer Study Group first Wilms' Tumor Study.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25449

Study title: Results of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25450

Study title: Results of treatment of primary metastatic Ewing sarcoma. A retrospective analysis of 48 patients

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25451

Study title: Rhabdomyosarcoma: response with chemotherapy prior to radiation in patients with gross residual disease.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25452

Study title: Role of chemotherapy in the treatment of Wilms' tumor in children

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25453

Study title: Salvage chemotherapy for patients with germ cell tumors. The Memorial Sloan-Kettering Cancer Center experience (1979-1989).

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25454

Study title: Scintigraphic follow-up of osteosarcoma during neoadjuvant chemotherapy. Results of the cooperative osteosarcoma study of the Society for Pediatric Oncology

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25455

Study title: Second malignancies after ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25456

Study title: Second primary rhabdomyosarcoma of bone after osteosarcoma 1

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25457

Study title: Severe hepatic toxicity after treatment with vincristine and dactinomycin using single-dose or divided-dose schedules: a report from the National Wilms' Tumor Study.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25458

Study title: Significance of surgical margin on the prognosis of patients with Ewing's sarcoma. A report from the Cooperative Ewing's Sarcoma Study.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25459

Study title: Single versus multiple dose dactinomycin therapy of Wilms's tumor. A controlled co-operative study conducted by the Children's Cancer Study Group A (formerly Acute Leukemia Co-operative Chemotherapy Group A).

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25460

Study title: Single-dose methotrexate regimen in the treatment of low-risk gestational trophoblastic neoplasia

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25461

Study title: Single-dose versus fractionated-dose dactinomycin in the treatment of Wilms' tumor. Preliminary results of a clinical trial. The Brazilian Wilms' Tumor Study Group.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25462

Study title: Smith-Lemli-Opitz syndrome and other sterol disorders among Finns with developmental disabilities.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25463

Study title: Soft tissue sarcoma or malignant mesenchymal tumors in the first year of life: experience of the International Society of Pediatric Oncology (SIOP) Malignant Mesenchymal Tumor Committee.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25464

Study title: Teratoid Wilms' tumor in a child

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25465

Study title: The CESS 81 cooperative Ewing sarcoma study of the Society for Pediatric Oncology: an interim report

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25466

Study title: The Cooperative Ewing Sarcoma Study CESS 81 of the German Pediatric Oncology Society--analysis after 4 years

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25467

Study title: The effect of a 7-day delay in chemotherapy cycles on complete response and event-free survival in good-risk disseminated germ cell tumor patients.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25468

Study title: Ben Arush MW et al, Bleomycin and cyclophosphamide toxicity simulating metastatic nodules to the lungs in childhood cancer, Pediatr Hematol Oncol. 1997 Jul-Aug;14(4):381-6Ben Arush MW et al, Bleomycin and cyclophosphamide toxicity simulating metastatic nodules to the lungs in childhood cancer, Pediatr Hematol Oncol. 1997 Jul-Aug;14(4):381-6

Active substance: CYCLOPHOSPHAMIDE

Study summary document link (including results):

View full study record

Document reference: 24765

Study title: Bacteriological, pharmacokinetic and clinical evaluations of cefpirome sulfate in the pediatric field - R. Fujii - 1990 (IV B1.10. Infections in pediatry IV B1.10.1.)Bacteriological, pharmacokinetic and clinical evaluations of cefpirome sulfate in the pediatric field - R. Fujii - 1990 (IV B1.10. Infections in pediatry IV B1.10.1.)

Active substance: CEFPIROME

Study summary document link (including results):

View full study record

Document reference: 23507

Study title: The effect of methylperon (Eunerpan) on aggressive and auto-aggressive behaviour in mentally retarded patients--a double blind study (author's transl)a

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25469

Study title: The German Society of Pediatric Oncology Cooperative Ewing Sarcoma Studies CESS 81/86: report after 6 1/2 years

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25470

Study title: The Intergroup Rhabdomyosarcoma Study-I. A final report.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25472

Study title: The Intergroup Rhabdomyosarcoma Study-II.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25473

Study title: Clinical Expert Statement of Framycetin sulfate containing formulations. - Dr R. Boyer - 21 Feb. 2002Clinical Expert Statement of Framycetin sulfate containing formulations. - Dr R. Boyer - 21 Feb. 2002

Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE

Study summary document link (including results):

View full study record

Document reference: 25725

Study title: Gershenson DM et al, Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin, J Clin Oncol. 1990 Apr;8(4):715-20Gershenson DM et al, Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin, J Clin Oncol. 1990 Apr;8(4):715-20

Active substance: CYCLOPHOSPHAMIDE

Study summary document link (including results):

View full study record

Document reference: 24899

Study title: BayQ3939 compared to erythromysin in pediatric cholera

Active substance: CIPROFLOXACIN

Study summary document link (including results): Bayer Pharma_Ciprofloxacin_10110_study_synopsis.pdf

View full study record

Document reference: 24203

Study title: Cipro pediatric observational study.interim analysis/ A prospective, open-label, non-randomized, naturalistic, long-term safety surveillance, observational study of either ciprofloxacin (either as oral suspension, oral tablets or sequential IV oral therapy or purely IV therapy) or a non-quinolone antibiotic (either as oral suspension, oral tablets or sequential IV oral therapy or purely IV therapy) in the treatment of pediatric patients with infectious diagnoses.

Active substance: CIPROFLOXACIN

Study summary document link (including results): Bayer Pharma_Ciprofloxacin_100225_study_synopsis.pdf

View full study record

Document reference: 24205

Study title: CIPROFLOXACIN IN THE TREATMENT OF GRAM-NEGATIVE INFECTIONS INCLUDING PSEUDOMONAS AERUGINOSA. STUDY NO. BAY-O9867/0368

Active substance: CIPROFLOXACIN

Study summary document link (including results):

View full study record

Document reference: 24221

Study title: Ciprofloxacin in the treatment of Pseudomonas infections in children with cystic fibrosis. Diagn Microbiol Infect Dis 1990; 13:153-155Ciprofloxacin in the treatment of Pseudomonas infections in children with cystic fibrosis. Diagn Microbiol Infect Dis 1990; 13:153-155

Active substance: CIPROFLOXACIN

Study summary document link (including results):

View full study record

Document reference: 24210

Study title: CIPROFLOXACIN PROPHYLAXIS FOR PREVENTION OF BACTERIAL INFECTIONS IN PEDIATRIC BONE MARROW TRANSPLANT PATIENTS; COMPARISON OF THE COMBINATION CIPROFLOXACIN/VANCOMYCIN TO PLACEBO (AMENDMENT NO.2 AND NO.3)

Active substance: CIPROFLOXACIN

Study summary document link (including results): Bayer Pharma_Ciprofloxacin_1350_study_synopsis.pdf

View full study record

Document reference: 24213

Study title: CIPROFLOXACIN SINGLE DOSE AND STEADY STATE PHARMACOKINETICS IN CHILDREN. (IDENT. WITH BAYQ3939/0536) Study Design: NOT RANDOMIZED, NOT BLIND NO CONTROL GROUPS

Active substance: CIPROFLOXACIN

Study summary document link (including results):

View full study record

Document reference: 24206

Study title: Landman-Parker J et al Localized childhood Hodgkin's disease: response-adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisone before low-dose radiation therapy-results of the French Society of Pediatric Oncology Study MDH90.J Clin Oncol 2000 Apr;18(7):1500-7Landman-Parker J et al Localized childhood Hodgkin's disease: response-adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisone before low-dose radiation therapy-results of the French Society of Pediatric Oncology Study MDH90.J Clin Oncol 2000 Apr;18(7):1500-7

Active substance: CYCLOPHOSPHAMIDE

Study summary document link (including results):

View full study record

Document reference: 24979

Study title: 1. A randomised, double-blind, single centre, parallel group clinical trial to evaluate the comparative therapeutic efficacy of ciclopirox olamine 1.5% salicylic acid 3% scalp treatment, ciclopiroxolamine 1.5% scalp treatment and salicylic acid 3% scalp treatment against placebo, in patients with scalp psoriasis. 2. Two week home use test to assess the skin tolerance and acceptability of 1.5% CPO Body and Hair Shampoo. 3. 48 hour human patch test for primary irritation of ciclopirox olamine shampoos. 4. A double-blind, placebo-controlled trial of a ciclopirox olamine 1% shampoo for the treatment of scalp seborrhoeic dermatitis. 5. 48 hour human patch test for skin irritation of Physiogel Shampoo with Conditioner and Sarnol Lotion

Active substance: CICLOSPORIX

Study summary document link (including results):

View full study record

Document reference: 24128

Study title: Tolerance study of Mollipect mixtur

Active substance: BROMHEXINE AND EPHEDRINE

Study summary document link (including results):

View full study record

Document reference: 22880

Study title: Otten J et al Treatment of rhabdomyosarcoma and other malignant mesenchymal tumours ofchildhood with ifosfamide + vincristine + dactinomycin (IVA) as front-line therapy (a SIOP study) Cancer Chemother Pharmacol. 1989;24 Suppl 1:S30. No abstract availableOtten J et al Treatment of rhabdomyosarcoma and other malignant mesenchymal tumours ofchildhood with ifosfamide + vincristine + dactinomycin (IVA) as front-line therapy (a SIOP study) Cancer Chemother Pharmacol. 1989;24 Suppl 1:S30. No abstract available

Active substance: CYCLOPHOSPHAMIDE

Study summary document link (including results):

View full study record

Document reference: 25050

Study title: COMPARATIVE STUDY TO ASSESS THE EFFICACY, TOLERABILITY AND SAFETY OF CIPROFLOXACIN ORAL SUSPENSION VS TRIMETH OPRIM/SULFAMETHOXAZOLE IN THE TREATMENT OF ACUTE BLOODY DIARRHEA IN CHILDREN UNDER 5 YEARS OF AGE.

Active substance: CIPROFLOXACIN

Study summary document link (including results): Bayer Pharma_Ciprofloxacin_0551_study_synopsis.pdf

View full study record

Document reference: 24199

Study title: Efficacy and safety of topical ciprofloxacin/dexamethasone versus neomycin/polymyxin B/hydrocortisone for otitis externa. Roland PS, Pien FD, Schultz CC, Henry DC, Conroy PJ, Wall GM, Garadi R, Dupre SJ, Potts SL, Hogg LG, Stroman DW; Ciprodex Otic AOE Study Group. Curr Med Res Opin. 2004 Aug;20(8):1175-83. Efficacy and safety of topical ciprofloxacin/dexamethasone versus neomycin/polymyxin B/hydrocortisone for otitis externa. Roland PS, Pien FD, Schultz CC, Henry DC, Conroy PJ, Wall GM, Garadi R, Dupre SJ, Potts SL, Hogg LG, Stroman DW; Ciprodex Otic AOE Study Group. Curr Med Res Opin. 2004 Aug;20(8):1175-83.

Active substance: CIPROFLOXACIN HYDROCORTIZONE

Study summary document link (including results):

View full study record

Document reference: 24263

Study title: Efficacy and safety of topical ciprofloxacin/dexamethasone versus neomycin/polymyxin B/hydrocortisone for otitis externa. Roland PS, Pien FD, Schultz CC, Henry DC, Conroy PJ, Wall GM, Garadi R, Dupre SJ, Potts SL, Hogg LG, Stroman DW; Ciprodex Otic AOE Study Group. Curr Med Res Opin. 2004 Aug;20(8):1175-83. Efficacy and safety of topical ciprofloxacin/dexamethasone versus neomycin/polymyxin B/hydrocortisone for otitis externa. Roland PS, Pien FD, Schultz CC, Henry DC, Conroy PJ, Wall GM, Garadi R, Dupre SJ, Potts SL, Hogg LG, Stroman DW; Ciprodex Otic AOE Study Group. Curr Med Res Opin. 2004 Aug;20(8):1175-83.

Active substance: CIPROFLOXACIN HYDROCORTIZONE

Study summary document link (including results):

View full study record

Document reference: 24282

Study title: Ofloxacin otic drops vs neomycin-polymyxin B otic drops as prophylaxis against early postoperative tympanostomy tube otorrhea. Poetker DM, Lindstrom DR, Patel NJ, Conley SF, Flanary VA, Link TR, Kerschner JE. Arch Otolaryngol Head Neck Surg. 2006 Dec;132(12):1294-8. Ofloxacin otic drops vs neomycin-polymyxin B otic drops as prophylaxis against early postoperative tympanostomy tube otorrhea. Poetker DM, Lindstrom DR, Patel NJ, Conley SF, Flanary VA, Link TR, Kerschner JE. Arch Otolaryngol Head Neck Surg. 2006 Dec;132(12):1294-8.

Active substance: CIPROFLOXACIN HYDROCORTIZONE

Study summary document link (including results):

View full study record

Document reference: 24279

Study title: A double -blind comparative study ciclopirox (HOE 296 b) gel 0,77% versus ciclopirox (HOE 296 b) gel 0,77% vehicle base in patients with tinea pedis - Ronald C. Savin et al. - 14/09/1994 - Publication in -Part IV volume 29-Clinical study synopsis Ciclopirox (HOE 296 b) gel 0,77% protocol 390 -

Active substance: CICLOSPORIX

Study summary document link (including results):

View full study record

Document reference: 24129

Study title: Acute Intraperitoneal tolerance of compound HOE 296 for neonatal rats - F.R Springman et al. - 5/02/1976 (Hoescht AG) - Publication in Part III -

Active substance: CICLOSPORIX

Study summary document link (including results):

View full study record

Document reference: 24133

Study title: A COMPARISON OF CLEOCIN T TOPICAL GEL VS PLACEBO IN THE TREATMENT OF ACNE VULGARIS

Active substance: CLINDAMYCIN

Study summary document link (including results): M11120001 EMA Pediatrics Web Synopsis.pdf

View full study record

Document reference: 24369

Study title: A COMPARISON OF CLEOCIN T TOPICAL SOLUTION VS CLEOCIN T TOPICAL GEL IN THE TREATMENT OF ACNE VULGARIS

Active substance: CLINDAMYCIN

Study summary document link (including results): M11120002 EMA Pediatrics Web Synopsis.pdf

View full study record

Document reference: 24370

Study title: A COMPARISON OF CLEOCIN T TOPICAL SOLUTION, CLEOCIN T GEL AND PLACEBO IN THE TREATMENT OF ACNE VULGARIS

Active substance: CLINDAMYCIN

Study summary document link (including results): M11120004 EMA Pediatrics Web Synopsis.pdf

View full study record

Document reference: 24371

Study title: A DOUBLE BLIND COMPARATIVE STUDY OF ORAL CLINDAMYCIN HYDROCHLORIDE 300 MG BID COMPARED AGAINST ORAL CLARITHROMYCIN 250 MG BID IN THE TREATMENT OF ACUTE RECURRENT TONSILLITIS/PHARYNGITIS DUE TO GROUP A-B HEMOLYTIC STREPTOCOCCI. A MULTINATIONAL MULTICENTRI

Active substance: CLINDAMYCIN

Study summary document link (including results): 251F-INF-9052-0279 EMA Pediatrics Web Synopsis.pdf

View full study record

Document reference: 24362

Study title: A DOUBLE-BLIND MULTICENTER COMPARATIVE STUDY OF TWO ADMINISTRATION REGIMENS OF CLINDAMYCIN HYDROCHLORIDE IN THE TREATMENT OF ACUTE STREPTOCOCCAL TONSILITIS/PHARYNGITIS (PROTOCOL M/1120/0178)

Active substance: CLINDAMYCIN

Study summary document link (including results): M11200178 EMA Pediatrics Web Synopsis.pdf

View full study record

Document reference: 24374

Study title: Resultados clinicos e micologico obtidos com o uso do ciclopirox (HOE 296) em micoses superficiais-clinical and mycological results obtained with the use of ciclopirox (HOE 296) in superficial mycoses - Manoel luis Moraes - 1974 ( Rev Bras Clin Ter vol 3, n°10, suppl 7) - Publication in Part Clinical documentation Batrafen Losung -No author - 11/1999 -

Active substance: CICLOSPORIX

Study summary document link (including results):

View full study record

Document reference: 24167

Study title: Study on acute toxicity of 1-hydroxy-4 - methyl-6- cyclohexyl - 2- pyridone ethalonamine salt (HOE 296) in rats - Teruo Kitatani et al. - 08/06/1973 (Hoescht AG) - Publication in Part III -

Active substance: CICLOSPORIX

Study summary document link (including results):

View full study record

Document reference: 24127

Study title: Study on acute toxicity of 1-hydroxy-4 - methyl-6- cyclohexyl - 2- pyridone ethalonamine salt (HOE 296) in mice - Teruo Kitatani et al. - 08/06/1973 (Hoescht AG) - Publication in Part III -

Active substance: CICLOSPORIX

Study summary document link (including results):

View full study record

Document reference: 24168

Study title: Terapia delel onicomicosi con ciclopioxolamina per uso topico - G. Lo Scocco et al. - 1986 (Derm Clin vol 3) - Publication in Part clinical documentation-Batrafen Losung Study CIOMS-No author-11/ 1999 -

Active substance: CICLOSPORIX

Study summary document link (including results):

View full study record

Document reference: 24170

Study title: Tratamento topico das micoses superficiais pelo HOE 296, um novo piridonico - Topical treatment of superficial mycoses with HOE 296, a new pyridonic antimycotic drug - Lorivaldo Minelli et al. - 1974 ( Rev Bras Clin Ter vol 3) -Publication in Part Clinical documentation Batrafen Losung - No author - 11/1999 -

Active substance: CICLOSPORIX

Study summary document link (including results):

View full study record

Document reference: 24171

Study title: Tratamiento corto ciclopirox olamina 1% (Ciclochem) en pitriasis versicolor - A. Del Palacio Hernandez et al. - 1988 (Acta Dermos Sil vol 79) - Publication in Part clinical documentation- Batrafen Losung Study CIOMS- No author-11/ 1999 -

Active substance: CICLOSPORIX

Study summary document link (including results):

View full study record

Document reference: 24172

Study title: Treatment of bacterially superinfected dermatomycoses - K. Jablonski - 1987 (Kassenartz vol 27) - Publication in clinical studies (volume 6) -

Active substance: CICLOSPORIX

Study summary document link (including results):

View full study record

Document reference: 24173

Study title: A Multiclinic Study of the Efficacy, Safety Tolerance and Pharmacology of a Range of Doses of Intravenous PRIMAXIN (MK-787/MK-791) in the Treatment of Hospitalized Neonates and Infants with Infections Caused by Susceptible Bacteria.

Active substance: CILASTATIN AND IMIPENEM

Study summary document link (including results):

View full study record

Document reference: 24177

Study title: A Study of the Efficacy, Pharmaco-kinetics, Safety and Tolerability of Intravenously Administered Multiple doses of MK-787/MK-791 in Neonates, including Premature Infants.

Active substance: CILASTATIN AND IMIPENEM

Study summary document link (including results):

View full study record

Document reference: 24179

Study title: A Study of the Pharmacology Profile, Safety and Tolerability of Intravenously Administered Single Doses of MK0787/MK0791 in Neonates.

Active substance: CILASTATIN AND IMIPENEM

Study summary document link (including results):

View full study record

Document reference: 24175

Study title: A study of the Pharmacology Profile, Safety and Tolerability of Intravenously Administered Doses of PRIMAXIN (MK0787/MK0791) or Imipenem/Cilastatin in low Birth weight (LBW) Infants.

Active substance: CILASTATIN AND IMIPENEM

Study summary document link (including results):

View full study record

Document reference: 24178

Study title: EFFICACY AND SAFETY OF CIPROFLOXACIN IN THE TREATMENT OF CHILDREN WITH INFECTIONS REFRACTORY TO CURRENTLY MARKETED ANTIBIOTICS (COMPASSIONATE USE).(IDENT.MIT BAYQ3939/0441)

Active substance: CIPROFLOXACIN

Study summary document link (including results):

View full study record

Document reference: 24218

Study title: EFFICACY AND SAFETY OF CIPROFLOXACIN IN THE TREATMENT OF SYSTEMIC SALMONELLOSIS IN CHILDREN (IDENT.MIT BAYQ3939/0472)

Active substance: CIPROFLOXACIN

Study summary document link (including results): Bayer Pharma_Ciprofloxacin_1251_study_synopsis.pdf

View full study record

Document reference: 24214

Study title: EFFICACY AND SAFETY OF CIPROFLOXACIN VERSUS CONTINUED PARENTERAL CEFTAZIDIME IN NEUTROPENIC PEDIATRIC CANCER PATIENTS WHO HAVE RESPONDED TO INITIAL PARENTERAL THERAPY.

Active substance: CIPROFLOXACIN

Study summary document link (including results): Bayer Pharma_Ciprofloxacin_1310_study_synopsis.pdf

View full study record

Document reference: 24212

Study title: Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with otitis externa. Schwartz RH. Curr Med Res Opin. 2006 Sep;22(9):1725-36. Once-daily ofloxacin otic solution versus neomycin sulfate/polymyxin B sulfate/hydrocortisone otic suspension four times a day: a multicenter, randomized, evaluator-blinded trial to compare the efficacy, safety, and pain relief in pediatric patients with otitis externa. Schwartz RH. Curr Med Res Opin. 2006 Sep;22(9):1725-36.

Active substance: CIPROFLOXACIN HYDROCORTIZONE

Study summary document link (including results):

View full study record

Document reference: 24280

Study title: Chang TK et al, Combination chemotherapy with vinblastine, bleomycin, cisplatin, and etoposide, (VBPE) in children with primary intracranial germ cell tumors, Med Pediatr Oncol. 1995 Jun;24(6):368-72Chang TK et al, Combination chemotherapy with vinblastine, bleomycin, cisplatin, and etoposide, (VBPE) in children with primary intracranial germ cell tumors, Med Pediatr Oncol. 1995 Jun;24(6):368-72

Active substance: CYCLOPHOSPHAMIDE

Study summary document link (including results):

View full study record

Document reference: 24822

Study title: A Study of the Pharmacology Profile, Safety and Tolerability of Intravenously Administered Single and Multiple Doses of MK0787/MK0791 in Neonates.

Active substance: CILASTATIN AND IMIPENEM

Study summary document link (including results):

View full study record

Document reference: 24176

Study title: Humanitarian Use of Imipenem/Cilastatin Sodium in Neonates.

Active substance: CILASTATIN AND IMIPENEM

Study summary document link (including results):

View full study record

Document reference: 24180

Study title: ¿Es segura la administración de quinolonas en la edad pediátrica?Med Clin 2001; 117:676-677¿Es segura la administración de quinolonas en la edad pediátrica?Med Clin 2001; 117:676-677

Active substance: CIPROFLOXACIN

Study summary document link (including results):

View full study record

Document reference: 24209

Study title: ORAL CIPROFLOXACIN IN URINARY TRACT, RESPIRATORY AND OTHER BACTERIAL INFECTIONS DUE TO PSEUDOMONAS AERUGINOSA AND OTHER GERMS (STUDIES NO. 268 AND 277)

Active substance: CIPROFLOXACIN

Study summary document link (including results):

View full study record

Document reference: 24222

Study title:

Active substance: CLOTRIMAZOLE

Study summary document link (including results):

View full study record

Document reference: 24466

Study title: 500 mg BAY b 5097 Vaginal Tablets. Effectiveness and Tolerance of 500 mg BAY b 5097 Vaginal Tablets After a Single Administration in Comparison with 3-Day Therapy with 150 mg Econazole Ovula

Active substance: CLOTRIMAZOLE

Study summary document link (including results): Bayer CC_Clotrimazole_0475_study_synopsis.pdf

View full study record

Document reference: 24463

Study title: Activity and tolerability of Bay B 5097, 10%vaginal cream in patients with vaginal candida infections (open, mycologically controlled study)

Active substance: CLOTRIMAZOLE

Study summary document link (including results): Bayer CC_Clotrimazole_0263_study_synopsis.pdf

View full study record

Document reference: 24446

Study title: Activity and tolerability of clotrimazole 10% vaginal cream in patients with vaginal yeast infections (bimetrically planned study with no control group)

Active substance: CLOTRIMAZOLE

Study summary document link (including results): 504.pdf

View full study record

Document reference: 24449

Study title: Activity and tolerability of clotrimazole 10% vaginal cream in patients with vaginal yeast infections (biometrically planned study with no control group).

Active substance: CLOTRIMAZOLE

Study summary document link (including results): Bayer CC_Clotrimazole_0511_study_synopsis.pdf

View full study record

Document reference: 24452

Study title: BAY b 5097 - 500-mg Vaginal Tablet. Effectiveness and Tolerance of BAY b 5097 500-mg Vaginal Tablets in Single-Dose or One-Day Therapy for Vaginal Yeast Infections

Active substance: CLOTRIMAZOLE

Study summary document link (including results): Bayer CC_Clotrimazole_0410_study_synopsis.pdf

View full study record

Document reference: 24456

Study title: Bay b 5097 - 500-mg Vaginal Tablet. Activity and Tolerability of Bay b 5097 500-mg Vaginal Tablets After a Single Application in Patients with Vaginal Yeast Infections (Open, Mycologically Controlled Study)

Active substance: CLOTRIMAZOLE

Study summary document link (including results):

View full study record

Document reference: 24459

Study title: Bisogno G et al The IVADo regimen--a pilot study with ifosfamide, vincristine, actinomycin D, and doxorubicin in children with metastatic soft tissue sarcoma: a pilot study of behalf of the European pediatric Soft tissue sarcoma Study Group Cancer. 2005 Apr 15;103(8):1719-24Bisogno G et al The IVADo regimen--a pilot study with ifosfamide, vincristine, actinomycin D, and doxorubicin in children with metastatic soft tissue sarcoma: a pilot study of behalf of the European pediatric Soft tissue sarcoma Study Group Cancer. 2005 Apr 15;103(8):1719-24

Active substance: CYCLOPHOSPHAMIDE

Study summary document link (including results):

View full study record

Document reference: 24779

Active substance: CICLOPIROX

Study summary document link (including results): CICLOPIROX STUDY HOE296B-8-USA-390-AF.xls

View full study record

Document reference: 24130

Study title: A double blind multicente rparallel group study comparing ciclopirox olamine cream 1% and LOTRIMIN (clotrimazole cream 1%) in the subjects with tinea corporis or tinea cruris - Richard L. Dobson et al. - 08/ 1988 - Publication in clinical studies ( volume

Active substance: CICLOPIROX

Study summary document link (including results): Ciclopirox STUDY 305.xls

View full study record

Document reference: 24131

Study title: Ferrari S et al Ifosfamide and actinomycin-D, added in the induction phase to vincristine,cyclophosphamide and doxorubicin, improve histologic response and prognosis in patients with non metastatic Ewing's sarcoma of the extremity J Chemother. 1998 Dec;10(6):484-91Ferrari S et al Ifosfamide and actinomycin-D, added in the induction phase to vincristine,cyclophosphamide and doxorubicin, improve histologic response and prognosis in patients with non metastatic Ewing's sarcoma of the extremity J Chemother. 1998 Dec;10(6):484-91

Active substance: CYCLOPHOSPHAMIDE

Study summary document link (including results):

View full study record

Document reference: 24871

Active substance: CYCLOPHOSPHAMIDE

Study summary document link (including results):

View full study record

Document reference: 24872

Active substance: CYCLOPHOSPHAMIDE

Study summary document link (including results):

View full study record

Document reference: 24780

Study title: A double blind multicentre parallel study group comparing ciclopirox olamine 1% cream and vehicle, cream base in the subjects with Tinea corporis or Tinea cruris - No author - august 1988 : Clinical/statistical report for ciclopirox olamine ( Loprox, HOE296) protocole 303 - Phillip Frost et al. - No date -Publication in clinical studies ( volume 4)-

Active substance: CICLOPIROX

Study summary document link (including results): Ciclopirox STUDY 301.xls

View full study record

Document reference: 24132

Study title: Clinical/statistical report for ciclopirox olamine ( Loprox, HOE296) protocole 306- a double-bling multicenter parallel group study comparing ciclopirox olamine cream 1% and lotirimin (clotrimazole) cream 1% subjects with tinea pedis- W. christopher Duncan et al.- No date - Publication in clinical studies ( volume 4) - a double blind multicentre parallel study group comparing ciclopirox olamine 1% cream and vehicle, cream base in the subjects with Tinea corporis or Tinea cruris - No author - 08/1988 -Report 206

Active substance: CICLOPIROX

Study summary document link (including results): Ciclopirox STUDY 306.xls

View full study record

Document reference: 24143

Study title: Clinical/statistical report for ciclopirox olamine ( Loprox, HOE296) protocole 307 : a double-blind multicenter parallel group study comparing ciclopirox olamine 1% cream with Lotrimin (clotrimazole) cream 1% in subjects with Tinea versicolor - Stanley I Cullen et al. - No date - Publication in clinical studies ( volume 4) -

Active substance: CICLOPIROX

Study summary document link (including results): Ciclopirox STUDY 307.xls

View full study record

Document reference: 24126

Study title: Clinical/Statistical report for ciclopirox olamine (Loprox, HOE 296) protocole 304- a double-blind multicenter parallel group study comparing ciclopirox olamine cream 1% and the vehicle, cream baste in subjects with cutaneous candiasis - Huberto Bogaert et al.- No date - Publication in clinical studies (volume 5) -

Active substance: CICLOPIROX

Study summary document link (including results): CICLOPIROX STUDY Protocol 304.xls

View full study record

Document reference: 24144

Study title: Report on a double -blind study with HOE 296 cream versus vehicle in the treatment of dematophytose - T. Fredriksson et al. - 1981 - Publication in clinical studies (volume 6) -

Active substance: CICLOPIROX

Study summary document link (including results): Ciclopirox STUDY Fredriksson.xls

View full study record

Document reference: 24166

Study title: Report on a double -blind study with HOE296 cream versus vehicle in the treatment of cutaneous candidiasis

Active substance: CICLOPIROX

Study summary document link (including results): CICLOPIROX STUDY Gip.xls

View full study record

Document reference: 47983

Study title: Study on the efficacity and tolerabilityof mycoster lacquer (8% ciclopirox) versus Ketoconazole tablets in onychomycoses - Dr. Baran - 1990 - Publication in Clinical trials on ciclopirox 8% nail lacquer -

Active substance: CICLOPIROX

Study summary document link (including results): CICLOPIROX Report 2.8.xls

View full study record

Document reference: 24169

Study title: Forni C et al Granisetron, tropisetron, and ondansetron in the prevention of acute emesis induced by a combination of cisplatin-Adriamycin and by high-dose ifosfamide delivered in multiple-day continuous infusions Support Care Cancer. 2000 Mar;8(2):131-3Forni C et al Granisetron, tropisetron, and ondansetron in the prevention of acute emesis induced by a combination of cisplatin-Adriamycin and by high-dose ifosfamide delivered in multiple-day continuous infusions Support Care Cancer. 2000 Mar;8(2):131-3

Active substance: CYCLOPHOSPHAMIDE

Study summary document link (including results):

View full study record

Document reference: 24877

Study title: The treatment of acute fissure-in-ano in children : evaluation of the efficacy of the Proctossedyl - No author - 1971 (Clinical Trials Journal 1971; 4: 9-13) - Compilation of clinical papers for the UK review of Medicines in 1983 -

Active substance: CINCHOCAINE AND HYDROCORTIZONE_or_HYDROCORTISONE/FRAMYCETIN SULFATE/CINCHOCAINE HYDROCHLORIDE

Study summary document link (including results):

View full study record

Document reference: 24190

Study title: Treatment of haemorrhoids with Proctossedyl - Soegaard PK - No date (private communication) - Compilation of clinical papers for the UK review of Medicines in 1983 -

Active substance: CINCHOCAINE AND HYDROCORTIZONE_or_HYDROCORTISONE/FRAMYCETIN SULFATE/CINCHOCAINE HYDROCHLORIDE

Study summary document link (including results):

View full study record

Document reference: 24191

Study title: Prospective, Randomized, Third-Party Blind, Study to Compare the Safety and Efficacy of Ciprofloxacin (Sequential IV/PO) with intravenous Ceftazidime and Tobramycin in the Treatment of Pediatric Cystic Fibrosis Patients with Acute Pulmonary Exacerbation.

Active substance: CIPROFLOXACIN

Study summary document link (including results): 512.pdf

View full study record

Document reference: 24224

Study title: Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. Ceftazidine/trobamycin in the treatment of acute pulmonary exacerbation. Pediatric Infections Disease Journal 1997; 16(1): 97-105Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. Ceftazidine/trobamycin in the treatment of acute pulmonary exacerbation. Pediatric Infections Disease Journal 1997; 16(1): 97-105

Active substance: CIPROFLOXACIN

Study summary document link (including results):

View full study record

Document reference: 24211

Study title: Kharasch VS et al, Long-term pulmonary toxicity of multiagent chemotherapy including bleomycin and, cyclophosphamide in osteosarcoma survivors, Med Pediatr Oncol. 1996 Aug;27(2):85-91Kharasch VS et al, Long-term pulmonary toxicity of multiagent chemotherapy including bleomycin and, cyclophosphamide in osteosarcoma survivors, Med Pediatr Oncol. 1996 Aug;27(2):85-91

Active substance: CYCLOPHOSPHAMIDE

Study summary document link (including results):

View full study record

Document reference: 24959

Study title: Bay b 5097 - 500-mg Vaginal Tablets. . Activity and Tolerability of Bay b 5097 500-mg Vaginal Tablets in Single or One-Day Treatment of Vaginal Candida Infections (Open, Mycologically Controlled Study)

Active substance: CLOTRIMAZOLE

Study summary document link (including results):

View full study record

Document reference: 24460

Study title: Topical ciprofloxacin/dexamethasone otic suspension is superior to ofloxacin otic solution in the treatment of children with acute otitis media with otorrhea through tympanostomy tubes. Roland PS, Kreisler LS, Reese B, Anon JB, Lanier B, Conroy PJ, Wall GM, Dupre SJ, Potts S, Hogg G, Stroman DW, McLean C. Pediatrics. 2004 Jan;113(1 Pt 1):e40-6. ...

Active substance: CIPROFLOXACIN

Study summary document link (including results):

View full study record

Document reference: 24226

Study title: Study Comparing Two Doses of Clarithromycin in Pediatric Tonsillitis

Active substance: CLARITHROMYCIN

Study summary document link (including results): clarithromycin-aca-grec-2001.pdf

View full study record

Document reference: 48061

Study title: Treatment of acute pharyngitis in children using clarithromycin under usual clinical practice conditions

Active substance: CLARITHROMYCIN

Study summary document link (including results): clarithromycin-fran03-004.pdf

View full study record

Document reference: 48063

Study title: Treatment of lower respiratory tract infections in children by clarithromycin under real practice conditions

Active substance: CLARITHROMYCIN

Study summary document link (including results): clarithromycin-fran03-005.pdf

View full study record

Document reference: 48064

Study title:

Active substance: CLAVULANIC ACID AND TICARCILLIN

Study summary document link (including results): Study BRL-028500-TIM-14 Ticarcillin (Timentin).xlsx

View full study record

Document reference: 24305

Study title: A pharmacokinetic evaluation of intravenously administered Timentin in paediatric patients.

Active substance: CLAVULANIC ACID AND TICARCILLIN

Study summary document link (including results):

View full study record

Document reference: 24304

Study title: Bacci G et al Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studies Cancer 1998 Mar 15;82(6):1174-83Bacci G et al Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studies Cancer 1998 Mar 15;82(6):1174-83

Active substance: CYCLOPHOSPHAMIDE

Study summary document link (including results):

View full study record

Document reference: 24741

Study title: Evaluation of intensified chemotherapy in children with advanced rhabdomyosarcoma (clinical groups III and IV).The Intergroup Rhabdomyosarcoma Study (IRS) Committee of the Cancer and Leukemia Group B Children's Cancer Study Group, Southwest Oncology Group.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25348

Study title: Evaluation of prognostic factors in a tumor volume-adapted treatment strategy for localized Ewing sarcoma of bone: the CESS 86 experience. Cooperative Ewing Sarcoma Study.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25349

Study title: Ewing tumours: Outcome in children, adolescents and adult patients

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25350

Study title: Ewing's sarcoma: treatment with high-dose radiation and adjuvant chemotherapy.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25351

Study title: Expression of the hepatic insulin receptor gene in the rat during postnatal development.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25352

Study title: BAY b 5097 Spray Efficacy and Tolerance in Dermatomycoses. Open, Mycologically Controlled Study

Active substance: CYPROTERONE + ETHINYLESTRADIOL

Study summary document link (including results):

View full study record

Document reference: 25270

Study title: Daunomycin in the treatment of acute leukaemia and neoplastic diseases in childhood - Massimo L., Fossati-Guglielmoni A. & Fortuna E. - 1968 - Publication in the dos. allemand jan 1981 and in Clinical Expert Report (J.K.H. Rees - 1989) - Daunomycin in the treatment of acute leukaemia and neoplastic diseases in childhood - Massimo L., Fossati-Guglielmoni A. & Fortuna E. - 1968 - Publication in the dos. allemand jan 1981 and in Clinical Expert Report (J.K.H. Rees - 1989) -

Active substance: DAUNORUBICIN

Study summary document link (including results):

View full study record

Document reference: 25579

Study title: Failure of high-dose alkylating agents in osteosarcoma.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25353

Study title: False-positive anti-Toxoplasma fluorescent-antibody tests in patients with antinuclear antibodies.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25354

Study title: Fibromatosis (desmoid tumor) involving the orbit and cheek.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25355

Study title: GAMEC--a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25356

Study title: Hematopathy-thrombocytopenia syndrome in children treated with dactinomycin

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25357

Study title: Hemophagocytic alveolar rhabdomyosarcoma

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25358

Study title: Hepatotoxicity in irradiated nephroblastoma patients during postoperative treatment according to SIOP9/GPOH.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25359

Study title: Hepatotoxicity in patients treated according to the nephroblastoma trial and study SIOP-9/GPOH.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25360

Study title: High-dose melphalan with autologous stem-cell rescue in metastatic rhabdomyosarcoma.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25361

Study title: Hourly monitoring of circulating CD34+ cells to optimize timing of autologous apheresis in pediatric patients

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25362

Study title: How to establish equivalence between treatments: a one-sided clinical trial in paediatric oncology.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25363

Study title: Ifosfamide and actinomycin-D, added in the induction phase to vincristine, cyclophosphamide and doxorubicin, improve histologic response and prognosis in patients with non metastatic Ewing's sarcoma of the extremity.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25364

Study title: Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25365

Study title: Ifosfamide in soft tissue sarcoma.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25366

Study title: Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms' tumour: results of a randomised trial (UKW3) by the UK Children's Cancer Study Group.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25367

Study title: Importance of dactinomycin in the current therapy of tumors

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25368

Study title: Improving outcomes after relapse in Ewing's sarcoma: Analysis of 114 patients from a single institution

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25369

Study title: Increased systemic toxicity of sarcoma chemotherapy due to combination with the P-glycoprotein inhibitor cyclosporin.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25370

Study title: Initial chemotherapy including ifosfamide in the management of Ewing's sarcoma: preliminary results. A protocol of the French Pediatric Oncology Society (SFOP).

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25371

Study title: Integrated therapy for Ewing's sarcoma.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25372

Study title: Integrative tumor board: Pediatric synovial sarcoma

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25373

Study title: Post-marketing surveillance study of Seractil 200 mg and 300 mg film-coated tablets involving 1400 patients with rheumatic diseases. Phelps W. et al.. (Nov 1994): Final report Gebro; English translation, original report (in German language).Post-marketing surveillance study of Seractil 200 mg and 300 mg film-coated tablets involving 1400 patients with rheumatic diseases. Phelps W. et al.. (Nov 1994): Final report Gebro; English translation, original report (in German language).

Active substance: DEXAMETHASONE AND NEOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25750

Study title: Postoperative miotics for patients with infantile esotropia.Spierer A, Zeeli T. Ophthalmic Surg Lasers. 1997 Dec;28(12):1002-5. Postoperative miotics for patients with infantile esotropia.Spierer A, Zeeli T. Ophthalmic Surg Lasers. 1997 Dec;28(12):1002-5.

Active substance: DEXAMETHASONE AND NEOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25744

Study title: Trimethoprim-polymyxin B ophthalmic solution in treatment of surface ocular bacterial infections. Nozik RA, Smolin G, Knowlton G, Austin R. Ann Ophthalmol. 1985 Dec;17(12):746-8. Trimethoprim-polymyxin B ophthalmic solution in treatment of surface ocular bacterial infections. Nozik RA, Smolin G, Knowlton G, Austin R. Ann Ophthalmol. 1985 Dec;17(12):746-8.

Active substance: DEXAMETHASONE AND NEOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25748

Study title: Vernal keratoconjunctivitis in the black child and its response to therapy.Dahan E, Appel R. Br J Ophthalmol. 1983 Oct;67(10):688-92. Vernal keratoconjunctivitis in the black child and its response to therapy.Dahan E, Appel R. Br J Ophthalmol. 1983 Oct;67(10):688-92.

Active substance: DEXAMETHASONE AND NEOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25747

Study title: A comparison of ciprofloxacin and tobramycin in bacterial conjunctivitis in children.Gross RD, Hoffman RO, Lindsay RN. Clin Pediatr (Phila). 1997 Aug;36(8):435-44 Comment in: Clin Pediatr (Phila). 1997 Aug;36(8):445-8. PMID: 9272317. A comparison of ciprofloxacin and tobramycin in bacterial conjunctivitis in children.Gross RD, Hoffman RO, Lindsay RN. Clin Pediatr (Phila). 1997 Aug;36(8):435-44 Comment in: Clin Pediatr (Phila). 1997 Aug;36(8):445-8. PMID: 9272317.

Active substance: DEXAMETHASONE AND TOBRAMYCIN

Study summary document link (including results): Comparison of ciprofloxacin and tobramycin in bacterial conj.pdf

View full study record

Document reference: 25753

Study title: Primary chemotherapy in rhabdomyosarcomas and other malignant mesenchymal tumors of the orbit: results of the International Society of Pediatric Oncology MMT 84 Study.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25424

Study title: Primary chemotherapy in the treatment of rhabdomyosarcoma in children: trial of the International Society of Pediatric Oncology (SIOP) preliminary results.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25425

Study title: Primary chemotherapy with the Rosen T10 protocol before conservative surgery in limb primitive osteosarcomas: results about 56 cases

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25426

Study title: Primary osteogenic sarcoma of the femur: a model for the use of preoperative chemotherapy in high risk malignant tumors.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25427

Study title: Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25428

Study title: Probable cure of metastatic testicular tumors treated with sequential therapy.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25429

Study title: Prognosis in children with Wilms' tumor metastases prior to or following primary treatment: results from the first National Wilms' Tumor Study (NWTS-1).

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25430

Study title: Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study).

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25431

Study title: Prognostic factors in patients with localized Ewing's sarcoma: the effect on survival of actual received drug dose intensity and of histologic response to induction therapy.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25432

Study title: Prophylactic actinomycin D for high-risk complete hydatidiform mole.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25434

Study title: Radiation related toxicities in National Wilms' Tumor Study Number 1.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25435

Study title: Radiation therapy in the multimodal management of Ewing's sarcoma of bone: report of the Intergroup Ewing's Sarcoma Study.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25437

Study title: Randomized study of systemic chemotherapy following complete excision of nonosseous sarcomas.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25438

Study title: Rarity of surgical complications after postchemotherapy nephrectomy for nephroblastoma. Experience of the International Society of Paediatric Oncology-Trial and Study 'SIOP-9'. International Society of Paediatric Oncology Nephroblastoma Trial and Study Committee.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25439

Study title: Recent trends in the medical treatment of Hodgkin's disease.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25440

Study title: Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): a randomised controlled trial.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25441

Study title: Relapse rate of patients with low-risk gestational trophoblastic tumor initially treated with single-agent chemotherapy

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25442

Study title: Relationship between dose schedule and charges for treatment on National Wilms' Tumor Study-4. A report from the National Wilms' Tumor Study Group.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25443

Study title: Response and survival of patients with metastatic neuroblastoma after combination chemotherapy with adriamycin (NSC-123127), cyclophosphamide (NSC-26271), and vincristine (NSC-67574).

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25444

Study title: Results of chemotherapy and salvage surgery for advanced testicular cancer

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25445

Study title: Results of intensive therapy in children with localized alveolar extremity rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25446

Study title: Results of the COSS-77 and COSS-80 studies on adjuvant chemotherapy in osteosarcoma of the extremities

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25447

Study title: [Conjunctivitis of bacterial origin in children. Local antibiotic treatment with tobramycin collyrium] Fioretti GM, Campanari C. Pediatr Med Chir. 1989 Jul-Aug;11(4):421-3. [Conjunctivitis of bacterial origin in children. Local antibiotic treatment with tobramycin collyrium] Fioretti GM, Campanari C. Pediatr Med Chir. 1989 Jul-Aug;11(4):421-3.

Active substance: DEXAMETHASONE AND TOBRAMYCIN

Study summary document link (including results):

View full study record

Document reference: 25754

Study title: Treatment of acute bacterial conjunctivitis: 1% fusidic acid viscous drops vs. 0.3% tobramycin drops. Jackson WB, Low DE, Dattani D, Whitsitt PF, Leeder RG, MacDougall R. Can J Ophthalmol. 2002 Jun;37(4):228-37; discussion 237. Treatment of acute bacterial conjunctivitis: 1% fusidic acid viscous drops vs. 0.3% tobramycin drops. Jackson WB, Low DE, Dattani D, Whitsitt PF, Leeder RG, MacDougall R. Can J Ophthalmol. 2002 Jun;37(4):228-37; discussion 237.

Active substance: DEXAMETHASONE AND TOBRAMYCIN

Study summary document link (including results): Treatment of acute neonatal bacterial conjunctivitis.pdf

View full study record

Document reference: 25752

Study title:

Active substance: DEXAMETHASONE NEOMYCIN POLYMYXIN B

Study summary document link (including results): Neomycin sulfate-polymixin B-Dexmthasone - C-94-28.xls

View full study record

Document reference: 47627

Study title: Adriamycin, bleomycin, DIC, CCNU, and prednisone (ABDIC) chemotherapy in MOPP-resistant Hodgkin disease. Cancer, 46; 2349-55 - Rodgers - 1980 - Publication in the dossier Dacarbazine injectable 100 and 200 mg - Data on human (dossier B) -

Active substance: DACARBAZINE

Study summary document link (including results):

View full study record

Document reference: 25274

Study title: Chemotherapy of sarcomas with a combination of adriamycin and dimethyl triazeno imidazole carboxamide. Cancer. 30; 6:1632-38 - Gottlieb - Dec 1972 - Publication in the dossier Dacarbazine injectable 100 and 200 mg - Data on human (dossier B) -

Active substance: DACARBAZINE

Study summary document link (including results):

View full study record

Document reference: 25275

Study title: A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25280

Study title: A prospective, randomized, national trial for treatment of ovarian cancer: the role of chemotherapy and external irradiation.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25281

Study title: A randomized clinical trial of single-dose versus fractionated-dose dactinomycin in the treatment of Wilms' tumor. Results after extended follow-up. Brazilian Wilms' Tumor Study Group.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25282

Study title: Mann JR et al, The United Kingdom Children's Cancer Study Group's second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity, J Clin Oncol. 2000 Nov 15;18(22):3809-18, Mann JR et al, The United Kingdom Children's Cancer Study Group's second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity, J Clin Oncol. 2000 Nov 15;18(22):3809-18,

Active substance: CYCLOPHOSPHAMIDE

Study summary document link (including results):

View full study record

Document reference: 24999

Study title: Mann JR et al, UKCCSG's germ cell tumour (GCT) studies: improving outcome for children with malignant extracranial non-gonadal tumours--carboplatin, etoposide, and bleomycin, are effective and less toxic than previous regimens. United Kingdom Children's Cancer Study Group, Med Pediatr Oncol. 1998 Apr;30(4):217-27Mann JR et al, UKCCSG's germ cell tumour (GCT) studies: improving outcome for children with malignant extracranial non-gonadal tumours--carboplatin, etoposide, and bleomycin, are effective and less toxic than previous regimens. United Kingdom Children's Cancer Study Group, Med Pediatr Oncol. 1998 Apr;30(4):217-27

Active substance: CYCLOPHOSPHAMIDE

Study summary document link (including results):

View full study record

Document reference: 25000

Study title: A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25283

Study title: Abdominal irradiation in unilateral nephroblastoma and its impact on local control and survival.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25284

Study title: Actinomycin D--the drug of choice for initial therapy of gestational trophoblastic disease.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25285

Study title: Actinomycin-D plus 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamine (DTIC) with or without intravenous Corynebacterium parvum in metastatic malignant melanoma.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25286

Study title: Acupuncture against chemotherapy-induced nausea and vomiting in pediatric oncology: Interim results of a multicenter crossover study

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25287

Study title: Acute toxicities associated with radiation in the second National Wilms' Tumor Study.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25288

Study title: Adjuvant chemotherapy with a nitrosourea-based protocol in advanced malignant melanoma.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25289

Study title: Advances in chemotherapy for gynecologic cancer.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25290

Study title: Age is a risk factor for chemotherapy-induced hepatopathy with vincristine, dactinomycin, and cyclophosphamide.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25291

Study title: Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25292

Study title: Alternative chemotherapy of malignant bone neoplasms in children

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25293

Study title: Alveolar soft-part sarcoma: A cardiac metastasis as a rare site of relapse

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25294

Study title: Efficacy and morbidity of Daunomycin (NSC-82151) added to vincristine (NSC-67574) and Prednisone (NSC-10023) for remission induction of childhood acute lymphocytic leukemia - Verzosa, M., Fite, A. - 1971 (Cancer Chemotherapy Reports Part.1 Vol. 55 n°1, 79-82) - Publication in the dos. Allemand jan 1981 - Efficacy and morbidity of Daunomycin (NSC-82151) added to vincristine (NSC-67574) and Prednisone (NSC-10023) for remission induction of childhood acute lymphocytic leukemia - Verzosa, M., Fite, A. - 1971 (Cancer Chemotherapy Reports Part.1 Vol. 55 n°1, 79-82) - Publication in the dos. Allemand jan 1981 -

Active substance: DAUNORUBICIN

Study summary document link (including results):

View full study record

Document reference: 25589

Active substance: DAUNORUBICIN

Study summary document link (including results):

View full study record

Document reference: 25621

Study title: Bacci G et al Neoadjuvant treatment of Ewing's sarcoma: results obtained in 122 patientstreated with a 6-drug chemotherapeutic protocol (vincristine, adriamycin,cyclophosphamide, dactinomycin, ifosfamide and etoposide) Minerva Pediatr. 1995 Nov;47(11):457-69. ItalianBacci G et al Neoadjuvant treatment of Ewing's sarcoma: results obtained in 122 patientstreated with a 6-drug chemotherapeutic protocol (vincristine, adriamycin,cyclophosphamide, dactinomycin, ifosfamide and etoposide) Minerva Pediatr. 1995 Nov;47(11):457-69. Italian

Active substance: CYCLOPHOSPHAMIDE AND ETOPOSIDE AND IFOSFAMIDE

Study summary document link (including results):

View full study record

Document reference: 25183

Active substance: CYCLOPHOSPHAMIDE AND IFOSFAMIDE

Study summary document link (including results):

View full study record

Document reference: 25184

Study title: Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25374

Study title: The intergroup rhabdomyosarcoma study: a preliminary report.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25471

Study title: The IVADo regimen--a pilot study with ifosfamide, vincristine, actinomycin D, and doxorubicin in children with metastatic soft tissue sarcoma: a pilot study of behalf of the European pediatric Soft tissue sarcoma Study Group.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25474

Study title: The multi-institutional osteosarcoma study: an update.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25475

Study title: The pharmacological management of aggressive and autoaggressive behaviour in mentally retarded patients with melperone

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25476

Study title: The relationship between microsubstaging variables, age at diagnosis, and tumor weight of children with stage I/favorable histology Wilms' tumor. A report from the National Wilms' Tumor study.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25477

Study title: The role of chemotherapy in the management of soft tissue sarcomas.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25478

Study title: The role of radiation therapy in the management of non-metastatic Ewing's sarcoma of bone. Report of the Intergroup Ewing's Sarcoma Study.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25479

Study title: The treatment of Wilms' tumor: Results of the national Wilms' tumor study.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25480

Study title: The treatment of Wilms' tumour: Results of the United Kingdom children's cancer study group third Wilms' tumour Study.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25481

Study title: Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25482

Study title: Treatment of childhood Wilms' tumor without radiotherapy in Nicaragua.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25483

Study title: Treatment of children with clear-cell sarcoma of the kidney: a report from the National Wilms' Tumor Study Group.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25484

Study title: Treatment of children with stage IV favorable histology Wilms tumor: a report from the National Wilms Tumor Study Group.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25485

Study title: Treatment of children with stages II to IV anaplastic Wilms' tumor: a report from the National Wilms' Tumor Study Group.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25486

Study title: Treatment of endodermal sinus tumor in children using a regimen that lacks bleomycin.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25487

Study title: Treatment of Ewing's sarcoma in children and adolescents: a cooperative study of the German society of pediatric oncology (author's transl)a

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25488

Study title: Treatment of Ewing's sarcoma with intensive initial chemotherapy. 1st evaluation of a French pediatric multicenter protocol

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25489

Study title: Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25490

Study title: Treatment of Kaposi's sarcoma by combination of actinomycin-D, vincristine and imidazole carboxamide (nsc-45388): results of a randomized clinical trial.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25491

Study title: Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25492

Study title: Treatment of metastatic Ewing's sarcoma with actinomycin D (NSC-3053).

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25493

Study title: A review of 110 cases - D.D. Von Hoff, M. Rosencweig, M. Layard & coll. - 1977 - Publication in the dos. Français jan 1977 - Daunomycin induced cardiotoxicity in children and adults - A review of 110 cases - D.D. Von Hoff, M. Rosencweig, M. Layard & coll. - 1977 - Publication in the dos. Français jan 1977 - Daunomycin induced cardiotoxicity in children and adults -

Active substance: DAUNORUBICIN

Study summary document link (including results):

View full study record

Document reference: 25561

Study title: Acute Lymphoblastic Leukaemia treated with a combination of Prednisone, Vincristine, and Rubidomycin - Mathé, G., Schwarzenberg, L., Schneider, M., et al. - 1967 (The Lancet, 380 - 382) - Publication in the dos. Allemand jan 1981 -Acute Lymphoblastic Leukaemia treated with a combination of Prednisone, Vincristine, and Rubidomycin - Mathé, G., Schwarzenberg, L., Schneider, M., et al. - 1967 (The Lancet, 380 - 382) - Publication in the dos. Allemand jan 1981 -

Active substance: DAUNORUBICIN

Study summary document link (including results):

View full study record

Document reference: 25564

Study title: A prospective randomized study of medications after silicone intubation. Liu D. Ophthalmic Surg Lasers. 1996 Jun;27(6):434-7. A prospective randomized study of medications after silicone intubation. Liu D. Ophthalmic Surg Lasers. 1996 Jun;27(6):434-7.

Active substance: DEXAMETHASONE NEOMYCIN POLYMYXIN B

Study summary document link (including results): A prospective randomized study of medications.pdf

View full study record

Document reference: 25763

Study title: Efficacy of diclofenac versus dexamethasone for treatment after strabismus surgery.Snir M, Axer-Siegel R, Friling R, Weinberger D. Ophthalmology. 2000 Oct;107(10):1884-8. Efficacy of diclofenac versus dexamethasone for treatment after strabismus surgery.Snir M, Axer-Siegel R, Friling R, Weinberger D. Ophthalmology. 2000 Oct;107(10):1884-8.

Active substance: DEXAMETHASONE NEOMYCIN POLYMYXIN B

Study summary document link (including results):

View full study record

Document reference: 25757

Study title: [Epidemic keratoconjunctivitis: treatment results during an epidemic] Hutter H. Klin Monatsbl Augenheilkd. 1990 Sep;197(3):214-7. [Epidemic keratoconjunctivitis: treatment results during an epidemic] Hutter H. Klin Monatsbl Augenheilkd. 1990 Sep;197(3):214-7.

Active substance: DEXAMETHASONE NEOMYCIN POLYMYXIN B

Study summary document link (including results):

View full study record

Document reference: 25761

Study title: Ocular hypertensive response to topical dexamethasone in children: a dose-dependent phenomenon.Ng JS, Fan DS, Young AL, Yip NK, Tam K, Kwok AK, Lam DS. Ophthalmology. 2000 Nov;107(11):2097-100 Comment in: Ophthalmology. 2001 Oct;108(10):1715-6. PMID: 11581031. Ocular hypertensive response to topical dexamethasone in children: a dose-dependent phenomenon.Ng JS, Fan DS, Young AL, Yip NK, Tam K, Kwok AK, Lam DS. Ophthalmology. 2000 Nov;107(11):2097-100 Comment in: Ophthalmology. 2001 Oct;108(10):1715-6. PMID: 11581031.

Active substance: DEXAMETHASONE NEOMYCIN POLYMYXIN B

Study summary document link (including results):

View full study record

Document reference: 25756

Study title: Ocular-hypertensive response to topical steroids in children. Kwok AK, Lam DS, Ng JS, Fan DS, Chew SJ, Tso MO. Ophthalmology. 1997 Dec;104(12):2112-6. Ocular-hypertensive response to topical steroids in children. Kwok AK, Lam DS, Ng JS, Fan DS, Chew SJ, Tso MO. Ophthalmology. 1997 Dec;104(12):2112-6.

Active substance: DEXAMETHASONE NEOMYCIN POLYMYXIN B

Study summary document link (including results):

View full study record

Document reference: 25759

Active substance: DEXAMETHASONE NEOMYCIN POLYMYXIN B

Study summary document link (including results):

View full study record

Document reference: 25758

Study title: Interferon alfa-2a in recurrent metastatic hemangiopericytoma.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25375

Study title: Intracranial germ cell tumors: analysis of the therapy study MAKEI 83/86 and changes in protocol for the follow-up study

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25376

Study title: Intraoperative radiotherapy in the multidisciplinary treatment of bone sarcomas in children and adolescents.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25377

Study title: Intrathoracic soft tissue sarcomas in children.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25378

Study title: Kidney tumors of children

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25379

Study title: Late malignant melanoma after treatment of rhabdomyosarcoma of the orbit during childhood.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25380

Study title: Late recurrence in children with Wilms' tumor

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25381

Study title: Local control and survival related to radiation dose and volume and to chemotherapy in non-metastatic Ewing's sarcoma of pelvic bones.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25382

Study title: Local control in pelvic Ewing sarcoma: analysis from INT-0091--a report from the Children's Oncology Group.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25383

Study title: Local recurrence, rate and sites of metastases, and time to relapse as a function of treatment regimen, size of primary and surgical history in 62 patients presenting with non-metastatic Ewing's sarcoma of the pelvic bones.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25384

Study title: Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25385

Study title: Long-term evaluation of single versus multiple courses of actinomycin D therapy of Wilm's tumor.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25386

Study title: Long-term results of two VAB-like regimens (vinblastine + actinomycin-D + bleomycin + cyclophosphamide + cisplatin) in malignant germ cell tumours of the ovary

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25387

Study title: Long-term survival following a phase I/II trial with VETOPEC for solid tumors in childhood

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25388

Study title: Long-term survival rates with various chemotherapeutic regimens in stages III and IV ovarian adenocarcinoma. The influence of optimum pretreatment surgical resection.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25389

Study title: Melperone in low doses in anxious neurotic patients. A double-blind placebo-controlled clinical study.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25390

Study title: Metastatic soft tissue sarcomas in children - A remaining challenge for paediatric oncology. A retrospective multicenter study from the Polish Pediatric Solid Tumors' Group

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25391

Study title: Mirror-image osteosarcoma of the radius. A casea

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25392

Study title: Multicentre analysis of anthracycline-induced cardiotoxicity in children following treatment according to the nephroblastoma studies SIOP No.9/GPOH and SIOP 93-01/GPOH.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25393

Study title: Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone: intergroup study IESS-II.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25394

Study title: Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: an Intergroup Study.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25395

Study title: Neoadjuvant chemotherapy for Ewing's sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase--results of two sequential studies.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25396

Study title: Neoadjuvant chemotherapy for nonmetastatic osteosarcoma of the extremities: the recent experience at the Rizzoli Institute.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25397

Study title: Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian study.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25398

Study title: Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25496

Study title: Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25494

Study title: Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25495

Study title: Electrocardiographic Findings in Patients with Diphenhydramine Overdose, Zareba, W., Am. J. Cardiol. 1997; 80: 1168-1173Electrocardiographic Findings in Patients with Diphenhydramine Overdose, Zareba, W., Am. J. Cardiol. 1997; 80: 1168-1173

Active substance: DEXAMETHASONE AND DIPHENHYDRAMINE

Study summary document link (including results):

View full study record

Document reference: 25724

Study title: Vernal keratoconjunctivitis in the black child and its response to therapy.Dahan E, Appel R. Br J Ophthalmol. 1983 Oct;67(10):688-92.. Vernal keratoconjunctivitis in the black child and its response to therapy.Dahan E, Appel R. Br J Ophthalmol. 1983 Oct;67(10):688-92..

Active substance: DEXAMETHASONE NEOMYCIN POLYMYXIN B

Study summary document link (including results):

View full study record

Document reference: 25760

Study title: van den Berg H et al, Treatment of Hodgkin's disease in children with alternating mechlorethamine,, vincristine, procarbazine, and prednisone (MOPP) and adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) courses without radiotherapy, Med Pediatr Oncol. 1997 Jul;29(1):23-7van den Berg H et al, Treatment of Hodgkin's disease in children with alternating mechlorethamine,, vincristine, procarbazine, and prednisone (MOPP) and adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) courses without radiotherapy, Med Pediatr Oncol. 1997 Jul;29(1):23-7

Active substance: CYCLOPHOSPHAMIDE

Study summary document link (including results):

View full study record

Document reference: 25152

Study title: An alternative schedule based on ifosfamide (IFM) in combination with doxorubicin (ADM), vincristin (VCR) and actinomycin D (ACTD) in advanced soft tissue sarcomas (STS) of adults. A pilot study

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25295

Study title: An extensive Ewing's sarcoma of the left ischium treatment by optimal systemic chemotherapy, intra-arterial dactinomycin, and delayed irradiation

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25296

Study title: Analysis of local tumor control in Ewing's sarcoma: preliminary results of a cooperative intergroup study.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25297

Study title: Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25298

Study title: Anaplastic nephrogenic rest 3

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25299

Study title: Antitumoral activity of oxaliplatin/cisplatin-based combination therapy in cisplatin-refractory germ cell cancer patients.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25300

Study title: Biliary emesis as the presenting sign in a neonate with Wilms tumor.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25302

Study title: Matsukado Y et al, Cisplatin, vinblastine and bleomycin (PVB) combination chemotherapy in the treatment of intracranial malignant germ cell tumors--a preliminary report of a, phase II study--The Japanese Intracranial Germ Cell Tumor Study Group, Gan No Rinsho. 1986 Sep;32(11):1387-93. JapaneseMatsukado Y et al, Cisplatin, vinblastine and bleomycin (PVB) combination chemotherapy in the treatment of intracranial malignant germ cell tumors--a preliminary report of a, phase II study--The Japanese Intracranial Germ Cell Tumor Study Group, Gan No Rinsho. 1986 Sep;32(11):1387-93. Japanese

Active substance: CYCLOPHOSPHAMIDE

Study summary document link (including results):

View full study record

Document reference: 25009

Study title: Clinical Study of Daunomycin (NSC-82151) in children with acute leukemia - Holton, C.P., Lonsdale, D., Nora, A. H., Thurman, W.G., Vietti, T.J. - 1968 (Cancer Vol. 22 N° 5, 1014 - 1017) - Publication in the dos. Allemand jan 1981 - Clinical Study of Daunomycin (NSC-82151) in children with acute leukemia - Holton, C.P., Lonsdale, D., Nora, A. H., Thurman, W.G., Vietti, T.J. - 1968 (Cancer Vol. 22 N° 5, 1014 - 1017) - Publication in the dos. Allemand jan 1981 -

Active substance: DAUNORUBICIN

Study summary document link (including results):

View full study record

Document reference: 25571

Study title: Clinical Study of Daunomycin and Prednisone for induction of remission in children with advanced leukemia - Holton, C.P., Vietti, T. J., Nora, A. H., Donaldson, M. H., Stuckey, W. J., Watkins, W. L., Lane, D. M. - 1969 (The New England Journal of Medicine Vol. 280, N°. 4, 171 - 174) - Publication in the dos. Allemand jan 1981 - Clinical Study of Daunomycin and Prednisone for induction of remission in children with advanced leukemia - Holton, C.P., Vietti, T. J., Nora, A. H., Donaldson, M. H., Stuckey, W. J., Watkins, W. L., Lane, D. M. - 1969 (The New England Journal of Medicine Vol. 280, N°. 4, 171 - 174) - Publication in the dos. Allemand jan 1981 -

Active substance: DAUNORUBICIN

Study summary document link (including results):

View full study record

Document reference: 25572

Study title: Bladder and prostatic tumors in the intergroup Rhabdomyosarcoma study (IRS-I): results of therapy.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25303

Study title: Bleomycin, actinomycin-D, and cisplatin treatment of ovarian germ-cell malignancies contributes to reducing adverse drug reactions.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25304

Study title: Bleomycin, cyclophosphamide, and dactinomycin in metastatic osteosarcoma: lack of tumor regression in previously treated patients.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25305

Study title: Carboplatin and etoposide (CarE) combined with radiotherapy and vincristine, doxorubicin and cyclophosphamide (VAC) in limited small cell lung cancer. A phase II study.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25306

Study title: Chemotherapy for testicular cancer: current status of the National Cancer Institute Combined Modality Trial.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25307

Study title: Chemotherapy in osteogenic sarcoma: the experience of the Pediatric Department of the Gustave Roussy Institute.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25308

Study title: Chemotherapy of bladder and prostatic neoplasms in children

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25309

Study title: Chemotherapy of immature ovarian teratomas

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25310

Study title: Chemotherapy of sarcomas-a perspective.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25311

Study title: Chemotherapy-related toxicity in infants treated according to the Second National Wilms' Tumor Study.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25312

Study title: Clinical impact of histologic subtypes in localized non-anaplastic nephroblastoma treated according to the trial and study SIOP-9/GPOH.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25313

Study title: Clinical study of testicular cancer

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25314

Study title: Clinical trial of CCLSG OS-88 protocol in childhood osteosarcoma: Selection of postoperative chemotherapy based on histological tumor response.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25315

Study title: Clinical trial of chlorozotocin, DTIC, and dactinomycin in metastatic malignant melanoma.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25316

Study title: Combination chemotherapy using adriamycin, DTIC, cyclophosphamide, and actinomycin D for advanced soft tissue sarcomas: a randomized comparative trial. A phase III, Southwest Oncology Group Study (7613).

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25317

Study title: Combined chemotherapy in childhood rhabdomyosarcoma.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25318

Study title: Combined chemotherapy of the metastases of testicular teratoblastomas

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25319

Study title: Comparative evaluation of three combination regimens for advanced malignant melanoma: results of an international cooperative study.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25320

Study title: Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25399

Study title: Treatment of rhabdomyosarcoma and other malignant mesenchymal tumours of childhood with ifosfamide + vincristine + dactinomycin (IVA) as front-line therapy (a SIOP study).

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25497

Study title: Treatment of soft tissue sarcoma in childhood and adolescence. A report of the German Cooperative Soft Tissue Sarcoma Study.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25498

Study title: Treatment of soft tissue sarcomas in childhood and adolescence: results of the CWS-81 multicenter therapy study

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25499

Study title: Treatment of unresectable or metastatic pediatric soft tissue sarcomas with surgery, irradiation, and chemotherapy: a Pediatric Oncology Group study.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25500

Study title: Treatment outcomes in patients less than 2 years of age with small, stage I, favorable-histology Wilms' tumors: a report from the National Wilms' Tumor Study.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25502

Study title: Treatment-related myelodysplastic syndrome after chemotherapy for childhood low-grade astrocytoma 2

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25503

Study title: Trial and study on nephroblastomas S.I.O.P. No. 1.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25504

Study title: Tumor response and toxicity after single high-dose versus standard five-day divided-dose dactinomycin in childhood rhabdomyosarcoma.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25505

Study title: Two consecutive phase II window trials of irinotecan alone or in combination with vincristine for the treatment of metastatic rhabdomyosarcoma: the Children's Oncology Group.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25506

Study title: VAB-3 combination chemotherapy of metastatic testicular cancer.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25507

Study title: VAB-4 combination chemotherapy in the treatment of metastatic testis tumors.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25508

Study title: Value of postchemotherapy bioptical verification of complete clinical remission in previously incompletely resected (stage I and II pT3) malignant mesenchymal tumors in children: International Society of Pediatric Oncology 1984 Malignant Mesenchymal Tumors Study.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25509

Study title: Vascular-endothelial-growth-factor (VEGF) expression and possible response to angiogenesis inhibitor bevacizumab in metastatic alveolar soft part sarcoma

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25510

Study title: Vertebral abnormalities after treatment for Ewing sarcoma.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25511

Study title: Weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25512

Active substance: DAUNORUBICIN

Study summary document link (including results):

View full study record

Document reference: 25613

Active substance: DAUNORUBICIN

Study summary document link (including results):

View full study record

Document reference: 25618

Active substance: DAUNORUBICIN

Study summary document link (including results):

View full study record

Document reference: 25622

Study title: Comparison of daunorubicin (NSC-83142) with adriamycin (NSC-123127) in the treatment of late-stage childhood solid tumors. - A.E. Evans, R.L. Baehner, R.L. Chard & coll. - 1974 - Publication in the dos. Français jan 1977 and and in the dos. allemand jan 1981 and in Clinical Expert Report (J.K.H. Rees - 1989) -Comparison of daunorubicin (NSC-83142) with adriamycin (NSC-123127) in the treatment of late-stage childhood solid tumors. - A.E. Evans, R.L. Baehner, R.L. Chard & coll. - 1974 - Publication in the dos. Français jan 1977 and and in the dos. allemand jan 1981 and in Clinical Expert Report (J.K.H. Rees - 1989) -

Active substance: DAUNORUBICIN

Study summary document link (including results):

View full study record

Document reference: 25573

Study title: Rubidomycin. A new agent in the treatment of acute lymphoblastic leukaemia - Jacquillat .C et al. - 1966 - Publication in the dos. allemand jan 1981 and in Clinical Expert Report (J.K.H. Rees - 1989) - Rubidomycin. A new agent in the treatment of acute lymphoblastic leukaemia - Jacquillat .C et al. - 1966 - Publication in the dos. allemand jan 1981 and in Clinical Expert Report (J.K.H. Rees - 1989) -

Active substance: DAUNORUBICIN

Study summary document link (including results):

View full study record

Document reference: 25604

Study title: Tan, C., Tasaka, H. - 1965 (Proc. Amer. Assoc. Cancer Research N°. 6, 64) - Publication in the dos. Allemand jan 1981 - Clinical Studies of Daunomycin - Tan, C., Tasaka, H. - 1965 (Proc. Amer. Assoc. Cancer Research N°. 6, 64) - Publication in the dos. Allemand jan 1981 - Clinical Studies of Daunomycin -

Active substance: DAUNORUBICIN

Study summary document link (including results):

View full study record

Document reference: 25606

Study title: The cardiotoxicity of adriamycin and daunomycin in children - A.C. Gilladoga, C. Manuel, C.T.C. Tan & coll. - 1976 - Publication in the dos. Français jan 1977 and in the dos. Allemand jan 1981 - The cardiotoxicity of adriamycin and daunomycin in children - A.C. Gilladoga, C. Manuel, C.T.C. Tan & coll. - 1976 - Publication in the dos. Français jan 1977 and in the dos. Allemand jan 1981 -

Active substance: DAUNORUBICIN

Study summary document link (including results):

View full study record

Document reference: 25607

Study title: Vincristine, Prednisone, and Daunomycin in acute Leukemia of childhood - Vietti, T. J., Starling, K., Wildbur, J. R., et al. - 1971 (Cancer Vol. 27, 602 - 607) - Publication in the dos. Allemand jan 1981 - Vincristine, Prednisone, and Daunomycin in acute Leukemia of childhood - Vietti, T. J., Starling, K., Wildbur, J. R., et al. - 1971 (Cancer Vol. 27, 602 - 607) - Publication in the dos. Allemand jan 1981 -

Active substance: DAUNORUBICIN

Study summary document link (including results):

View full study record

Document reference: 25609

Study title: Nephrotoxicity of cisplatin and carboplatin in sarcoma patients: A report from the late effects surveillance system

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25400

Study title: Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25402

Study title: Orbital rhabdomyosarcoma in Li-Fraumeni syndrome

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25403

Study title: Osteosarcoma in adolescents and young adults: new developments and controversies. The Childrens Cancer Group (CCG) studies.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25404

Study title: Outcome of patients with stage III or inoperable WT treated on the second United Kingdom WT protocol (UKWT2); a United Kingdom Children's Cancer Study Group (UKCCSG) study.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25405

Study title: Ovarian preservation with gonadotropin-releasing hormone analog during chemotherapy

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25406

Study title: Paratesticular rhabdomyosarcoma in children. Is retroperitoneal lymphadenectomy necessary in disease limited to the scrotum?

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25407

Study title: Pathology teach and tell: Solid variant alveolar rhabdomyosarcoma of the orbit

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25408

Study title: Pediatric oncology

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25409

Study title: Pediatric urologic oncology: bladder, prostate, testis

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25410

Study title: Perianal alveolar rhabdomyosarcoma in a child. Report of a long-term survival case.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25411

Study title: Perlman syndrome: Clinical report and nine-year follow-up

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25412

Study title: Pharmacokinetics of dactinomycin in a pediatric patient population: a United Kingdom Children's Cancer Study Group Study.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25413

Study title: Phase I study of tumor necrosis factor-alpha and actinomycin D in pediatric patients with cancer: a Children's Cancer Group study.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25414

Study title: Phase II study demonstrating failure of both a five-drug continuous-therapy regimen and a two-drug pulse-therapy regimen in the treatment of metastatic neuroblastoma: Southwest Oncology Group Study 822.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25415

Study title: Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25416

Study title: Pleural effusion in wilms tumor after tru-cut biopsy 1

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25417

Study title: POMB/ACE chemotherapy in non-seminomatous germ cell tumours: outcome and importance of dose intensity.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25418

Study title: PRE OPERATIVE VS POST OPERATIVE RADIO THERAPY SINGLE VS MULTIPLE COURSES OF ACTINOMYCIN D IN THE TREATMENT OF WILMS TUMOR PRELIMINARY RESULTS OF A CONTROLLED CLINICAL TRIAL CONDUCTED BY THE INTERNATIONAL SOCIETY OF PEDIATRIC ONCOLOGY

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25419

Study title: Preliminary evaluation of the toxicity and effectiveness of chemotherapy using the VAB-6 protocol in the treatment of non-seminoma of the testis

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25420

Study title: Preoperative chemotherapy of nephroblastoma. Preliminary results of the SIOP-9/GPO therapy study

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25421

Study title: Preoperative versus postoperative radiotherapy, single versus multiple courses of actinomycin D, in the treatment of Wilms' tumor. Preliminary results of a controlled clinical trial conducted by the International Society of Paediatric Oncology (S.I.O.P.).

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25422

Study title: Brady K. M., Atkinson S., Kilty L. A., Hiles D. A., J Cataract Refract Surg 1997; 23 Suppl. 1: 669

Active substance: DEXAMETHASONE AND FRAMYCETIN AND GRAMICIDIN

Study summary document link (including results):

View full study record

Document reference: 25731

Study title: Clinical Expert Statement of Framycetin sulfate containing formulations. - Dr R. Ohlrogge - 7 Apr.2004

Active substance: DEXAMETHASONE AND FRAMYCETIN AND GRAMICIDIN

Study summary document link (including results):

View full study record

Document reference: 25726

Study title: Küchle H. J., Busse H., Augenerkrankungen im Kindesalter, Thieme Verlag Stuttgart New York 1985Küchle H. J., Busse H., Augenerkrankungen im Kindesalter, Thieme Verlag Stuttgart New York 1985

Active substance: DEXAMETHASONE AND GENTAMYCIN

Study summary document link (including results):

View full study record

Document reference: 25733

Study title: Ocular hypertensive and anti-inflammatory responses to different dosages of topical dexamethasone in children: a randomized trial.Lam DS, Fan DS, Ng JS, Yu CB, Wong CY, Cheung AY. Clin Experiment Ophthalmol. 2005 Jun;33(3):252-8. Comment in: Clin Experiment Ophthalmol. 2005 Jun;33(3):229-30. PMID: 15932523. Ocular hypertensive and anti-inflammatory responses to different dosages of topical dexamethasone in children: a randomized trial.Lam DS, Fan DS, Ng JS, Yu CB, Wong CY, Cheung AY. Clin Experiment Ophthalmol. 2005 Jun;33(3):252-8. Comment in: Clin Experiment Ophthalmol. 2005 Jun;33(3):229-30. PMID: 15932523.

Active substance: DEXAMETHASONE AND GENTAMYCIN

Study summary document link (including results):

View full study record

Document reference: 25734

Study title: Wiltshaw E et al Ifosfamide plus mesna with and without adriamycin in soft tissue sarcoma Cancer Chemother Pharmacol. 1986;18 Suppl 2:S10-2Wiltshaw E et al Ifosfamide plus mesna with and without adriamycin in soft tissue sarcoma Cancer Chemother Pharmacol. 1986;18 Suppl 2:S10-2

Active substance: CYCLOPHOSPHAMIDE

Study summary document link (including results):

View full study record

Document reference: 25163

Study title: Comparison of pulse methotrexate and pulse dactinomycin in the treatment of low-risk gestational trophoblastic neoplasia.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25321

Study title: Comparison of the efficacy of imidazole-carboxamide and of a combination of nitrosomethylurea, vincristine and dactinomycin in disseminated melanoma

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25322

Study title: Competing risks analysis of patients with osteosarcoma: a comparison of four different approaches.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25323

Study title: Concurrent combination chemotherapy of human solid tumors: experience with a three-drug regimen and review of the literature.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25324

Study title: Congenital disseminated malignant rhabdoid tumor of the soft tissue 2

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25325

Study title: Congenital sacrococcygeal primitive neuroectodermal tumor.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25326

Study title: Conjunctival rhabdomyosarcoma presenting as a squamous papilloma 29

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25327

Active substance: DAUNORUBICIN

Study summary document link (including results):

View full study record

Document reference: 25614

Active substance: DAUNORUBICIN

Study summary document link (including results):

View full study record

Document reference: 25619

Active substance: DAUNORUBICIN

Study summary document link (including results):

View full study record

Document reference: 25623

Study title: Coordinated treatment of childhood rhabdomyosarcoma with surgery, radiotherapy, and combination chemotherapy.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25328

Study title: Current phase III clinical trials investigating pediatric cancers

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25329

Study title: Cyclophosphamide dose escalation in combination with vincristine and actinomycin-D (VAC) in gross residual sarcoma. A pilot study without hematopoietic growth factor support evaluating toxicity and response.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25330

Study title: Dacarbazine (DTIC)-based chemotherapy or chemoimmunotherapy of patients with disseminated malignant melanoma.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25331

Study title: Desmoptastic small round cell tumor of meckels diverticulum

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25332

Study title: Dose intensity of chemotherapy for osteosarcoma and outcome in the Cooperative Osteosarcoma Study Group (COSS) trials

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25334

Study title: Doxorubicin for favorable histology, Stage II-III Wilms tumor: results from the National Wilms Tumor Studies.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25335

Study title: Effect of duration of treatment on treatment outcome for patients with clear-cell sarcoma of the kidney: a report from the National Wilms' Tumor Study Group.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25337

Study title: Effectiveness of chemotherapy of advanced forms of neuroblastoma in children according to the program of the RWPG

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25338

Study title: Effectiveness of rhGM-CSF mouthwashes on chemotherapy induced mucositis in childhood solid tumors

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25339

Study title: Effects of different magnitudes of cyclic stretch on Na+-K+-ATPase in skeletal muscle cells in vitro.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25340

Study title: Effects of oral glutamine supplementation on children with solid tumors receiving chemotherapy

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25341

Study title: Efficacy of carboplatin given in a phase II window study to children and adolescents with newly diagnosed metastatic soft tissue sarcoma

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25342

Study title: Efficacy of topotecan and cyclophosphamide given in a phase II window trial in children with newly diagnosed metastatic rhabdomyosarcoma: a Children's Oncology Group study.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25343

Study title: EMA-EP regimen, as firstline multiple agent chemotherapy in high-risk GTT patients (stage II-IV).

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25344

Study title: Emergence of secondary acute lymphoblastic leukemia of Burkitt type after treatment of rhabdomyosarcoma.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25345

Study title: Endometrioid variant of yolk sac tumour 1

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25346

Study title: ETV6-NTRK3 gene fusion in metastasizing congenital fibrosarcoma.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25347

Study title: W.W. Sutow, T.J. Vietti, D. Lonsdale & coll. - 1972 - Publication in the dos. Français jan 1977 - Daunomycin in the treatment of metastatic soft tissue sarcoma in children - W.W. Sutow, T.J. Vietti, D. Lonsdale & coll. - 1972 - Publication in the dos. Français jan 1977 - Daunomycin in the treatment of metastatic soft tissue sarcoma in children -

Active substance: DAUNORUBICIN

Study summary document link (including results):

View full study record

Document reference: 25610

Study title: Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651.

Active substance: DACTINOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25423

Study title: Daunomycin - induced cardiotoxicity in children and adults - Von Hoff, D. D., Rozencweig, M. Layard, M. Slavik, M. Muggia, A. M. - 1977 (The American Journal of Medicine Vol. 62, 200 - 208) - Publication in the dos. Allemand jan 1981 - Daunomycin - induced cardiotoxicity in children and adults - Von Hoff, D. D., Rozencweig, M. Layard, M. Slavik, M. Muggia, A. M. - 1977 (The American Journal of Medicine Vol. 62, 200 - 208) - Publication in the dos. Allemand jan 1981 -

Active substance: DAUNORUBICIN

Study summary document link (including results):

View full study record

Document reference: 25576

Study title: Daunomycin , an antitumour antibiotic in the treatment of neoplastic disease - Tan C. et al. - 1967 - Publication in Clinical Expert Report (J.K.H. Rees - 1989) and in the dos. Allemand jan 1981 - Daunomycin , an antitumour antibiotic in the treatment of neoplastic disease - Tan C. et al. - 1967 - Publication in Clinical Expert Report (J.K.H. Rees - 1989) and in the dos. Allemand jan 1981 -

Active substance: DAUNORUBICIN

Study summary document link (including results):

View full study record

Document reference: 25578

Study title: Daunomycin (NSC - 82151) in the treatment of metastatic neuroblastoma - Sutow, W. W., Fernbach, D.J., Thurman, W. G., et al. - 1970 (Cancer Chemother. Reports Part 1 Vol. 54 No. 4, 283 - 289) - Publication in the dos. Allemand jan 1981 - Daunomycin (NSC - 82151) in the treatment of metastatic neuroblastoma - Sutow, W. W., Fernbach, D.J., Thurman, W. G., et al. - 1970 (Cancer Chemother. Reports Part 1 Vol. 54 No. 4, 283 - 289) - Publication in the dos. Allemand jan 1981 -

Active substance: DAUNORUBICIN

Study summary document link (including results):

View full study record

Document reference: 25577

Study title: Efficacy of diclofenac versus dexamethasone for treatment after strabismus surgery.Snir M, Axer-Siegel R, Friling R, Weinberger D. Ophthalmology. 2000 Oct;107(10):1884-8. 4. Postoperative miotics for patients with infantile esotropia.Spierer A, Zeeli T. Ophthalmic Surg Lasers. 1997 Dec;28(12):1002-5. Efficacy of diclofenac versus dexamethasone for treatment after strabismus surgery.Snir M, Axer-Siegel R, Friling R, Weinberger D. Ophthalmology. 2000 Oct;107(10):1884-8. 4. Postoperative miotics for patients with infantile esotropia.Spierer A, Zeeli T. Ophthalmic Surg Lasers. 1997 Dec;28(12):1002-5.

Active substance: DEXAMETHASONE AND GENTAMYCIN AND TETRYZOLINE

Study summary document link (including results):

View full study record

Document reference: 25736

Active substance: DEXAMETHASONE AND GENTAMYCIN AND TETRYZOLINE

Study summary document link (including results):

View full study record

Document reference: 25738

Active substance: DEXAMETHASONE AND GENTAMYCIN AND TETRYZOLINE

Study summary document link (including results):

View full study record

Document reference: 25741

Active substance: DEXAMETHASONE AND GENTAMYCIN AND TETRYZOLINE

Study summary document link (including results):

View full study record

Document reference: 25735

Active substance: DEXAMETHASONE AND GENTAMYCIN AND TETRYZOLINE

Study summary document link (including results):

View full study record

Document reference: 25737

Study title: Single-dose kanamycin therapy of gonococcal ophthalmia neonatorum. Fransen L, Nsanze H, D'Costa L, Brunham RC, Ronald AR, Piot P. Lancet. 1984 Dec 1;2(8414):1234-7.Single-dose kanamycin therapy of gonococcal ophthalmia neonatorum. Fransen L, Nsanze H, D'Costa L, Brunham RC, Ronald AR, Piot P. Lancet. 1984 Dec 1;2(8414):1234-7.

Active substance: DEXAMETHASONE AND GENTAMYCIN AND TETRYZOLINE

Study summary document link (including results):

View full study record

Document reference: 25740

Active substance: DEXAMETHASONE AND GENTAMYCIN AND TETRYZOLINE

Study summary document link (including results):

View full study record

Document reference: 25739

Study title: Efficacy of diclofenac versus dexamethasone for treatment after strabismus surgery.Snir M, Axer-Siegel R, Friling R, Weinberger D. Ophthalmology. 2000 Oct;107(10):1884-8. Efficacy of diclofenac versus dexamethasone for treatment after strabismus surgery.Snir M, Axer-Siegel R, Friling R, Weinberger D. Ophthalmology. 2000 Oct;107(10):1884-8.

Active substance: DEXAMETHASONE AND NEOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25743

Study title: Sposto R et al. Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children's Cancer Group. Med Pediatr Oncol. 2001 Nov;37(5):432-41.Sposto R et al. Comparison of long-term outcome of children and adolescents with disseminated non-lymphoblastic non-Hodgkin lymphoma treated with COMP or daunomycin-COMP: A report from the Children's Cancer Group. Med Pediatr Oncol. 2001 Nov;37(5):432-41.

Active substance: CYCLOPHOSPHAMIDE

Study summary document link (including results):

View full study record

Document reference: 25131

Active substance: DEXAMETHASONE AND NEOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25746

Active substance: DEXAMETHASONE AND NEOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25742

Active substance: DEXAMETHASONE AND NEOMYCIN

Study summary document link (including results):

View full study record

Document reference: 25745

Study title: TO ASSESS THE EFFICACY AND SAFETY OF FLUCONAZOLE I.V. (+ AMPHOTERICIN B BY ORAL ROUTE) VS. PLACEBO I.V. (+AMPHOTERICIN B BY ORAL ROUTE) TO PREVENT THE ONSET OF INFECTIONS WITH A MYCOTIC ETIOLOGY IN MULTICOLONIZED NEUTROPENIC PATIENTS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27825

Study title: TO ASSESS THE EFFICACY AND TOLERATION OF VIBRAMYCINE (DOXYCYCLIN) IN THE TREATMENT OF PATIENTS WITH ACUTE RESPIRATORY TRACT INFECTIONS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27334

Study title: Zuluaga A comparison of oral itraconazole with griseofulvin in the treaement of tinea corporis and tinea cruris. A double-blind study. Clinical summary on R51211, August 1987 (11-64 years, LMD56445)Zuluaga A comparison of oral itraconazole with griseofulvin in the treaement of tinea corporis and tinea cruris. A double-blind study. Clinical summary on R51211, August 1987 (11-64 years, LMD56445)

Active substance: ITRACONAZOLE

Study summary document link (including results):

View full study record

Document reference: 30787

Study title: Non-interventional study on the use of Kanamycin-POS® in children; Küchle H. J., Busse H., Augenerkrankungen im Kindesalter, Thieme Verlag Stuttgart New York 1985

Active substance: KANAMYCIN

Study summary document link (including results):

View full study record

Document reference: 30828

Study title: AN OPEN NON-COMPARATIVE MULTICENTRE STUDY OF THE EFFICACY AND TOLERATION OF UNASYN (SULTAMICILLIN) ORAL IN THE TREATMENT OF COMMUNITY-ACQUIRED MILD-MODERATE BACTERIAL INFECTIONS IN GENERAL PRACTICE

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43041

Study title: AN OPEN NON-COMPARATIVE STUDY OF THE EFFICACY AND TOLERATION OF STM IN THE TREATMENT OF GENERAL BACTERIAL INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42994

Study title: AN OPEN NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL SULTAMICILLIN (25MG/KG) IN THE TREATMENT OF MILD TO MODERATE TONSILLITIS INFECTIONS BY STREPTOCOCCUS B HEMOLYTIC.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43026

Study title: AN OPEN NON-COMPARATIVE STUDY OF UNASYN ORAL (BRAND OF SULTAMICILLIN ) IN VARIOUS INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43049

Study title: AN OPEN NON-COMPARATIVE STUDY OF UNASYN ORAL (BRAND OF SULTAMICILLIN) IN VARIOUS INFECTIONS

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42974

Study title: AN OPEN NON-COMPARATIVE STUDY OF UNASYN ORAL (BRAND OF SULTAMICILLIN) IN VARIOUS INFECTIONS

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43050

Study title: AN OPEN NON-COMPARATIVE STUDY OF UNASYN ORAL (BRAND OF SULTAMICILLIN) IN VARIOUS INFECTIONS

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43051

Study title: AN OPEN NON-COMPARATIVE STUDY OF UNASYN ORAL (BRAND OF SULTAMICILLIN) IN VARIOUS INFECTIONS

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43052

Study title: AN OPEN NON-COMPARATIVE STUDY OF UNASYN ORAL (BRAND OF SULTAMICILLIN) IN VARIOUS INFECTIONS

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43053

Study title: A bacteriological study of the middle ear and upper respiratory tract in children with chronic secretory otitis media.Mills et al., Clin Otolaryngol Allied Sci. 1985 Dec;10(6):335-41A bacteriological study of the middle ear and upper respiratory tract in children with chronic secretory otitis media.Mills et al., Clin Otolaryngol Allied Sci. 1985 Dec;10(6):335-41

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46818

Study title: A clinical and therapeutic study of 29 patients with infantile acne.Cunliffe et al., Br J Dermatol. 2001 Sep;145(3):463-6.A clinical and therapeutic study of 29 patients with infantile acne.Cunliffe et al., Br J Dermatol. 2001 Sep;145(3):463-6.

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46793

Study title: Paediatric nosocomial urinary tract infection at a regional hospital.Orrett et al., Int Urol Nephrol. 1999;31(2):173-9Paediatric nosocomial urinary tract infection at a regional hospital.Orrett et al., Int Urol Nephrol. 1999;31(2):173-9

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46799

Study title: Positive correlation between the age of patients and the degree of antimicrobial resistance among urinary strains of Escherichia coli.Arstila et al., J Infect. 1994 Jul;29(1):9-16Positive correlation between the age of patients and the degree of antimicrobial resistance among urinary strains of Escherichia coli.Arstila et al., J Infect. 1994 Jul;29(1):9-16

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46804

Study title: Prenatally diagnosed reflux: a follow-up study.Gordon et al., Br J Urol. 1990 Apr;65(4):407-12Prenatally diagnosed reflux: a follow-up study.Gordon et al., Br J Urol. 1990 Apr;65(4):407-12

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46809

Study title: Presence of bacteriuria caused by trimethoprim resistant bacteria in patients prescribed antibiotics: multilevel model with practice and individual patient data.Donnan et al., BMJ. 2004 May 29;328(7451):1297Presence of bacteriuria caused by trimethoprim resistant bacteria in patients prescribed antibiotics: multilevel model with practice and individual patient data.Donnan et al., BMJ. 2004 May 29;328(7451):1297

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46779

Study title: Prevalence of carriage of antimicrobial resistant strains of Streptococcus pneumoniae in primary school children in Hong Kong.Boost MV et al., Epidemiol Infect. 2001 Aug;127(1):49-55Prevalence of carriage of antimicrobial resistant strains of Streptococcus pneumoniae in primary school children in Hong Kong.Boost MV et al., Epidemiol Infect. 2001 Aug;127(1):49-55

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46792

Study title: Primary vesicoureteral reflux detected in neonates with a history of fetal renal pelvis dilatation: a prospective clinical and imaging study.Ismaili et al., J Pediatr. 2006 Feb;148(2):222-7.Primary vesicoureteral reflux detected in neonates with a history of fetal renal pelvis dilatation: a prospective clinical and imaging study.Ismaili et al., J Pediatr. 2006 Feb;148(2):222-7.

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46774

Study title: Prior trimethoprim use and trimethoprim-resistant urinary tract infection: a nested case–control study with multivariate analysis for other risk factors.Steinke etal., Journal of Antimicrobial Chemotherapy (2001) 47, 781-787Prior trimethoprim use and trimethoprim-resistant urinary tract infection: a nested case–control study with multivariate analysis for other risk factors.Steinke etal., Journal of Antimicrobial Chemotherapy (2001) 47, 781-787

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46780

Study title: Response to antibiotics of women with symptoms of urinary tract infection but negative dipstick urine test results: double blind randomised controlled trial.Richards et al., BMJ. 2005 Jul 16;331(7509):143. Epub 2005 Jun 22.Response to antibiotics of women with symptoms of urinary tract infection but negative dipstick urine test results: double blind randomised controlled trial.Richards et al., BMJ. 2005 Jul 16;331(7509):143. Epub 2005 Jun 22.

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46777

Study title: Risk factors for the nasopharyngeal carriage of respiratory pathogens by Portuguese children: phenotype and antimicrobial susceptibility of Haemophilus influenzae and Streptococcus pneumoniae.Neto et al., Microb Drug Resist. 2003 Spring;9(1):99-108Risk factors for the nasopharyngeal carriage of respiratory pathogens by Portuguese children: phenotype and antimicrobial susceptibility of Haemophilus influenzae and Streptococcus pneumoniae.Neto et al., Microb Drug Resist. 2003 Spring;9(1):99-108

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46785

Study title:

Active substance: FLUOROMETHOLONE AND GENTAMYCIN

Study summary document link (including results):

View full study record

Document reference: 28261

Study title: Ruiz Alvez, M et al. Medical report of the clinical comparative study with 0.3% Gentamicin and 0.1% Fluorometholone eye drops in comparison with 0.35% Neomicine and 0.1% Fluorometholone eye drops in therapy of bacterial conjunctivitis. May 18, 1989. (age range 4-76 years)

Active substance: FLUOROMETHOLONE AND GENTAMYCIN

Study summary document link (including results):

View full study record

Document reference: 28260

Study title: AN OPEN NON-COMPARATIVE STUDY OF UNASYN ORAL (BRAND OF SULTAMICILLIN) IN VARIOUS INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42973

Study title: AN OPEN NON-COMPARATIVE STUDY, Q COMBINATION OF SULBACTAM SODIUM WITH AMPICILLIN IN SERIOUS INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42914

Study title: AN OPEN NONCOMPARATIVE STUDY OF UNASYN ORAL (BRAND OF STM) IN VARIOUS INFECTIONS

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42972

Study title: AN OPEN NONCOMPARATIVE STUDY OF UNASYN ORAL (BRAND OF STM) IN VARIOUS INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42996

Study title: AN OPEN STUDY OF THE EFFICACY AND SAFETY OF SULBACTAM/AMPICILLIN ADMINISTERED PARENTERALLY AND SULTAMICILLIN ADMINISTERED ORALLY IN CHILDHOOD SKELETAL INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42918

Study title: AN OPEN STUDY OF THE EFFICACY AND TOLERANCE OF SULTAMICILLIN IN THE IN THE TREATMENT OF PEDIATRIC PATIENTS WITH CHRONIC OTITIS MEDIA

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43014

Study title: AN OPEN STUDY OF THE SAFETY AND EFFICACY OF ORAL SULTAMICILLIN IN THE TREATMENT OF MILD TO MODERATE UPPER RESPIRATORY TRACT INFECTIONS IN ADULTS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43039

Study title: AN OPEN STUDY OF THE SAFETY AND EFFICACY OF ORAL SULTAMICILLIN IN THE TREATMENT OF MILD TO MODERATE URTI IN ADULTS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43040

Study title: AN OPEN, NON COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF SULTAMICILLIN FOR THE TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS IN CHILDREN.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42995

Study title: CLINICAL EVALUATION OF STM FINE GRANULES FOR THE TREATMENT OF ACUTE SINUSITIS OF CHILDREN.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43009

Study title: CLINICAL EVALUATION OF STM FINE GRANULES FOR THE TREATMENT OF ACUTE SUPPURATIVE OTITIS MEDIA OF CHILDREN.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43008

Study title: A cross-national study of acute otitis media: risk factors, severity, and treatment at initial visit. Report from the International Primary Care Network (IPCN) and the Ambulatory Sentinel Practice Network (ASPN).Froom et al., J Am Board Fam Pract. 2001 Nov-Dec;14(6):406-17A cross-national study of acute otitis media: risk factors, severity, and treatment at initial visit. Report from the International Primary Care Network (IPCN) and the Ambulatory Sentinel Practice Network (ASPN).Froom et al., J Am Board Fam Pract. 2001 Nov-Dec;14(6):406-17

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46789

Study title: Acute lymphoblastic leukaemia: trimethoprim resistant organisms during treatment.McDowell et al., Arch Dis Child. 1987 Jun;62(6):573-5.Acute lymphoblastic leukaemia: trimethoprim resistant organisms during treatment.McDowell et al., Arch Dis Child. 1987 Jun;62(6):573-5.

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46816

Study title: Age differences in trimethoprim pharmacokinetics: need for revised dosing in children?Hoppu K., Clin Pharmacol Ther. 1987 Mar;41(3):336-43.Age differences in trimethoprim pharmacokinetics: need for revised dosing in children?Hoppu K., Clin Pharmacol Ther. 1987 Mar;41(3):336-43.

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46817

Study title: An open, comparative study on trimethoprim and doxycycline in the treatment of acute bronchitis.Haukijärvi et al., Br J Dermatol. 1989 Nov;121(5):623-8.J Chemother. 1989 Jul;1(4 Suppl):798-9An open, comparative study on trimethoprim and doxycycline in the treatment of acute bronchitis.Haukijärvi et al., Br J Dermatol. 1989 Nov;121(5):623-8.J Chemother. 1989 Jul;1(4 Suppl):798-9

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46811

Study title: Antibacterial prophylaxis in children with urinary tract infection.Bollgren I, Acta Paediatr Suppl. 1999 Nov;88(431):48-52.Antibacterial prophylaxis in children with urinary tract infection.Bollgren I, Acta Paediatr Suppl. 1999 Nov;88(431):48-52.

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46798

Study title: Antibiotic failure in the treatment of urinary tract infections in young women.Lawrenson et al., J Antimicrob Chemother. 2001 Dec;48(6):895-901Antibiotic failure in the treatment of urinary tract infections in young women.Lawrenson et al., J Antimicrob Chemother. 2001 Dec;48(6):895-901

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46790

Study title: Antibiotic treatment for five days is effective in children with acute cystitis.Abrahamsson et al., Acta Paediatr. 2002;91(1):55-8.Antibiotic treatment for five days is effective in children with acute cystitis.Abrahamsson et al., Acta Paediatr. 2002;91(1):55-8.

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46787

Study title: Antimicrobial resistance in Escherichia coli in urine samples from children and adults: a 12 year analysis.Abelson Storby et al., Acta Paediatr. 2004 Apr;93(4):487-91Antimicrobial resistance in Escherichia coli in urine samples from children and adults: a 12 year analysis.Abelson Storby et al., Acta Paediatr. 2004 Apr;93(4):487-91

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46778

Study title: Antimicrobial resistance in fecal flora: longitudinal community-based surveillance of children from urban Mexico.Calva et al., Antimicrob Agents Chemother. 1996 Jul;40(7):1699-702Antimicrobial resistance in fecal flora: longitudinal community-based surveillance of children from urban Mexico.Calva et al., Antimicrob Agents Chemother. 1996 Jul;40(7):1699-702

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46802

Study title: Antimicrobial resistance of Shigella spp isolated from diarrheal patients between 1989 and 1998 in Vietnam.Anh et al., Southeast Asian J Trop Med Public Health. 2001 Dec;32(4):856-62.Antimicrobial resistance of Shigella spp isolated from diarrheal patients between 1989 and 1998 in Vietnam.Anh et al., Southeast Asian J Trop Med Public Health. 2001 Dec;32(4):856-62.

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46786

Study title: Percutaneous nephrostomy in children with ureteropelvic junction obstruction and poor renal function.Gupta et al., Urology. 2001 Mar;57(3):547-50.Percutaneous nephrostomy in children with ureteropelvic junction obstruction and poor renal function.Gupta et al., Urology. 2001 Mar;57(3):547-50.

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46794

Study title: Skin reactions to antibacterial agents in general practice.van der Linden et al., J Clin Epidemiol. 1998 Aug;51(8):703-8Skin reactions to antibacterial agents in general practice.van der Linden et al., J Clin Epidemiol. 1998 Aug;51(8):703-8

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46800

Study title: Strategy of acne therapy with long-term antibiotics.Hughes et al., Br J Dermatol. 1989 Nov;121(5):623-8.Strategy of acne therapy with long-term antibiotics.Hughes et al., Br J Dermatol. 1989 Nov;121(5):623-8.

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46810

Study title: [The treatment of uncomplicated lower-urinary tract infection: a single dose of trimethoprim as opposed to 10 days with pipemidic acid].Ponce de León Roca et al., Aten Primaria. 1992 Jan;9(1):53[The treatment of uncomplicated lower-urinary tract infection: a single dose of trimethoprim as opposed to 10 days with pipemidic acid].Ponce de León Roca et al., Aten Primaria. 1992 Jan;9(1):53

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46806

Study title: Transferable antibiotic resistance in Escherichia coli isolated from healthy Nigerian school children.Lamikanra et al., Int J Antimicrob Agents. 1996 May;7(1):59-64.Transferable antibiotic resistance in Escherichia coli isolated from healthy Nigerian school children.Lamikanra et al., Int J Antimicrob Agents. 1996 May;7(1):59-64.

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46803

Study title: Trimethoprim in the treatment of acute urinary tract infections in children.Hoppu et al., Int J Clin Pharmacol Ther Toxicol. 1988 Feb;26(2):65-8.Trimethoprim in the treatment of acute urinary tract infections in children.Hoppu et al., Int J Clin Pharmacol Ther Toxicol. 1988 Feb;26(2):65-8.

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46812

Study title: Trimethoprim pharmacokinetics in children with renal insufficiency.Hoppu et al., Clin Pharmacol Ther. 1987 Aug;42(2):181-6.Trimethoprim pharmacokinetics in children with renal insufficiency.Hoppu et al., Clin Pharmacol Ther. 1987 Aug;42(2):181-6.

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46815

Study title: Uncomplicated urinary tract infections. Bacterial findings and efficacy of empirical antibacterial treatment.Grude et al., Scand J Prim Health Care. 2005 Jun;23(2):115-9.Uncomplicated urinary tract infections. Bacterial findings and efficacy of empirical antibacterial treatment.Grude et al., Scand J Prim Health Care. 2005 Jun;23(2):115-9.

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46776

Study title: Urinary tract infections, antibiotic resistance and sales of antimicrobial drugs--an observational study of uncomplicated urinary tract infections in Icelandic women.Olafsson et al., Scand J Prim Health Care. 2000 Mar;18(1):35-8.Urinary tract infections, antibiotic resistance and sales of antimicrobial drugs--an observational study of uncomplicated urinary tract infections in Icelandic women.Olafsson et al., Scand J Prim Health Care. 2000 Mar;18(1):35-8.

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46796

Study title: Single dose treatment of cystitis in children.Lidefelt et al., Acta Paediatr Scand. 1991 Jun-Jul;80(6-7):648-53Single dose treatment of cystitis in children.Lidefelt et al., Acta Paediatr Scand. 1991 Jun-Jul;80(6-7):648-53

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46807

Study title: CONCERNTRATIONS OF SULTAMICILLIN IN SERUM AND MIDDLE EAR FLUID OF CHILDREN WITH ACUTE SUPPURATIVE OTITIS MEDIA WITH EFFUSION.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42913

Study title: DOUBLE BLIND COMPARATIVE STUDY OF SULTAMICILLIN IN THE TREATMENT OF DERMAL INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42906

Study title: DOUBLE BLIND STUDY IN OTITIS MEDIA TREATED WITH SULTAMICILLIN VS. CEFACTOR.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42908

Study title: DOUBLE BLIND STUDY IN TONSILLITIS TREATED WITH SULTAMICILLIN VS. CEFACLOR.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42907

Study title: DOUBLE BLIND STUDY IN UTI TREATED WITH SULTAMICILLIN VS. CEFADROXIL.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42909

Study title: DRUG SURVEILLANCE STUDY OF ORAL SULTAMICILLIN VS. AMOXICILLIN-CLAVULANIC ACID IN THE TREATMENT OF PATIENTS WITH COMMUNITY-ACQUIRED INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42976

Study title: EFFICACY AND SAFETY OF SBT/AMP,STM IN PEDIATRIC PATIENTS WITH MOD-SEVERE INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42945

Study title: EFFICACY AND SAFETY OF STM IN CYSTIC FIBROSIS INFECTED WITH HAEMOPHILUS INFLUENZA AND/OR STAPHYLOCOCCUS AUREUS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43032

Study title: EFFICACY AND SAFETY OF SULTAMICILLIN (DUOCID ORAL) IN THE TREATMENT OF ACUTE SUPPURATIVE OTITIS MEDIA AN OPEN NON-COMPARATIVE, MULTICENTER (3 CENTERS) STUDY.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43056

Study title: EFFICACY AND SAFETY OF SULTAMICILLIN IN ACUTE URINARY INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43031

Study title: EFFICACY AND SAFETY OF SULTAMICILLIN IN ADULTS WITH NOSOCOMIAL ACUTE BACTERIA INFECTIONS OF LOWER RESPIRATORY TRACT.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43001

Study title: EFFICACY AND SAFETY OF SULTAMICILLIN IN CHILDREN WITH ARI.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43027

Study title: EFFICACY AND SAFETY OF SULTAMICILLIN IN CHILDREN WITH BACTERIAL INFECTIONS OF UPPER RESPIRATORY TRACT.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43003

Study title: EFFICACY AND SAFETY OF SULTAMICILLIN IN CHILDREN WITH NOT NOSOCOMIAL ACUTE BACTERIAL INFECTIONS OF LOWER RESPIRATORY TRACT.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43002

Study title: EFFICACY AND SAFETY OF SULTAMICILLIN IN CHILDREN WITH SLIGHT AND MODERATE URTI

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42967

Study title: EFFICACY AND SAFETY OF SULTAMICILLIN IN PATIENTS WITH ACUTE URINARY INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43029

Study title: EFFICACY AND SAFETY OF SULTAMICILLIN IN PATIENTS WITH ORAL INFECTIONS

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43028

Study title: EFFICACY AND SAFETY OF SULTAMICILLIN IN PEDIATRIC PATIENTS WITH UPPER RESPIRATORY TRACT INFECTION.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43000

Study title: COMPARATIVE STUDY OF SULTAMICILLIN WITH OR WITHOUT LACTOBACILLUS. TO GET A PREVENTIVE MEASURE OF DIARRHEA AND LOOSE STOOL IN PEDIATRICS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43005

Study title: EFFICACY AND SAFETY OF SULTAMICILLIN IN SKIN AND SOFT TISSUES INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43030

Study title: EFFICACY AND SAFETY OF SULTAMICILLIN IN THE TREATMENT OF PEDIATRIC INFECTIONS OF BACTERIAL ETIOLOGY--OPEN, NON-COMPARATIVE STUDY

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43055

Study title: EFFICACY AND SAFETY OF SULTAMICILLIN IN TREATMENT OF RESPIRATORY TRACT, SKIN AND SOFT TISSUE, UT AND ENT INFECTIONS OF BACTERIAL ETIOLOGY--OPEN PARALLEL COMPARATIVE STUDY VERSUS CLAVULANIC ACID + AMOXYCILLIN

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43054

Study title: Cephalosporin resistant urinary tract infections in young children. Mehr et al., J Paediatr Child Health. 2004 Jan-Feb;40(1-2):48-52.Cephalosporin resistant urinary tract infections in young children. Mehr et al., J Paediatr Child Health. 2004 Jan-Feb;40(1-2):48-52.

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46782

Study title: Children with trimethoprim- and ampicillin-resistant fecal Escherichia coli in day care centers.Reves et al., J Infect Dis. 1987 Nov;156(5):758-62Children with trimethoprim- and ampicillin-resistant fecal Escherichia coli in day care centers.Reves et al., J Infect Dis. 1987 Nov;156(5):758-62

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46814

Study title: Cinoxacin vs trimethoprim--safety and efficacy in the prophylaxis of uncomplicated urinary tract infections.Seppänen J, Drugs Exp Clin Res. 1988;14(10):669-71Cinoxacin vs trimethoprim--safety and efficacy in the prophylaxis of uncomplicated urinary tract infections.Seppänen J, Drugs Exp Clin Res. 1988;14(10):669-71

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46813

Study title: Colonization and persistence of antibiotic-resistant Enterobacteriaceae strains in infants nursed in two neonatal intensive care units in East London, United Kingdom.Millar et al., J Clin Microbiol. 2008 Feb;46(2):560-7. Epub 2007 Nov 26.Colonization and persistence of antibiotic-resistant Enterobacteriaceae strains in infants nursed in two neonatal intensive care units in East London, United Kingdom.Millar et al., J Clin Microbiol. 2008 Feb;46(2):560-7. Epub 2007 Nov 26.

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46771

Study title: Decision making, evidence, audit, and education: case study of antibiotic prescribing in general practice.Lipman et al., BMJ. 2000 Apr 22;320(7242):1114-8.Decision making, evidence, audit, and education: case study of antibiotic prescribing in general practice.Lipman et al., BMJ. 2000 Apr 22;320(7242):1114-8.

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46797

Study title: Diagnosis-prescribing surveys in 2000, 2002 and 2005 in Swedish general practice: Consultations, diagnosis, diagnostics and treatment choices.Andre et al., Scand J Infect Dis. 2008 Apr 1:1-7. [Epub ahead of print]Diagnosis-prescribing surveys in 2000, 2002 and 2005 in Swedish general practice: Consultations, diagnosis, diagnostics and treatment choices.Andre et al., Scand J Infect Dis. 2008 Apr 1:1-7. [Epub ahead of print]

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46770

Study title: Difference in trimethoprim pharmacokinetics between children and adults.Hoppu et al., Chemotherapy. 1984;30(5):283-7.Difference in trimethoprim pharmacokinetics between children and adults.Hoppu et al., Chemotherapy. 1984;30(5):283-7.

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46819

Study title: Distribution of patterns of sensitivity and associated phenotypes of resistance in nosocomial and community acquired Escherichia coli during 2005.García et al., Rev Esp Quimioter. 2008 Sep;21(3):157-65Distribution of patterns of sensitivity and associated phenotypes of resistance in nosocomial and community acquired Escherichia coli during 2005.García et al., Rev Esp Quimioter. 2008 Sep;21(3):157-65

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46769

Study title: Drug utilisation in outpatient children. A comparison among Tenerife, Valencia, and Barcelona (Spain), Toulouse (France), Sofia (Bulgaria), Bratislava (Slovakia) and Smolensk (Russia.Sanz et al., Eur J Clin Pharmacol. 2004 Apr;60(2):127-34. Epub 2004 Mar 12Drug utilisation in outpatient children. A comparison among Tenerife, Valencia, and Barcelona (Spain), Toulouse (France), Sofia (Bulgaria), Bratislava (Slovakia) and Smolensk (Russia.Sanz et al., Eur J Clin Pharmacol. 2004 Apr;60(2):127-34. Epub 2004 Mar 12

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46781

Study title: EFFICACY AND SECURITY OF SULTAMICILLIN IN PATIENTS WITH MILD TO MODERATE INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42966

Study title: EFFICACY AND TOLERANCE OF PARENTERAL SULBACTAM/AMPICILLIN AND ORAL UNASYN IN CHILDREN AND ADULTS WITH MODERATE TO SEVERE INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43058

Study title: EFFICACY AND TOLERANCE OF SULTAMICILLIN IN THE TREATMENT OF MILD TO MODERATE INFECTIONS IN CHILDREN AND ADULTS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43057

Study title: EFFICACY AND TOLERANCE OF SULTAMICILLIN VS. AMPICILLIN IN CHILDREN WITH ACUTE DIARRHEA.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43013

Study title: EFFICACY AND TOLERATION OF SULBACTAM/AMPICILLIN IM FOLLOWED BY SULTAMICILLIN PO IN NON-SEVERE INFECTIONS IN GENERAL PRACTICE.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42946

Study title: EFFICACY AND TOLERATION OF SULTAMICILLIN GIVEN ORALLY B.I.D. IN ADULTS WITH GYNECOLOGICAL OR OBSTETRIC INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42985

Study title: EFFICACY AND TOLERATION OF SULTAMICILLIN GIVEN ORALLY IN PATIENTS WITH RESPIRATORY TRACT INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42984

Study title: EFFICACY AND TOLERATION OF SULTAMICILLIN PO IN ADULTS WITH ENT INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42987

Study title: TO COMPARE THE CLINICAL AND MYCOLOGIC EFFECTIVENESS AND SAFETY OF A SINGLE 150 MG ORAL DOSE OF FLUCONAZOLE VS. 3 DAYS OF ORAL DOSES OF ITRACONAZOLE GIVEN AT 200 MG PER DAY IN THE TREATMENT OF VAGINAL

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27595

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27958

Study title: TO COMPARE THE EFFICACY AND SAFETY OF FLUCONAZOLE AND AMPHOTERICIN B IN THE PREVENTION OF FUNGAL INFECTIONS; WITH ACUTE LEUKEMIA DURING THE PERIOD OF APLASIA.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27450

Study title: TO COMPARE THE EFFICACY AND SAFETY OF FLUCONAZOLE AND AMPHOTERICIN B IN THE PREVENTION OF FUNGAL INFECTIONS; WITH ACUTE LEUKEMIA DURING THE PERIOD OF APLASIA.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27814

Study title: TO COMPARE THE EFFICACY AND SAFETY OF FLUCONAZOLE VS. AMPHOTERICIN IN THE TREATMENT OF CHRONIC ATROPHIC ERYTHEMATOUS CANDIDIASIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27667

Study title: TO COMPARE THE EFFICACY AND SAFETY OF FLUCONAZOLE VS. AMPHOTERICIN IN THE TREATMENT OF CHRONIC ATROPHIC ERYTHEMATOUS CANDIDIASIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 28029

Study title: EFFICACY AND TOLERATION OF SULTAMICILLIN PO IN ADULTS WITH SKIN AND SOFT TISSUE INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42986

Study title: EFFICACY AND TOLERATION OF SULTAMICILLIN PO IN CHILDREN WITH BACTERIAL INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42988

Study title: EFFICACY AND TOLERATION OF SULTAMICILLIN VS AMOXICILLIN IN PEDIATRIC INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42998

Study title: EFFICACY AND TOLERATION OF UNASYN IN PEDIATRIC INFECTIONS

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43015

Study title: Enterotoxigenic Escherichia coli causing cholerogenic syndrome during an interepidemic period of cholera in North India.Taneja et al., Jpn J Infect Dis. 2006 Aug;59(4):245-8Enterotoxigenic Escherichia coli causing cholerogenic syndrome during an interepidemic period of cholera in North India.Taneja et al., Jpn J Infect Dis. 2006 Aug;59(4):245-8

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46772

Study title: Factors associated with antibiotic resistance in coliform organisms from community urinary tract infection in Wales.Howard et al., J Antimicrob Chemother. 2001 Mar;47(3):305-13.Factors associated with antibiotic resistance in coliform organisms from community urinary tract infection in Wales.Howard et al., J Antimicrob Chemother. 2001 Mar;47(3):305-13.

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46795

Study title: High rates of antibiotic resistance among normal fecal flora Escherichia coli isolates in children from Greece.Vatopoulos et al., Clin Microbiol Infect. 1998;4(10):563-569.High rates of antibiotic resistance among normal fecal flora Escherichia coli isolates in children from Greece.Vatopoulos et al., Clin Microbiol Infect. 1998;4(10):563-569.

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46788

Study title: Incidence & enteropathogenicity of Aeromonas spp in children suffering from acute diarrhoea in Chennai.Komathi et al., Indian J Med Res. 1998 Jun;107:252-6Incidence & enteropathogenicity of Aeromonas spp in children suffering from acute diarrhoea in Chennai.Komathi et al., Indian J Med Res. 1998 Jun;107:252-6

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46801

Study title: Increased rates of trimethoprim resistance in uncomplicated urinary tract infection: cause for concern?Mangin et al., N Z Med J. 2005 Nov 11;118(1225):U1726Increased rates of trimethoprim resistance in uncomplicated urinary tract infection: cause for concern?Mangin et al., N Z Med J. 2005 Nov 11;118(1225):U1726

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46775

Study title: Increasing antibiotic resistance among urinary tract isolates.Ladhani et al., Arch Dis Child. 2003 May;88(5):444-5.Increasing antibiotic resistance among urinary tract isolates.Ladhani et al., Arch Dis Child. 2003 May;88(5):444-5.

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46784

Study title: Long-term antibiotics for preventing recurrent urinary tract infection in children.(2)Williams et al., Cochrane Database Syst Rev. 2001;(4):CD001534.Long-term antibiotics for preventing recurrent urinary tract infection in children.(2)Williams et al., Cochrane Database Syst Rev. 2001;(4):CD001534.

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46791

Study title: Long-term antibiotics for preventing recurrent urinary tract infection in children.Williams et al., Cochrane Database Syst Rev. 2006 Jul 19;3:CD001534Long-term antibiotics for preventing recurrent urinary tract infection in children.Williams et al., Cochrane Database Syst Rev. 2006 Jul 19;3:CD001534

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46773

Study title: Nitrofurantoin versus trimethoprim prophylaxis in recurrent urinary tract infection in children. A randomized, double-blind study.Brendstrup et al., Acta Paediatr Scand. 1990 Dec;79(12):1225-34.Nitrofurantoin versus trimethoprim prophylaxis in recurrent urinary tract infection in children. A randomized, double-blind study.Brendstrup et al., Acta Paediatr Scand. 1990 Dec;79(12):1225-34.

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46808

Study title: Occurrence of Salmonella typhi and Salmonella paratyphi in Jordan.Battikhi MN., New Microbiol. 2003 Oct;26(4):363-73.Occurrence of Salmonella typhi and Salmonella paratyphi in Jordan.Battikhi MN., New Microbiol. 2003 Oct;26(4):363-73.

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46783

Study title: Oral trimethoprim as a third-line antibiotic in the management of acne vulgaris.Bottomley et al., Dermatology. 1993;187(3):193-6.Oral trimethoprim as a third-line antibiotic in the management of acne vulgaris.Bottomley et al., Dermatology. 1993;187(3):193-6.

Active substance: TRIMETHOPRIM

Study summary document link (including results):

View full study record

Document reference: 46805

Study title: TO COMPARE THE EFFICACY AND SAFETY OF ORAL FLUCONAZOLE GIVEN AS A SINGLE ORAL DOSE OF 150 MG PER WEEK OR 50 MG 3 TIMES PER WEEK FOR THE PREVENTION OF ORO-PHARYNGEAL CANDIDIASIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27451

Study title: TO COMPARE THE EFFICACY AND SAFETY OF ORAL FLUCONAZOLE GIVEN AS A SINGLE ORAL DOSE OF 150 MG PER WEEK OR 50 MG 3 TIMES PER WEEK FOR THE PREVENTION OF ORO-PHARYNGEAL CANDIDIASIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27815

Study title: TO COMPARE THE EFFICACY OF FLUCONAZOLE TO ORAL AMPHOTERICIN AND NYSTATIN IN THE PREVENTION OF FUNGAL INFECTION IN PATIENTS WITH HEMATOLOGICAL DISEASE RECEIVING CHEMOTHERAPY.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27668

Study title: TO COMPARE THE EFFICACY OF FLUCONAZOLE TO ORAL AMPHOTERICIN AND NYSTATIN IN THE PREVENTION OF FUNGAL INFECTION IN PATIENTS WITH HEMATOLOGICAL DISEASE RECEIVING CHEMOTHERAPY.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 28030

Study title: TO COMPARE THE EFFICACY OF FLUCONAZOLE VS. ORAL KETOCONAZOLE IN THE PREVENTION OF FUNGAL INFECTION IN PATIENTS RECEIVING CHEMOTHERAPY FOR HEMATOLOGICAL DISEASE.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27666

Study title: TO COMPARE THE EFFICACY OF FLUCONAZOLE VS. ORAL NYSTATIN IN THE PREVENTION OF FUNGAL INFECTION IN PATIENTS RECEIVING CHEMOTHERAPY FOR HEMATOLOGICAL DISEASE.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27665

Study title: TO COMPARE THE EFFICACY OF FLUCONAZOLE VS. ORAL NYSTATIN IN THE PREVENTION OF FUNGAL INFECTION IN PATIENTS RECEIVING CHEMOTHERAPY FOR HEMATOLOGICAL DISEASE.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 28027

Study title: Combination chemotherapy (vincristine, adriamycin, cyclophosphamide, and 5-fluorouracil) in the treatment of children with malignant hepatoma. Evans AE et al. Cancer. 1982 Sep 1;50(5):821-6

Active substance: FLUOROURACIL

Study summary document link (including results):

View full study record

Document reference: 28323

Study title: Kostromina V.P.et al: Estimation of detoxicational effects of antihomotoxic medicines in the treatment of children suffering from relapsing bronchitis and infected with mycobacteria. Biological Therapy (Ukraine), 2007, 3: 20-23 [IIT-publication]

Active substance: Mucosa compositum

Study summary document link (including results):

View full study record

Document reference: 40077

Study title: A 12-month, multicenter, open, single arm, pilot study to evaluate the safety, tolerability and efficacy of Myfortic® in combination with Neoral® and steroids in paediatric de novo renal transplant patients

Active substance: MYCOPHENOLIC ACID

Study summary document link (including results): Myfortic_publication of Article 45 result-related information_final Aug 2011.xls

View full study record

Document reference: 47289

Study title: A prospective, open label, multicenter, international protocol to assess the efficacy and safety of Myfortic® in kidney transplant recipients

Active substance: MYCOPHENOLIC ACID

Study summary document link (including results): Myfortic_publication of Article 45 result-related information_final Aug 2011.xls

View full study record

Document reference: 32437

Study title: "A meta-analysisi of randomized, controlled trials comparing short and long-course antibiotic therapy for urinary tract infections in children - Keren R. - 2002 (Pediatrics, 109,5) - Publication in CES EXPCRC-CES0164-EN01 - Eugène D. - 25 Apr. 2003 -"

Active substance: Nalidixic acid

Study summary document link (including results):

View full study record

Document reference: 32455

Study title: Nalidixic acid : Critical assessment on the pharmacotoxicological documentation - Gouy D. - 23 May 2003

Active substance: NALIDIXIC ACID

Study summary document link (including results):

View full study record

Document reference: 32454

Study title: Publication in the critical assessment on the pharmacotoxicological documentation - Gouy D. - 23 May 2003 : Quinolone arthropathy in juvenile New Zealand White rabbits.- Sharpnack DD. - 1994

Active substance: Nalidixic acid

Study summary document link (including results):

View full study record

Document reference: 32456

Study title: Publication in the critical assessment on the pharmacotoxicological documentation - Gouy D. - 23 May 2003 : Review of quinolone arthropathy in the dog. - Burkhardt JE - 1996 (Chemotherapy Journal, 5, 13:14-18)

Active substance: Nalidixic acid

Study summary document link (including results):

View full study record

Document reference: 32457

Study title: De Beule K, Van Cutsem J, Cauwenbergh G, Wesel S, Herman PH, Baekelandt J, Houben PWM, Scheurwegh W, Godts P. Oral itraconazole versus topical clotrimazole in acute vulvovaginal candidosis: a randomized comparative trial. Clinical research report on R051211 no-101, May 1989.(16-65 years, LMD68115)De Beule K, Van Cutsem J, Cauwenbergh G, Wesel S, Herman PH, Baekelandt J, Houben PWM, Scheurwegh W, Godts P. Oral itraconazole versus topical clotrimazole in acute vulvovaginal candidosis: a randomized comparative trial. Clinical research report on R051211 no-101, May 1989.(16-65 years, LMD68115)

Active substance: ITRACONAZOLE

Study summary document link (including results):

View full study record

Document reference: 30816

Study title: De Beulke K, Van Cutsem J, Cauwenbergh G. Itraconazole: A one-day oral treatment for vaginal candidosis: results of an open multicentre study. Clinical research report on R051211 no-100, March 1989. (15-64 years, LMD65820)De Beulke K, Van Cutsem J, Cauwenbergh G. Itraconazole: A one-day oral treatment for vaginal candidosis: results of an open multicentre study. Clinical research report on R051211 no-100, March 1989. (15-64 years, LMD65820)

Active substance: ITRACONAZOLE

Study summary document link (including results):

View full study record

Document reference: 30815

Study title: Decroix J, et al Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea pedis and tinea manus. Clinical research report on R051211 no-70, May 1987. (10-75 years, LMD56441)Decroix J, et al Double-blind comparison of itraconazole with griseofulvin in the treatment of tinea pedis and tinea manus. Clinical research report on R051211 no-70, May 1987. (10-75 years, LMD56441)

Active substance: ITRACONAZOLE

Study summary document link (including results):

View full study record

Document reference: 30786

Study title: Decroix J, et al Open evaluation of itraconazole at daily doses of 50, 100, and 150 mg in the treatment of dermatophyte infections of the skin. A study of the time to response. Clinical summary on R51211, August 1987. (6-81 years, LMD56453)Decroix J, et al Open evaluation of itraconazole at daily doses of 50, 100, and 150 mg in the treatment of dermatophyte infections of the skin. A study of the time to response. Clinical summary on R51211, August 1987. (6-81 years, LMD56453)

Active substance: ITRACONAZOLE

Study summary document link (including results):

View full study record

Document reference: 30795

Study title: Degreef H, Marien K, De Veylder H, Duprez K, Borghys A, Verhoeve L Itraconazole in the treatment of dermatophytoses: A comparison of two daily dosages. Reviews of infectious diseases 9 suppl.1, p.S104-S108, 1987. (6-81 years, LMD45556)Degreef H, Marien K, De Veylder H, Duprez K, Borghys A, Verhoeve L Itraconazole in the treatment of dermatophytoses: A comparison of two daily dosages. Reviews of infectious diseases 9 suppl.1, p.S104-S108, 1987. (6-81 years, LMD45556)

Active substance: ITRACONAZOLE

Study summary document link (including results):

View full study record

Document reference: 30798

Study title: Del Palacio Hernanz A double-blind randomized comparison of itraconazole with griseofulvin in the treatment of tinea pedis and tinea manus. Clinical research report on R051211 no-62, May 1987. (17-54 years, LMD56440)Del Palacio Hernanz A double-blind randomized comparison of itraconazole with griseofulvin in the treatment of tinea pedis and tinea manus. Clinical research report on R051211 no-62, May 1987. (17-54 years, LMD56440)

Active substance: ITRACONAZOLE

Study summary document link (including results):

View full study record

Document reference: 30785

Study title: Del Palacio Hernanz A double-blind randomized comparison of itraconazole with griseofulvin in the treatment ot tinea corporis ans tinea cruris. Clinical research report on R051211 no-64, May 1987. (17-67 years, LMD56219)Del Palacio Hernanz A double-blind randomized comparison of itraconazole with griseofulvin in the treatment ot tinea corporis ans tinea cruris. Clinical research report on R051211 no-64, May 1987. (17-67 years, LMD56219)

Active substance: ITRACONAZOLE

Study summary document link (including results):

View full study record

Document reference: 30783

Study title: Del Palacio Hernanz A, Delgado Vicente S, Menendez Ramos F, Rodriquez-Noriega Belaustegui A. Radomized comparative clinical trial of itraconazole and selenium sulfide shampoo for the treatment of pityriasis vesicolor. Reviews of infectious diseases 9 suppl.1, p.S121-S127, 1987. (17-63 years, LMD45550)Del Palacio Hernanz A, Delgado Vicente S, Menendez Ramos F, Rodriquez-Noriega Belaustegui A. Radomized comparative clinical trial of itraconazole and selenium sulfide shampoo for the treatment of pityriasis vesicolor. Reviews of infectious diseases 9 suppl.1, p.S121-S127, 1987. (17-63 years, LMD45550)

Active substance: ITRACONAZOLE

Study summary document link (including results):

View full study record

Document reference: 30802

Study title: Del Palacio Hernanz A, Frias-Iniesta J, Gonzalez-Valle O, Borgers M, Van Cutsem J, Cauvwenbergh G. Itraconazole therapy in pityriasis versicolor. British journal of dermatology 115, p.217-225, 1986. (17-71 years, LMD45458)Del Palacio Hernanz A, Frias-Iniesta J, Gonzalez-Valle O, Borgers M, Van Cutsem J, Cauvwenbergh G. Itraconazole therapy in pityriasis versicolor. British journal of dermatology 115, p.217-225, 1986. (17-71 years, LMD45458)

Active substance: ITRACONAZOLE

Study summary document link (including results):

View full study record

Document reference: 30803

Study title: SAFETY AND EFFICACY OF ORAL AND INTRAVENOUS FLUCONAZOLE IN PATIENTS WITH OROPHARYNGEAL CANDIDIASIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27422

Study title: SAFETY AND EFFICACY OF ORAL AND INTRAVENOUS FLUCONAZOLE IN PATIENTS WITH OROPHARYNGEAL CANDIDIASIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27424

Study title: SAFETY AND EFFICACY OF ORAL AND INTRAVENOUS FLUCONAZOLE IN PATIENTS WITH OROPHARYNGEAL CANDIDIASIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27787

Study title: SAFETY AND EFFICACY OF ORAL AND INTRAVENOUS FLUCONAZOLE IN PATIENTS WITH OROPHARYNGEAL CANDIDIASIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27789

Study title: SAFETY AND EFFICACY OF ORAL AND INTRAVENOUS FLUCONAZOLE IN PATIENTS WITH SYSTEMIC CANDIDIASIS OR CRYPTOCOCCAL MENINGITIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27410

Study title: SAFETY AND EFFICACY OF ORAL AND INTRAVENOUS FLUCONAZOLE IN PATIENTS WITH SYSTEMIC CANDIDIASIS OR CRYPTOCOCCAL MENINGITIS.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27775

Study title: F. Rosaschino, L. Cattaneo, Strategies for optimizing compliance of paediatric patients for seasonal antibacterial vaccination with sublingually administered Polyvalent Mechanical Bacterial Lysates (PMBL), ACTA BIO MEDICA ATENEO PARMENSE 2004; 75; 171-178,

Active substance: Klebsiella pneumoniae;Streptococcus pyogenes;Diplococcus pneumoniae;Staphylococcus aureus;Neisseria catarrhalis;Streptococcus viridans;Haemophilus influenzae;Klebsiella ozaenae;

Study summary document link (including results):

View full study record

Document reference: 41339

Study title: I. La Mantia, F. Nicolosi, L. Maiolino, A. Serra, Immunoprophylaxis of recurring bacterial infections of respiratory tracts in pediatric age: clinical experience through a new immunostimulating vaccine, GIMMOC Quaderni di Microbiologia e Clinica, Vol XI, Q2, 2007, p1-8.

Active substance: Klebsiella pneumoniae;Streptococcus pyogenes;Diplococcus pneumoniae;Staphylococcus aureus;Neisseria catarrhalis;Streptococcus viridans;Haemophilus influenzae;Klebsiella ozaenae;

Study summary document link (including results):

View full study record

Document reference: 41338

Study title: SAFETY AND EFFICACY OF TWO DIFFERENT DOSAGE OF FLUCONAZOLE IN PATIENTS WITH TINEA VERSICOLOR.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27370

Study title: SAFETY AND EFFICACY OF TWO DIFFERENT DOSAGE OF FLUCONAZOLE IN PATIENTS WITH TINEA VERSICOLOR.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27735

Study title: SAFETY, ACCEPTANCE, TOLERATION AND EFFICACY OF FLUCONAZOLE IN COMPARISON WITH ORAL POLYENES IN PATIENTS ON ISOLATION. ALSO TO ESTIMATE FEASIBILITY OF SUCH A TRIAL IN MULTICENTER SETTING.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27395

Study title: SAFETY, ACCEPTANCE, TOLERATION AND EFFICACY OF FLUCONAZOLE IN COMPARISON WITH ORAL POLYENES IN PATIENTS ON ISOLATION. ALSO TO ESTIMATE FEASIBILITY OF SUCH A TRIAL IN MULTICENTER SETTING.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27760

Study title: SECONDARY PREVENTION OF OROPHARYNGEAL CANDIDIASIS IN HIV+ PATIENTS. A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, CONTROLLED STUDY WITH FOCUS ON RESISTANCE TO FLUCONAZOLE THERAPY.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27402

Study title: SECONDARY PREVENTION OF OROPHARYNGEAL CANDIDIASIS IN HIV+ PATIENTS. A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, CONTROLLED STUDY WITH FOCUS ON RESISTANCE TO FLUCONAZOLE THERAPY.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27767

Study title: SINGLE DOSE THERAPY FOR ORAL CANDIDIASIS WITH FCA IN HIV-INFECTED ADULTS: A PILOT STUDY.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27392

Study title: SINGLE DOSE THERAPY FOR ORAL CANDIDIASIS WITH FCA IN HIV-INFECTED ADULTS: A PILOT STUDY.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27757

Study title: STUDY TO ASSESS THE PHARMACOKINETICS OF A SINGLE ORAL OR INTRAVENOUS DOSE OF FLUCONAZOLE ADMINISTERED TO FULL TERM NEONATES

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27339

Study title: Di Fonzo EM, Biggio P, Tulli A, Binazzi M, Ippolito F Oral itraconazole in the treatment of dermatomycoses. August 1987. (12-68 years, LMD56449)Di Fonzo EM, Biggio P, Tulli A, Binazzi M, Ippolito F Oral itraconazole in the treatment of dermatomycoses. August 1987. (12-68 years, LMD56449)

Active substance: ITRACONAZOLE

Study summary document link (including results):

View full study record

Document reference: 30791

Study title: Dom J, Goyvaerts H, Moens M, Schuermans V, Cauwenbergh G. Itraconazole in the treatment of pityriasis versicolor. A combined analysis of 15 clinical trials including about 600 patients. Clinical research report on R051211 no-68, June 1987. (10-78 years, LMD56299)Dom J, Goyvaerts H, Moens M, Schuermans V, Cauwenbergh G. Itraconazole in the treatment of pityriasis versicolor. A combined analysis of 15 clinical trials including about 600 patients. Clinical research report on R051211 no-68, June 1987. (10-78 years, LMD56299)

Active substance: ITRACONAZOLE

Study summary document link (including results):

View full study record

Document reference: 30812

Study title: Dominguez L, Lavalle P, Peremans W, 'T Kint R, Willemsen M, Mertens RLJ. Itraconazole for 2 or 4 weeks in the treatment of dermatophyte infections of the skin: A combined analysis of double-blind placebo-controlled studies. Clinical research report on R051211 no-78, June 1987. (15-69 years, LMD56443)Dominguez L, Lavalle P, Peremans W, 'T Kint R, Willemsen M, Mertens RLJ. Itraconazole for 2 or 4 weeks in the treatment of dermatophyte infections of the skin: A combined analysis of double-blind placebo-controlled studies. Clinical research report on R051211 no-78, June 1987. (15-69 years, LMD56443)

Active substance: ITRACONAZOLE

Study summary document link (including results):

View full study record

Document reference: 30781

Study title: Duran de Rueda MM Oral itraconazole in the treatment of tinea pedis. Clinical summary on R51211, August 1987. (16-83 years, LMD56455)Duran de Rueda MM Oral itraconazole in the treatment of tinea pedis. Clinical summary on R51211, August 1987. (16-83 years, LMD56455)

Active substance: ITRACONAZOLE

Study summary document link (including results):

View full study record

Document reference: 30797

Study title: O. T.Aksic, F.Rosaschino, L. Cattaneo, The evaluation of the clinical efficacy of a Polyvalent Mechanical Bacterial Lysate (PMBL) in a sample of 180 children of school age with recurrent respiratory infections, European Journal of Aerobiology, Environmental Medicine and Air-borne Infections, Vol 1, number 1/2005, p3-7

Active substance: Klebsiella pneumoniae;Streptococcus pyogenes;Diplococcus pneumoniae;Staphylococcus aureus;Neisseria catarrhalis;Streptococcus viridans;Haemophilus influenzae;Klebsiella ozaenae;

Study summary document link (including results):

View full study record

Document reference: 41340

Study title: A CLINICAL EVALUATION OF STM FINE GRANULES FOR SUPPURATIVE OTITIS MEDIA OF CHILDREN.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43007

Study title: A COMPARATIVE PHARMACOKINETIC STUDY OF SULTAMICILLIN (CP-49,952) AND AMPICILLIN IN INFANTS AND YOUNG CHILDREN.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42915

Study title: A COMPARATIVE STUDY OF STM IN THE TREATMENT OF ACUTE TONSILLITIS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42958

Study title: A COMPARATIVE STUDY OF STM IN THE TREATMENT OF SUPPURATIVE OTITIS MEDIA

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42959

Study title: A COMPARATIVE STUDY OF SULTAMICILLIN AND AUGMENTIN IN THE TREATMENT OF ACUTE SUPPURATIVE OTITIS MEDIA IN CHILDREN.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42911

Study title: A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH AMOXYCILLIN OR CLOXACILLIN, AS APPROPRIATE, IN THE TREATMENT OF INFECTION IN CHILDREN.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42938

Study title: A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH AMOXYCILLIN OR CLOXACILLIN, AS APPROPRIATE, IN THE TREATMENT OF INFECTION IN CHILDREN.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42939

Study title: A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH AMOXYCILLIN OR CLOXACILLIN, AS APPROPRIATE, IN THE TREATMENT OF INFECTION IN CHILDREN.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42940

Study title: A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH AMOXYCILLIN OR CLOXACILLIN, AS APPROPRIATE, IN THE TREATMENT OF INFECTION IN CHILDREN.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42941

Study title: A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH AMOXYCILLIN OR CLOXACILLIN, AS APPROPRIATE, IN THE TREATMENT OF INFECTION IN CHILDREN.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42942

Study title: A DOUBLE BLIND COMPARATIVE STUDY OF STM IN THE TREATMENT OF DERMAL INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42957

Study title: A DOUBLE-BLIND COMPARATIVE STUDY OF STM IN THE TREATMENT OF COMPLICATED URINARY TRACT INFECTIONS

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42960

Study title: A MULTICENTER NON-COMPARATIVE STUDY FOR THE TREATMENT OF MODERATE UPPER RESPIRATORY TRACT INFECTION IN ADULT PATIENTS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43045

Study title: A MULTICENTER NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF STM FOR THE TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS IN PEDIATRIC PATIENTS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43044

Study title: A MULTICENTER STUDY OF SULTAMICILLIN (CP-49,952) A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICLLIN COMPARED WITH FLUCLOXACILLIN IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42943

Study title: Evaluation of itraconazole oral solution in infants with oral thrush: an open trial comparing three, five or seven days of treatment with ten days of nystatin treatment.

Active substance: ITRACONAZOLE

Study summary document link (including results):

View full study record

Document reference: 45128

Study title: Evaluation of itraconazole solution in infants with oral thrush: a multicentre trial comparing four different treatment durations.

Active substance: ITRACONAZOLE

Study summary document link (including results): LMD129326_Interventional_Itraconazole.xls

View full study record

Document reference: 45127

Study title: Feuilhade M Oral itraconazole in the treatment of tinea pedis and tinea manus. Clinical summary on R51211, August 1987. (16-57 years, LMD56452)Feuilhade M Oral itraconazole in the treatment of tinea pedis and tinea manus. Clinical summary on R51211, August 1987. (16-57 years, LMD56452)

Active substance: ITRACONAZOLE

Study summary document link (including results):

View full study record

Document reference: 30794

Study title: Goyvaerts H, Dom J, De Dier AM, Schuermans V, Cauwenbergh G. Itraconazole in the treatment of vulvovaginal yeast infections. A combined analysis of 18 clinical trials in 1374 patients. Clinical research report on R051211 no-72, June 1987. (16-79 years, LMD56319)Goyvaerts H, Dom J, De Dier AM, Schuermans V, Cauwenbergh G. Itraconazole in the treatment of vulvovaginal yeast infections. A combined analysis of 18 clinical trials in 1374 patients. Clinical research report on R051211 no-72, June 1987. (16-79 years, LMD56319)

Active substance: ITRACONAZOLE

Study summary document link (including results):

View full study record

Document reference: 30814

Study title: Graybill J. Bone radiography and serum calcium and phosphorus levels during itraconazole treatment in a young patient with progressive coccidioidomycosis. Clinical research report on R051211 no-66, June 1987. (1.5 years, LMD56178)Graybill J. Bone radiography and serum calcium and phosphorus levels during itraconazole treatment in a young patient with progressive coccidioidomycosis. Clinical research report on R051211 no-66, June 1987. (1.5 years, LMD56178)

Active substance: ITRACONAZOLE

Study summary document link (including results):

View full study record

Document reference: 30806

Study title: Hay RJ, Clayton YM Treatment of chronic dermatophytosis and chronic oral candidosis with oral itraconazole. Reviews of infectious diseases 9 suppl.1, p.S114-S118, 1987. (16-52 years, LMD45551)Hay RJ, Clayton YM Treatment of chronic dermatophytosis and chronic oral candidosis with oral itraconazole. Reviews of infectious diseases 9 suppl.1, p.S114-S118, 1987. (16-52 years, LMD45551)

Active substance: ITRACONAZOLE

Study summary document link (including results):

View full study record

Document reference: 30799

Study title: Hay RJ, Clayton YM. Treatment of chronic dermatophytosis and chronic oral candidosis with itraconazole. Reviews of infectious diseases 9 suppl.1, p.S114-S118, 1987. (16-52 years, LMD45551)Hay RJ, Clayton YM. Treatment of chronic dermatophytosis and chronic oral candidosis with itraconazole. Reviews of infectious diseases 9 suppl.1, p.S114-S118, 1987. (16-52 years, LMD45551)

Active substance: ITRACONAZOLE

Study summary document link (including results):

View full study record

Document reference: 30801

Study title: Hull PR, Decroix J Double-blind comparison of itraconazole 100 MG o.d. with griseofulvin 500 mg o.d. in the treatment of dermatophyte infections of the skin. A combined analysis of two studies ot the time to negativation and time to response. Clinical research report on R051211 no-80, August 1987. (6-58 years, LMD56457)Hull PR, Decroix J Double-blind comparison of itraconazole 100 MG o.d. with griseofulvin 500 mg o.d. in the treatment of dermatophyte infections of the skin. A combined analysis of two studies ot the time to negativation and time to response. Clinical research report on R051211 no-80, August 1987. (6-58 years, LMD56457)

Active substance: ITRACONAZOLE

Study summary document link (including results):

View full study record

Document reference: 30782

Study title: Kamp H, et al Oral itraconazole in the treatment of dermatomycoses. Clinical summary on R51211, August 1987. (13-82 years, LMD56446)Kamp H, et al Oral itraconazole in the treatment of dermatomycoses. Clinical summary on R51211, August 1987. (13-82 years, LMD56446)

Active substance: ITRACONAZOLE

Study summary document link (including results):

View full study record

Document reference: 30788

Study title: Ketele A et al. Itraconazole in the treatment of dermatomycoses. A combined analysis of 18 clinical trials including over 1400 patients.Clinical research on R051211 no-70, May 1987. (10-75 years, LMD56441)Ketele A et al. Itraconazole in the treatment of dermatomycoses. A combined analysis of 18 clinical trials including over 1400 patients.Clinical research on R051211 no-70, May 1987. (10-75 years, LMD56441)

Active substance: ITRACONAZOLE

Study summary document link (including results):

View full study record

Document reference: 30776

Study title: Lachapelle JM et al. Itraconazole compared with griseofulvin in the treatment of Tinea corporis/cruris and Tinea pedis/manus: an interpretation of the clinical results of all completed double-blind studies with respect to the pharmacokinetic profile. Dermatology 184:45, 1992. (6-58 years, LMD81740)Lachapelle JM et al. Itraconazole compared with griseofulvin in the treatment of Tinea corporis/cruris and Tinea pedis/manus: an interpretation of the clinical results of all completed double-blind studies with respect to the pharmacokinetic profile. Dermatology 184:45, 1992. (6-58 years, LMD81740)

Active substance: ITRACONAZOLE

Study summary document link (including results):

View full study record

Document reference: 30780

Study title: Assessment of tolerance and immunogenicity of a ViCPs vaccine at 2 dosages

Active substance: Typhoid Vi Polysaccharide Vaccine

Study summary document link (including results):

View full study record

Document reference: 47480

Study title: Double blind, controlled trial testing the immunogenicity and side effects of parenteral Vi polysaccharide typhoid vaccine in Indonesian children and adults

Active substance: Typhoid Vi Polysaccharide Vaccine

Study summary document link (including results):

View full study record

Document reference: 47483

Study title: Effectiveness of a Vi capsular polysaccharide vaccine

Active substance: Typhoid Vi Polysaccharide Vaccine

Study summary document link (including results):

View full study record

Document reference: 47481

Study title: Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi

Active substance: Typhoid Vi Polysaccharide Vaccine

Study summary document link (including results):

View full study record

Document reference: 47479

Study title: Safety and dose related immunogenicity of the Vi capsular polysaccharide of Salmonella typhi (Pilot study)

Active substance: Typhoid Vi Polysaccharide Vaccine

Study summary document link (including results):

View full study record

Document reference: 47478

Study title: Safety and immunogenicity of Vi CPS vaccine in teenagers

Active substance: Typhoid Vi Polysaccharide Vaccine

Study summary document link (including results):

View full study record

Document reference: 47482

Study title: A MULTICENTER SULTAMICILLIN (CP-45,952) PHASE II STUDY. A CONTROLLED TRIAL TO ASSESS THE SAFETY AND EFFICACY OF SULTAMICILLIN COMPARED WITH CLOXACILLIN IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42927

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42928

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42929

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42930

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42931

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42932

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42933

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42934

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42935

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42936

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42937

Study title: A MULTICENTER SULTAMICILLIN (CP-49,952-15) PHASE III STUDY. A THIRD PARTY BLINDED COMPARATIVE STUDY OF SULTAMICILLIN (CP-49,952-15) AND AUGMENTIN FOR THE ASSESSMENT OF EFFICACY IN THE TREATMENT OF LOWER RESPIRATORY TRACT INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42912

Study title: A NON COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF SULTAMICILLIN FOR THE TREATMENT OF SKIN AND SOFT TISSUE PEDIATRIC INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43037

Study title: A NON COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF SULTAMICILLIN FOR THE TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42971

Study title: A NON-COMPARATIVE SHORT-TERM, OPEN STUDY OF EFFICACY AND TOLERABILITY OF ORAL SULTAMICILLIN SUSPENSION IN THE TREATMENT OF VARIOUS INFECTIONS IN PEDIATRIC INPATIENTS/OUTPATIENTS

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42989

Study title: A NON-COMPARATIVE STUDY OF SAFETY AND EFFICACY OF ORAL SULTAMICILLIN IN THE TREATMENT OF MODERATE PEDIATRIC INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43042

Study title: A NON-COMPARATIVE STUDY OF SAFETY AND EFFICACY OF ORAL SULTAMICILLIN IN THE TREATMENT OF MODERATE PEDIATRIC INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43043

Study title: A NON-COMPARATIVE STUDY OF SULTAMICILLIN SUSPENSION IN THE TREATMENT OF ACUTE SUPPURATIVE OTITIS MEDIA IN CHILDREN.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42920

Study title: Månsson T., Blychert LO, Åberg Å. The efficacy of itraconazole in dermatophyte infections in comparison with griseofulvin. Clinical study report, Janssen Pharma, Sweden, 1993. (12-72 years, LMD102676)Månsson T., Blychert LO, Åberg Å. The efficacy of itraconazole in dermatophyte infections in comparison with griseofulvin. Clinical study report, Janssen Pharma, Sweden, 1993. (12-72 years, LMD102676)

Active substance: ITRACONAZOLE

Study summary document link (including results):

View full study record

Document reference: 30778

Study title: Mariano A, Rocha MM Oral itraconazole in the treatment of dermatomycoses. Clinical summary on R51211, August 1987. (10-84 years, LMD56450)Mariano A, Rocha MM Oral itraconazole in the treatment of dermatomycoses. Clinical summary on R51211, August 1987. (10-84 years, LMD56450)

Active substance: ITRACONAZOLE

Study summary document link (including results):

View full study record

Document reference: 30792

Study title: Moens M, Van Meensel A, Willems W, Schuermans V, Cauwenbergh G. Combined analyses of adverse experiences and clinical laboratory data related to safety in patients treated with itraconazole for vulvovaginal candidosis, pityriasis versicolor, dermatomycoses, oral candidosis and fungal keratitis. Clinical research report on R051211 no-87, September 1987. (<15->65 years, LMD56766).Moens M, Van Meensel A, Willems W, Schuermans V, Cauwenbergh G. Combined analyses of adverse experiences and clinical laboratory data related to safety in patients treated with itraconazole for vulvovaginal candidosis, pityriasis versicolor, dermatomycoses, oral candidosis and fungal keratitis. Clinical research report on R051211 no-87, September 1987. (<15->65 years, LMD56766).

Active substance: ITRACONAZOLE

Study summary document link (including results):

View full study record

Document reference: 30817

Study title: Open-label, single-centre, active control (nystatin), four parallel group study.

Active substance: ITRACONAZOLE

Study summary document link (including results): LMD118956_Interventional_Itraconazole.xls

View full study record

Document reference: 47579

Study title: Panagiotidou D et al. A comparison of itraconazole and griseofulvin in the treatment of tinea corporis and tinea cruris: a double-blind study.The journal of international medical research 20, p.392-400, 1992. (17-70 years, LMD88424)Panagiotidou D et al. A comparison of itraconazole and griseofulvin in the treatment of tinea corporis and tinea cruris: a double-blind study.The journal of international medical research 20, p.392-400, 1992. (17-70 years, LMD88424)

Active substance: ITRACONAZOLE

Study summary document link (including results):

View full study record

Document reference: 30777

Study title: Panconesi E, Difonzo E Treatment of dermatophytoses and pityriasis versicolor with itraconazole. Reviews of infectious diseases 9 suppl.1, p.S109-S113, 1987. (15-45 years, LMD51772)Panconesi E, Difonzo E Treatment of dermatophytoses and pityriasis versicolor with itraconazole. Reviews of infectious diseases 9 suppl.1, p.S109-S113, 1987. (15-45 years, LMD51772)

Active substance: ITRACONAZOLE

Study summary document link (including results):

View full study record

Document reference: 30790

Study title: Pharmacokinetic study of itraconazole oral solution during chronic treatment in neutropenic children. (ITR-FRA-7)

Active substance: ITRACONAZOLE

Study summary document link (including results): LMD129355_Interventional_Itraconazole.xls

View full study record

Document reference: 45126

Study title: Phillips P, Graybill JR, Fetchick R, Dunn JF. Adrenal response to corticotropin during therapy with itraconazole. Antimicrobial agents and chemotherapy 31 (4), p.647-649, 1987. (7-72 years, LMD54302)Phillips P, Graybill JR, Fetchick R, Dunn JF. Adrenal response to corticotropin during therapy with itraconazole. Antimicrobial agents and chemotherapy 31 (4), p.647-649, 1987. (7-72 years, LMD54302)

Active substance: ITRACONAZOLE

Study summary document link (including results):

View full study record

Document reference: 30807

Study title: Rees T, Phillips R. Multicenter comparison of one-day oral therapy with fluconazole or itraconazole in vaginal candidiasis. International journal of gynecology and obstetrics 37 (suppl.), p.33-38, 1992. (17-68 years, LMD95334)Rees T, Phillips R. Multicenter comparison of one-day oral therapy with fluconazole or itraconazole in vaginal candidiasis. International journal of gynecology and obstetrics 37 (suppl.), p.33-38, 1992. (17-68 years, LMD95334)

Active substance: ITRACONAZOLE

Study summary document link (including results):

View full study record

Document reference: 30800

Study title: Repeated-dose pharmacokinetics of itraconazole in oral solution, 5 mg/kg once daily for two weeks, in infants and children.(ITR-INT-21)

Active substance: ITRACONAZOLE

Study summary document link (including results): LMD118873_Interventional_Itraconazole.xls

View full study record

Document reference: 45125

Study title: A NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL SULTAMICILLIN IN PEDIATRIC PATIENTS WITH MODERATE RESPIRATORY TRACT OR SKIN/SOFT TISSUE INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43020

Study title: A NON-COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL SULTAMICILLIN IN THE TREATMENT OF MODERATE PEDIATRIC INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43038

Study title: A PROSPECTIVE, RANDOMIZED, THIRD-PARTY BLINDED, PLACEBO CONTROLLED EVALUATION OF AMPICILLIN/SULBACTAM VERSUS CLINDAMYCIN AS ADJUNCTIVE TREATMENT FOR WOMEN EXPERIENCING PRETERM LABOR

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42944

Study title: A RANDOMIZED, OPEN LABEL, MULTICENTER TRIAL COMPARING ORAL SULTAMICILLIN 750 MG DAILY FOR 10 DAYS WITH AMOXICILLIN/CLAVULANIC 1500 MG DAILY FOR 10 DAYS FOR THE TREATMENT OF ACUTE EAR, NOSE AND THROAT INFECTIONS

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42919

Study title: A STUDY OF THE PENETRATION CHARACTERISTICS OF SULTAMICILLIN (CP-49,952) INTO THE MIDDLE EAR FLUID OF PEDIATRIC PATIENTS WITH CHRONIC SERIOUS OTITIS MEDIA.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42910

Study title: A THIRD PARTED BLINDED COMPARATIVE STUDY OF SULTAMICILLIN (CP-49,952) AND PENICILLIN V-K FOR THE ASSESSMENT OF SAFETY AND EFFICACY IN THE TREATMENT OF UPPER RESPIRATORY INFECTIONS IN PEDIATRIC PATIENTS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42926

Study title: A THIRD PARTY BLINDED COMPARATIVE STUDY OF SULTAMACILLIN (CP-49,952-15) AND PENICILLIN V-K FOR THE ASSESSMENT OF SAFETY AND EFFICACY IN THE TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42925

Study title: A THIRD PARTY BLINDED COMPARATIVE STUDY OF SULTAMICILLIN (CP-49,952-15) AND AMOXICILLIN FOR THE ASSESSMENT OF SAFETY AND EFFICACY IN THE TREATMENT LOWER RESPIRATORY TRACT INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43063

Study title: A THIRD PARTY BLINDED COMPARATIVE STUDY OF SULTAMICILLIN (CP-49,952-15) AND CECLOR FOR THE ASSESSMENT OF SAFETY AND EFFICACY IN THE TREATMENT OF LOWER RESPIRATORY TRACT INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43064

Study title: A THIRD PARTY BLINDED COMPARATIVE STUDY OF SULTAMICILLIN (CP-49,952-15) AND CLOXACILLIN FOR THE ASSESSMENT OF SAFETY AND EFFICACY IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42923

Study title: A THIRD PARTY BLINDED COMPARATIVE STUDY OF SULTAMICILLIN (CP-49,952) AND CLOXICILLIN FOR THE ASSESSMENT OF SAFETY AND EFFICACY IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS IN PEDIATRIC PATIENTS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42924

Study title: A THIRD PARTY BLINDED COMPARATIVE STUDY OF SULTAMICILLIN (CP-49,952) AND PENICILLIN V-K FOR THE ASSESSMENT OF SAFETY AND EFFICACY IN THE TREATMENT OF STREPTOCOCCAL PHARYNGITIS IN PEDIATRIC PATIENTS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42917

Study title: AN OPEN COMPARATIVE MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF STM VS. CEFACLOR IN THE TREATMENT OF ACUTE OTITIS MEDIA IN CHILDREN.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42997

Study title: AN OPEN COMPARATIVE STUDY OF THE SAFETY AND EFFICACY OF ORAL (STM 25-50MK)VS. ORAL AMOXYCILLIN (25-40 MK) IN THE TREATMENT OF MILD TO MODERATE UPPER RESPIRATORY TRACT INFECTIONS IN CHILDREN.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43004

Study title: AN OPEN COMPARATIVE STUDY TO COMPARE THE SAFETY AND EFFICACY OF A SINGLE ORAL DOSE OF SULTAMICILLIN VS DOUBLE STRENGTH OF TRIMETHOPRIM-SULF. TABLETS FOR UNCOMPLICATED LOWER URINARY TRACT INFECTIONS IN WOMEN.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 43019

Study title: AN OPEN MULTICENTER NON-COMPARATIVE SHORT TERM STUDY OF EFFICACY AND TOLERABILITY OF ORAL SULTAMICILLIN SUSPENSION IN THE TREATMENT OF UPPER AND LOWER RESPIRATORY TRACT INFECTIONS IN PEDIATRIC INPATIENTS/ OUTPATIENTS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42990

Study title: AN OPEN NON COMPARATIVE STUDY OF UNASYN ORAL (BRAND OF SULTAMICILLIN) IN VARIOUS INFECTIONS.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42975

Study title: AN OPEN NON-COMPARATIVE MULTICENTER STUDY ON THE EFFICACY AND TOLERABILITY OF SULTAMICILLIN (SULBACTAM/AMPICILLIN) IN THE TREATMENT OF PEDIATRIC PATIENTS WITH ACUTE OTITIS MEDIA.

Active substance: SULTAMICILLIN

Study summary document link (including results):

View full study record

Document reference: 42964

Study title: Saul A, Bonifaz A, Arias I Itraconazole in the treatment of superficial mycoses: an open trial of 40 cases. Reviews of infectious diseases 9 suppl.1, p.S100-S103, 1987. (13-74 years, LMD45549)Saul A, Bonifaz A, Arias I Itraconazole in the treatment of superficial mycoses: an open trial of 40 cases. Reviews of infectious diseases 9 suppl.1, p.S100-S103, 1987. (13-74 years, LMD45549)

Active substance: ITRACONAZOLE

Study summary document link (including results):

View full study record

Document reference: 30796

Study title: Thomas PA, Abraham DJ, Kalavathy CM, Rajasekaran J. Oral itraconazole therapy in keratomycosis. March 1986. (5-60 years, LMD45894)Thomas PA, Abraham DJ, Kalavathy CM, Rajasekaran J. Oral itraconazole therapy in keratomycosis. March 1986. (5-60 years, LMD45894)

Active substance: ITRACONAZOLE

Study summary document link (including results):

View full study record

Document reference: 30804

Study title: Thomas PA, Kalavathy CM, Abraham DJ, Rajasekaran J. Combined oral and topical itraconazole therapy in the treatment of keratomycosis. August 1986. (13-55 years, LMD51269)Thomas PA, Kalavathy CM, Abraham DJ, Rajasekaran J. Combined oral and topical itraconazole therapy in the treatment of keratomycosis. August 1986. (13-55 years, LMD51269)

Active substance: ITRACONAZOLE

Study summary document link (including results):

View full study record

Document reference: 30805

Study title: Van Peer A, Van de Velde V, Heykants J, Woestenborghs R, Meuldermans W, Cauwenbergh G. Itraconazole pharmacokinetics in healthy volunteers and patients. A review of the data available until August '90. Clinical Research report on R051211 no-79, revised August 1990. (4-78 years, LMD74817)Van Peer A, Van de Velde V, Heykants J, Woestenborghs R, Meuldermans W, Cauwenbergh G. Itraconazole pharmacokinetics in healthy volunteers and patients. A review of the data available until August '90. Clinical Research report on R051211 no-79, revised August 1990. (4-78 years, LMD74817)

Active substance: ITRACONAZOLE

Study summary document link (including results):

View full study record

Document reference: 30813

Study title: Viviani MA, Van de Velde V, Cilli P, Van de Poel S, Van Peer A, Woestenborghs R, Heykants J, Cauwenbergh G. Pharmacokinetics of itraconazole in patients with systemic mycoses. Clinical research report on R051211 no-112, January 1990. (4-66 years, LMD67873)Viviani MA, Van de Velde V, Cilli P, Van de Poel S, Van Peer A, Woestenborghs R, Heykants J, Cauwenbergh G. Pharmacokinetics of itraconazole in patients with systemic mycoses. Clinical research report on R051211 no-112, January 1990. (4-66 years, LMD67873)

Active substance: ITRACONAZOLE

Study summary document link (including results):

View full study record

Document reference: 30809

Study title: Wishart JM. The influence of food on the pharmacokinetics of itraconazole in patients with superficial fungal infection. Journal of the american academy of dermatology 17 (2) (part 1), p.220-223, 1987. (13-64 years, LMD49681)Wishart JM. The influence of food on the pharmacokinetics of itraconazole in patients with superficial fungal infection. Journal of the american academy of dermatology 17 (2) (part 1), p.220-223, 1987. (13-64 years, LMD49681)

Active substance: ITRACONAZOLE

Study summary document link (including results):

View full study record

Document reference: 30808

Study title: STUDY TO ASSESS THE PHARMACOKINETICS OF A SINGLE ORAL OR INTRAVENOUS DOSE OF FLUCONAZOLE ADMINISTERED TO FULL TERM NEONATES

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27705

Study title: SYSTEMIC TREATMENT OF INTRACTABLE ONYCHOMYCOSIS WITH FLUCONAZOLE.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27493

Study title: SYSTEMIC TREATMENT OF INTRACTABLE ONYCHOMYCOSIS WITH FLUCONAZOLE.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27857

Study title: THE PHARMACOKINETICS OF FCA DURING HEMODIALYSIS IN PATIENTS WITH CHRONIC RENAL DYSFUNCTION.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27503

Study title: THE PHARMACOKINETICS OF FCA DURING HEMODIALYSIS IN PATIENTS WITH CHRONIC RENAL DYSFUNCTION.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27867

Study title: THREE OPEN COMPARATIVE STUDIES OF THE EFFICAY AND SAFETY OF FLUCONAZOLE AND KETOCONAZOLE, ITRACONAZOLE OR CLOTRIMAZOLE IN THE TREATMENT OF PATIENTS WITH PITYRIASIS VERSICOLOR

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27578

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27461

Study title: Acute oral toxicity of compound HOE 296 for neonatal rats - F.R Springman et al. - 6/02/1976 (Hoescht AG) - Publication in Part III -

Active substance: CICLOSPORIX

Study summary document link (including results):

View full study record

Document reference: 24123

Study title: Avaliacao clinica de um novo antimicotico, piridonico topico, HOE 296, em dermatofitoses - Clinical evaluation of a new topical pyridonium antimycotic, HOE 296, in dermatophytoses -L.N. Ermetice et al. - 1973 (Rev bras. Clin Ter vol 2) - Publication in Part Clinical documentation Batrafen Losung -No author-11/1999 -

Active substance: CICLOSPORIX

Study summary document link (including results):

View full study record

Document reference: 24134

Study title: Behandlung bakteriell superinfizierter hautpilzerkrankungen - K. Jablonski - 1987 (Kassenartz vol 27) - Publication in clinical studies (volume 6) -

Active substance: CICLOSPORIX

Study summary document link (including results):

View full study record

Document reference: 24135

Study title: Behandlung von schimmelpliz-mykosen mit iclopiroxolamin - B. Deichmann - 1986 (Schwerpunktmedizin vol 9) - Publication in Part clinical documentation- Batrafen Losung Study CIOMS - No author -11/ 1999 -

Active substance: CICLOSPORIX

Study summary document link (including results):

View full study record

Document reference: 24136

Study title: Bericht über eine doppleblind-studie mit HOE 296 -creme - und canesten- creme (clotrimazol) - W. Adam et al. - 03/03/1978 - Publication in clinical studies (volume 6) -

Active substance: CICLOSPORIX

Study summary document link (including results):

View full study record

Document reference: 24124

Study title: Breite Praxis-Prufung (Phase III) mit HOE 296 (Ciclopirox -olamin) - H.G.Peil - No date - Publication in Part IV volume 3 - Batafren creme, Batafren Vaginalcreme, Batafren Duo klinische prufung -

Active substance: CICLOSPORIX

Study summary document link (including results):

View full study record

Document reference: 24137

Study title: Childhood white superficial onychomycosis caused by Trichophyton rubrum: Repor tof seven cases and review of the literature, Tanusin Ploysangam, Anne W. Lucky, J Am Acad Dermatol, 1997;36:29 32

Active substance: CICLOSPORIX

Study summary document link (including results):

View full study record

Document reference: 24138

Study title: Ciclopiroxolamin bei der Behandlundg von dermatomykosenbei kindern - E. Briscik et al. - 1988 (Min Ped vol 40) - Publication in Part clinical documentation- Batrafen Losung Study CIOMS - No author -11/ 1999 -

Active substance: CICLOSPORIX

Study summary document link (including results):

View full study record

Document reference: 24139

Study title: Clinical results with the Antimycotic agent ciclopirox olamine - W. Adam et al. - No date - Publication in clinical studies (volume 6) -

Active substance: CICLOSPORIX

Study summary document link (including results):

View full study record

Document reference: 24140

Study title: Clinical study of HOE 296 Solution in Trichophytia Superficialis- Espesially on systemic Influence after application - S. Yoshida - 1975 (Clinical Medecine vol 17) - Publication in Part clinical documentation- Batrafen Losung Study CIOMS- No author - 11/ 1999 -

Active substance: CICLOSPORIX

Study summary document link (including results):

View full study record

Document reference: 24125

Study title: Clinical trial with ciclopirox vaginal cream in vulvovaginal candidiasis - José Leal de Queiroz et al . - september 1990 - Publication in Part clinical documentation - Batrafen Losung Study CIOMS - No author - 11/ 1999 -

Active substance: CICLOSPORIX

Study summary document link (including results):

View full study record

Document reference: 24141

Study title: Clinical/statistical report for ciclopirox olamine ( Loprox, HOE296) - Humberto Bogaert et al. - No date - Publication in clinical studies ( volume 4)- a double blind multicentre parallel study group comparing ciclopirox olamine 1% cream and vehicle, cream base in the subjects with Tinea corporis or Tinea cruris - No author - 08/1988 -

Active substance: CICLOSPORIX

Study summary document link (including results):

View full study record

Document reference: 24142

Study title: Consideracoes terapeuticas sobre o uso de um novo antimicotico piridonico, o HOE 296, no tratamento topico de dermatofitoses - Therapeutical considerations about the use of a new piridonic antimycotic, HOE 296, in the topical treatment of dermatophytoses - Jarbas Porto et al. - 1974 (Rev Bras Clin Ter vol 3, n°10, suppl 7) - Publication in Part clinical Documentation Batrafen Losung- No author - 11/1999 -

Active substance: CICLOSPORIX

Study summary document link (including results):

View full study record

Document reference: 24145

Study title: Dopplelblind - Vergleichsstuddie mit Ciclopiroxolamin-und Plazebo -Creme bei dermatophytosen - T Fredriksson et al.- 1981 (Arzneim. Forsch/ Drug Res ) - Publication in clinical studies (volume 6) -

Active substance: CICLOSPORIX

Study summary document link (including results):

View full study record

Document reference: 24146

Study title: Double blind comparative study of 1% cicloprirox olamine (Batrafen) powder vs 2% Miconazole nitrate (Daktarin) powder in patients suffering from tinea pedis - F. Arreaza et al. - May 1991 - Publication in Part I -Expert report on clinical documentation- H

Active substance: CICLOSPORIX

Study summary document link (including results):

View full study record

Document reference: 24147

Active substance: CICLOSPORIX

Study summary document link (including results):

View full study record

Document reference: 24148

Study title: Empleo de HOE 296 (ciclopirox) en micosis superficiales - Dr Mario Magana Lorenzo - 1976 (Sem Med (Mex) vol 88) - Publication in Part Clinical documentation Batrafen Losung - No author - 11/1999 -

Active substance: CICLOSPORIX

Study summary document link (including results):

View full study record

Document reference: 24149

Study title: Emprego de novo antimicotico, HOE-296, no tratamento topico de micoses superficiais - A.F Defina et al. -1973 (Rev bras. Clin Ter vol 2) - Publication in Part Clinical documentation Batrafen Losung -No author - 11/1999 -

Active substance: CICLOSPORIX

Study summary document link (including results):

View full study record

Document reference: 24150

Study title: A SINGLE-BLIND (EVALUATOR BLIND) COMPARATIVE STUDY OF ORAL CLINDAMYCIN HYDROCHLORIDE 300 MG BID COMPARED AGAINST ORAL AUGMENTIN 1G BID IN THE TREATMENT OF ACUTE RECURRENT TONSILLITIS/PHARYNGITIS DUE TO GROUP A-B HEMOLYTIC STREPTOCOCCI. A MULTINATIONAL MUL

Active substance: CLINDAMYCIN

Study summary document link (including results): 251F-INF-9052-0280 EMA Pediatrics Web Synopsis.pdf

View full study record

Document reference: 24363

Study title: A STUDY TO COMPARE THE EFFICACY AND TOLERANCE OF CLINDAMYCIN WITH ERYTHROMYCIN IN THE TREATMENT OF FEMALES WITH CONFIRMED CHLAMYDIA TRACHOMARIS CERVICITIS

Active substance: CLINDAMYCIN

Study summary document link (including results): M11200134 EMA Pediatrics Web Synopsis.pdf

View full study record

Document reference: 24373

Study title: COMPARATIVE EFFICACY AND TOLERANCE OF CLEOCIN T GEL VERSUS ORAL MINOCYCLINE IN THE TREATMENT OF ACNE VULGARIS (PROTOCOL M/1112/0005)

Active substance: CLINDAMYCIN

Study summary document link (including results): M11120005 EMA Pediatrics Web Synopsis.pdf

View full study record

Document reference: 24372

Study title: COMPARATIVE EVALUATION OF CLINDAMYCIN VS CLINDAMYCIN PLUS TOBRAMYCIN IN THE TREATMENT OF PELVIC INFLAMMATORY DISEASE

Active substance: CLINDAMYCIN

Study summary document link (including results): M11000093 EMA Pediatrics Web Synopsis.pdf

View full study record

Document reference: 24368

Study title: DOUBLE-BLIND RANDOMIZED COMPARISON OF 2% CLINDAMYCIN VAGINAL CREAM VS ORAL METRONIDAZOLE CAPSULES FOR THE TREATMENT OF BACTERIAL VAGINOSIS

Active substance: CLINDAMYCIN

Study summary document link (including results):

View full study record

Document reference: 24367

Study title: EFFICACY & SAFETY OF DALACIN C (CLINIDAMYCIN) IN ACUTE OR RECURRENT PHARYNGO-TONSILLITIS

Active substance: CLINDAMYCIN

Study summary document link (including results): CLIND-9052-285-INDIA EMA Pediatrics Web Synopsis.pdf

View full study record

Document reference: 24366

Study title: INTERIM REPORT OF AN ON-GOING NON-COMPARATIVE INTERNATIONAL MULTICENTRE STUDY OF CEFOPERAZONE NA IN THE TREATMENT OF ORTHOPEDIC SURGICAL AND GENERAL MEDICAL INFECTIONS.

Active substance: CLINDAMYCIN

Study summary document link (including results):

View full study record

Document reference: 24358

Study title: INTERIM REPORT OF AN ON-GOING NON-COMPARATIVE MULTICENTRE STUDY OF CEFOPERAZONE NA IN THE TREATMENT OF SKIN AND SKIN STRUCTURE INFECTIONS.

Active substance: CLINDAMYCIN

Study summary document link (including results):

View full study record

Document reference: 24359

Study title: OPEN LABEL COMPARATIVE, RANDOMIZED STUDY ASSESSING USEFULNESS OF RAPID MICROBIOLOGICAL DIAGNOSTICS IN PATIENTS WITH TONSILLITIS/PHARYNGITIS TREATED WITH CLINDAMYCIN

Active substance: CLINDAMYCIN

Study summary document link (including results):

View full study record

Document reference: 24364

Study title: PHASE IV CLINICAL STUDY OF CLINDAMYCIN PHAOSPHATE TOPICAL GEL IN THE TREATMENT OF ACNE VULGARIS

Active substance: CLINDAMYCIN

Study summary document link (including results):

View full study record

Document reference: 24365

Study title: TO INVESTIGATE THE SAFETY AND EFFICACY OF A SINGLE ORAL DOSE OF FCA 150 MG CAPS FOR THE TX OF WOMEN WITH VAGINAL CANDIDIASIS

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 28045

Study title: TO MAKE FLUCONAZOLE AVAILABLE FOR USE IN PATIENTS WITH NON-LIFE THREATENING MYCOSES, WHO CANNOT BE TREATED ADEQUATELY WITH AVAILABLE AGENTS. ALSO SAFETY AND EFFICACY OF DRUG. THIS PROTOCOL NUMBER ORIGINALLY WAS FCA-BRA-90-002C.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27383

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27748

Study title: TO MAKE FLUCONAZOLE AVAILABLE IN PATIENTS WITH CRYPTOCOCCAL MENINGITIS WHO CANNOT BE TREATED ADEQUATELY WITH AVAILABLE AGENTS. ALSO SAFETY AND EFFECTIVENESS OF THE DRUG. THIS PROTOCOL NUMBER WAS ORIGINALLY FCA-BRA-90-002A.

Active substance: FLUCONAZOLE

Study summary document link (including results):

View full study record

Document reference: 27381

Study title: multicentre study of the efficacy and tolerability of clotrimazole 10% vaginal cream in the treatment of vaginal candidosis

Active substance: CLOTRIMAZOLE

Study summary document link (including results): Bayer CC_Clotrimazole_0524_study_synopsis.pdf

View full study record

Document reference: 24447

Study title: safety and efficacy of bay b 5097 2vaginal cream in 3-day treatment as compared with 7-day treatment with econazole cream (gyno-pevaryl cream).

Active substance: CLOTRIMAZOLE

Study summary document link (including results): Bayer CC_Clotrimazole_0583_study_synopsis.pdf

View full study record

Document reference: 24454

Select Country:	Select Age Range:
Select Trial Status:	Select Trial Phase:
Select Gender:
Select Date Range: to
Select Rare Disease:
IMP with orphan designation in the indication
Orphan Designation Number:
Results Status:
Clear advanced search filters

Austria
Belgium
Bulgaria
Croatia
Cyprus
Czechia
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
United Kingdom
Outside EU/EEA

Clinical trials for Myc